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ABSTRACT	  Epigenetics	  inheritance	  is	  a	  phenomenon	  where	  a	  cell	  state	  is	  inherited	  across	  cellular	  divisions.	  It	  is	  important	  for	  maintaining	  differentiated	  cells	  types,	  and	  thus	  is	  fundamental	  to	  the	  development	  of	  multicellular	  organisms.	  Failure	  in	  the	  system	  can	  lead	  to	  deleterious	  effects	  that	  range	  from	  embryonic	  lethality	  to	  the	  development	  of	  diseases	  such	  as	  cancer.	  	  The	  Polycomb	  group	  (PcG)	  proteins	  are	  important	  regulators	  of	  epigenetic	  inheritance:	  they	  maintain	  the	  repression	  of	  the	  Hox	  genes,	  which	  specify	  the	  body	  axes	  of	  an	  organism,	  throughout	  development	  and	  into	  adulthood.	  The	  loss	  of	  function	  of	  PcG	  genes	  therefore	  leads	  to	  homeotic	  transformations.	  A	  mechanistic	  understanding	  of	  PcG	  function	  will	  yield	  insight	  into	  the	  mechanisms	  involved	  in	  epigenetics	  inheritance.	  	  The	  Polycomb	  Repressive	  Complex	  1	  (PRC1)	  is	  able	  to	  inhibit	  chromatin	  remodeling	  and	  compact	  polynucleosomes	  in	  vitro;	  these	  activities	  could	  represent	  how	  stable	  gene	  repression	  is	  achieved	  in	  vivo.	  However,	  it	  has	  been	  difficult	  to	  determine	  the	  biological	  relevance	  of	  these	  activities	  because	  the	  nature	  of	  nucleosomal-­‐level	  compaction	  in	  the	  nucleus	  is	  unknown	  and	  there	  is	  no	  direct	  assay	  for	  it.	  	  To	  circumvent	  this	  problem,	  we	  adopted	  an	  approach	  where	  we	  introduced	  into	  mouse	  embryonic	  stem	  cells	  (mESCs)	  and	  mice	  the	  mutations	  that	  disrupt	  the	  in	  vitro	  activities.	  The	  mutations	  are	  specific	  lysine-­‐to-­‐alanine	  and	  arginine-­‐to-­‐alanine	  substitutions	  in	  a	  positively	  charged	  domain	  of	  the	  CBX2	  subunit	  of	  PRC1.	  These	  are	  known	  to	  disrupt	  
	   	   	  	  
	  	  	   iv	  
PRC1	  polynucleosmal	  compaction	  activities	  from	  previous	  studies.	  	  We	  compared	  the	  mutant	  mESCs	  and	  mice	  to	  wild	  type	  counterparts	  for	  PcG-­‐related	  phenotypes.	  	  We	  observed	  that	  the	  mutations	  prevented	  the	  repression	  of	  CBX2	  (also	  PRC1)	  target	  genes	  in	  mESCs.	  They	  did	  not	  prevent	  CBX2	  from	  forming	  PRC1	  or	  binding	  to	  chromatin.	  This	  suggests	  that	  the	  in	  vitro	  activities	  are	  specifically	  involved	  in	  inhibiting	  transcription.	  Moreover,	  we	  observed	  that	  the	  Cbx2	  mutant	  mice	  exhibit	  the	  classic	  PcG	  phenotype,	  which	  is	  homeotic	  transformation	  in	  the	  anterior-­‐posterior	  axis.	  The	  posterior	  transformations	  are	  similar	  to	  those	  observed	  in	  the	  Cbx2-­‐/-­‐	  mice,	  indicating	  that	  our	  mutations	  mimic	  loss-­‐of-­‐function	  of	  Cbx2.	  Notably,	  the	  Cbx2-­‐/-­‐	  mice	  had	  other	  phenotypes	  in	  addition	  to	  the	  PcG	  phenotype,	  which	  we	  did	  not	  observe	  in	  our	  mutants.	  This	  indicates	  that	  the	  mutations	  in	  the	  compaction	  domain	  of	  CBX2	  specifically	  disrupted	  a	  PcG	  function	  during	  development.	  	  These	  experimental	  outcomes	  are	  consistent	  with	  the	  hypothesis	  that	  the	  in	  vitro	  compaction	  activity	  of	  PRC1	  is	  important	  for	  how	  heritable	  gene	  repression	  can	  be	  achieved	  
in	  vivo.	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  Jason	  West,	  who	  worked	  hard	  to	  set	  up	  the	  mouse	  protocol;	  Sharon	  Marr,	  whose	  help	  with	  genotyping	  spared	  me	  from	  doing	  PCRs	  all	  day	  long.	  	  
I	  have	  the	  good	  fortune	  of	  meeting	  many	  wonderful	  people	  who	  stood	  with	  me	  through	  the	  good	  and	  bad	  times	  of	  graduate	  school:	  Papa	  Jerry	  and	  Mama	  Judy	  Ball,	  Pastors	  
	   	   	  	  
	  	  	   xi	  
Chris	  and	  Ishtar	  Gleason,	  Jofeanne	  Gaco	  and	  Raquel	  Mota-­‐Hays.	  I	  believe	  I	  will	  only	  know	  the	  full	  impact	  of	  your	  prayers	  and	  intercessions	  for	  me	  in	  Heaven.	  	  
I	  must	  also	  mention	  my	  parents	  Weng	  Ann	  Lau	  and	  Lung	  Meng	  Tang,	  and	  my	  brothers	  John	  and	  Henry	  Lau,	  who	  have	  not	  ceased	  to	  show	  their	  love	  and	  care	  for	  me	  in	  spite	  of	  the	  12	  to	  13	  hour	  time	  difference	  and	  immense	  physical	  distance	  between	  us.	  	  
Finally,	  I	  want	  to	  give	  all	  glory	  to	  my	  Lord	  and	  Savior	  Jesus	  Christ.	  Again	  and	  again,	  He	  has	  proven	  to	  me	  that	  He	  is	  El	  Shaddai,	  God	  Almighty.	  There	  is	  nothing	  too	  hard	  and	  too	  wonderful	  for	  Him.	  	  
	  
	  
“Blessed	  is	  the	  man	  (woman)…	  
who	  delights	  in	  the	  law	  of	  the	  LORD.	  
He	  (She)	  is	  like	  a	  tree	  
planted	  by	  streams	  of	  water	  
that	  yields	  its	  fruit	  in	  its	  season,	  
and	  its	  leaf	  does	  not	  wither.	  
In	  all	  that	  he	  (she)	  does,	  he	  (she)	  prospers.	  “	  
	  -­‐Psalm	  1:1-­‐3	  	  	   	  	  
	  CHAPTER	  1	  	  	  
INTRODUCTION	  
	  
Epigenetic	  inheritance	  	  
The	  formation	  of	  a	  multicellular	  organism	  during	  embryogenesis	  is	  a	  fascinating	  process.	  A	  single	  fertilized	  egg	  undergoes	  repeated	  rounds	  of	  cellular	  division,	  and	  the	  daughter	  cells	  become	  progressively	  specified,	  committed	  and	  eventually	  fully	  differentiated	  into	  the	  diverse	  cell	  types	  that	  make	  the	  organism.	  Cellular	  division	  and	  differentiation	  occur	  concurrently,	  which	  necessitates	  that	  an	  acquired	  cell	  fate	  to	  be	  passed	  on	  to	  the	  daughter	  cells.	  	  The	  signals	  that	  induce	  cell	  fate	  specification	  during	  embryogenesis	  are	  often	  transient,	  yet	  the	  cell	  fates	  are	  maintained	  throughout	  the	  developmental	  process	  and	  life	  of	  the	  organism.	  This	  implies	  that	  there	  are	  cellular	  memory	  mechanisms	  in	  place	  that	  allow	  acquired	  cell	  states	  to	  be	  maintained	  in	  the	  absence	  of	  external	  signals	  and	  to	  be	  propagated	  through	  cellular	  divisions.	  This	  cellular	  memory	  is	  a	  form	  of	  epigenetic	  inheritance.	  	  Many	  cell	  fates	  are	  determined	  through	  the	  activation	  and	  repression	  of	  specific	  gene	  networks	  in	  the	  cell.	  Epigenetic	  inheritance	  thus	  involves	  maintaining	  the	  gene	  expression	  patterns	  that	  have	  been	  established.	  The	  Polycomb	  group	  (PcG)	  genes	  are	  a	  class	  of	  regulators	  that	  are	  important	  in	  this	  process.	  	  The	  stability	  of	  a	  cell	  fate	  is	  clearly	  important.	  Mutations	  in	  the	  components	  that	  regulate	  this	  process,	  including	  the	  in	  the	  PcG	  genes,	  lead	  to	  developmental	  defects,	  some	  of	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which	  are	  embryonic	  lethal.	  Mutations	  in	  these	  components	  in	  adult	  tissues	  are	  associated	  with	  a	  wide	  range	  of	  cancers1.	  Therefore,	  understanding	  the	  mechanism	  of	  epigenetic	  inheritance	  is	  a	  central	  problem	  in	  biology.	  This	  dissertation	  focuses	  on	  the	  roles	  of	  the	  PcG	  genes	  as	  epigenetic	  regulators,	  specifically	  on	  their	  function	  in	  achieving	  heritable	  gene	  repression.	  
PcG	  genes	  are	  epigenetic	  regulators	  that	  are	  widely	  conserved	  The	  PcG	  genes	  are	  epigenetic	  regulators	  because	  they	  are	  required	  for	  maintaining	  
Hox	  gene	  repression	  in	  specific	  body	  segments	  throughout	  embryogenesis	  and	  in	  adulthood2,3.	  The	  Hox	  genes	  encode	  a	  class	  of	  transcription	  factors	  whose	  collective	  activity	  is	  an	  important	  determinant	  of	  the	  anterior-­‐posterior	  axis	  in	  almost	  all	  metazoans4,5.	  The	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Figure	  1.1	  	  Spatial	  and	  functional	  collinearity	  of	  the	  Hox	  genes.	  




BX-­‐C	  ANT-­‐C	  3’	   5’	  
3
posterior	  axis3,4.	  Through	  examining	  PcG	  mutant	  embryos	  at	  early	  and	  later	  stages	  of	  development,	  it	  was	  found	  that	  the	  Hox	  gene	  boundaries	  were	  appropriately	  set	  up	  but	  spread	  into	  more	  anterior	  segments	  in	  the	  later	  embryo2,9.	  This	  indicated	  that	  PcG	  genes	  are	  required	  to	  prevent	  ectopic	  Hox	  gene	  expression	  to	  maintain	  the	  pattern	  that	  was	  established	  during	  early	  development.	  Hence,	  PcG	  genes	  are	  epigenetic	  regulators	  that	  maintain	  gene	  repression.	  	  The	  PcG	  consists	  of	  many	  members;	  of	  particular	  relevance	  to	  this	  dissertation	  are	  Polycomb	  (Pc),	  Posterior	  sex	  comb	  (Psc),	  Polyhomeotic	  (Ph)	  and	  Sex	  
comb	  extra	  (Sce).	  	  	   Homologs	  to	  the	  fly	  PcG	  genes	  have	  been	  identified	  in	  animals	  and	  plants	  by	  virtue	  of	  sequence	  identities	  in	  the	  genes,	  the	  presence	  of	  conserved	  protein	  domains	  and/or	  functional	  conservation.	  In	  mammals,	  the	  earliest	  PcG	  genes	  known	  were	  the	  homologs	  to	  
Pc,	  Cbx2	  (also	  known	  as	  M33),	  the	  homologs	  to	  Psc,	  Bmi-­‐1	  and	  its	  paralog	  Mel-­‐18,	  and	  the	  homolog	  to	  Ph,	  Phc1	  (also	  known	  as	  Mph1)10-­‐13.	  Knockout	  mouse	  mutants	  of	  Cbx2,	  Bmi-­‐1,	  
Mel-­‐18	  and	  Phc1	  all	  lead	  to	  posterior	  transformation	  in	  the	  axial	  skeleton,	  suggesting	  that	  PcG	  regulation	  of	  the	  Hox	  genes	  during	  development	  is	  conserved	  between	  flies	  and	  mice.	  As	  in	  the	  case	  for	  the	  fly	  mutants,	  the	  posterior	  transformations	  in	  the	  mice	  were	  accompanied	  by	  anterior	  shifts	  the	  expression	  boundaries	  of	  several	  Hox	  genes.	  	  In	  addition,	  the	  expression	  of	  mouse	  Cbx2	  can	  partially	  rescue	  the	  Pc	  mutant	  phenotype	  in	  transgenic	  flies14.	  These	  observations	  imply	  that	  the	  molecular	  mechanism	  for	  epigenetic	  repression	  by	  PcG	  is	  widely	  conserved.	  	  	   The	  mammalian	  PcG	  system,	  however,	  is	  much	  more	  complex	  than	  its	  fly	  counterpart.	  There	  are	  multiple	  homologs	  for	  almost	  every	  fly	  PcG	  gene15,16.	  The	  paralogs	  have	  homologous	  domains	  and	  variable	  domains,	  and	  they	  tend	  to	  be	  differentially	  regulated	  during	  embryogenesis17,18.	  This	  suggests	  that	  they	  have	  both	  common	  and	  non-­‐overlapping	  functions.	  Indeed,	  knockout	  mutants	  of	  different	  paralogs	  have	  shared	  and	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distinct	  phenotypes.	  For	  example,	  Bmi-­‐/-­‐	  and	  Mel-­‐18-­‐/-­‐	  	  mice	  both	  have	  posterior	  transformations	  that	  corresponded	  to	  anterior	  shifts	  in	  Hox	  expression,	  but	  only	  Bmi-­‐/-­‐	  exhibited	  neurological	  abnormalities	  while	  Mel-­‐18-­‐/-­‐	  	  had	  intestinal	  defects	  11,12.	  Of	  note,	  the	  distinct	  phenotypes	  many	  or	  may	  not	  be	  related	  to	  the	  PcG	  function.	  In	  some	  instances,	  knocking-­‐out	  certain	  mammalian	  PcG	  homologs	  do	  not	  lead	  to	  anterior-­‐posterior	  transformations,	  for	  example	  in	  Cbx7-­‐/-­‐	  and	  Cbx8-­‐/-­‐,	  even	  though	  the	  molecular	  evidence	  (e.g.	  protein-­‐protein	  interactions	  and	  chromatin	  binding	  sites)	  strongly	  suggests	  that	  they	  are	  members	  of	  the	  PcG	  system19-­‐22.	  The	  absence	  of	  phenotype	  could	  be	  due	  to	  functional	  redundancy	  from	  another	  paralog,	  or	  that	  the	  molecular	  features	  commonly	  associated	  with	  PcG	  may	  not	  always	  be	  related	  to	  PcG	  function.	  Therefore,	  studying	  the	  mammalian	  PcG	  system	  has	  its	  additional	  challenges.	  	  	   In	  view	  of	  the	  integral	  role	  that	  PcG	  genes	  play	  in	  cell	  fate	  maintenance	  across	  species,	  an	  understanding	  of	  the	  mechanistic	  details	  of	  their	  activities	  will	  prove	  insightful	  to	  how	  cell	  fates	  are	  stabilized	  and	  propagated	  through	  cellular	  divisions.	  In	  the	  following	  sections,	  we	  review	  the	  molecular	  characterization	  of	  the	  PcG	  gene	  products.	  	  














	   Several	  early	  observations	  in	  flies	  had	  suggested	  that	  the	  PcG	  proteins	  exert	  their	  gene	  silencing	  effects	  through	  modulating	  chromatin.	  PcG	  proteins	  localized	  at	  many	  discrete	  loci	  on	  polytene	  chromatin	  from	  fly	  salivary	  glands.	  These	  sites	  included	  their	  known	  target	  genes,	  the	  Hox	  genes	  in	  the	  Antennapedia	  (ANT-­‐C)	  and	  Bithorax	  Complexes	  (BX-­‐C).	  The	  overexpression	  and	  loss-­‐of-­‐function	  of	  PcG	  genes	  lead	  to	  enhanced	  polytene	  chromosome	  condensation	  and	  decondensation,	  respectively23,24.	  	  	  	   The	  fly	  PC	  protein	  is	  a	  core	  component	  of	  PRC1	  and	  has	  an	  N-­‐terminal	  domain	  (later	  named	  ‘chromodomain’)	  that	  resembled	  the	  chromatin-­‐binding	  domain	  of	  Heterochromatin	  Protein	  1	  (HP1)25.	  HP1	  is	  important	  for	  position	  effect	  variegation	  (PEV).	  It	  associates	  with	  heterochromatin,	  which	  appears	  as	  dense	  structures	  under	  the	  light	  microscope.	  As	  PEV	  also	  involves	  propagating	  a	  repressed	  transcriptional	  state	  across	  cell	  divisions,	  it	  was	  thought	  that	  PC	  could	  maintain	  Hox	  gene	  repression	  through	  similarly	  creating	  higher	  order	  chromatin	  structures.	  While	  the	  chromodomain	  of	  HP1	  recognizes	  and	  binds	  to	  the	  trimethylated	  lysine	  9	  of	  histone	  H3	  (H3K9me3),	  the	  chromodomain	  of	  PC	  recognizes	  and	  binds	  to	  the	  trimethylated	  lysine	  27	  of	  histone	  H3	  (H3K27me3).	  H3K27me3	  is	  a	  mark	  that	  is	  deposited	  by	  PRC2.	  The	  localization	  sites	  PRC1,	  PRC2	  and	  H3K27me3	  on	  chromatin	  highly	  overlap	  genome-­‐wide26-­‐28.	  This	  led	  to	  a	  model	  where	  PRC2	  first	  tri-­‐methylates	  histone	  H3,	  which	  is	  recognized	  by	  the	  chromodomain	  of	  PC	  and	  thus	  recruits	  PRC1	  to	  the	  target	  genes.	  	  PRC1	  then	  inhibits	  transcription	  by	  its	  activities	  on	  the	  chromatin,	  as	  discussed	  in	  the	  next	  section.	  	  	  	   The	  PcG	  phenotype	  is	  suppressed	  by	  mutations	  in	  the	  trithorax	  group	  (trxG)	  genes29.	  The	  trxG	  group	  genes	  encode	  the	  subunits	  of	  SWI/SNF,	  an	  ATP-­‐dependent	  chromatin	  remodeler	  that	  is	  required	  for	  sustained	  Hox	  gene	  expression.	  The	  opposing	  functions	  of	  the	  PcG	  and	  trxG	  on	  Hox	  gene	  expression	  suggested	  that	  they	  have	  direct	  antagonistic	  effects	  on	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chromatin	  for	  creating	  prohibitive	  and	  permissive	  chromatin	  states,	  respectively,	  for	  transcription	  regulation.	  
Complementary	  approaches	  to	  understanding	  PcG-­‐mediated	  gene	  repression	  	   In	  view	  of	  the	  above	  observations,	  biochemical	  assays	  that	  aim	  to	  determine	  how	  PcG	  proteins	  might	  influence	  chromatin	  were	  developed.	  These	  assays	  were	  made	  possible	  by	  technical	  breakthroughs	  in	  two	  areas:	  firstly,	  the	  expression	  and	  purification	  of	  PRC1	  and	  PRC2	  subunits,	  and	  the	  reconstitution	  of	  the	  minimal	  complexes	  with	  recombinant	  proteins;	  secondly,	  the	  assembly	  of	  nucleosomes	  on	  DNA	  with	  specific	  nucleotide	  sequences	  that	  serve	  as	  in	  vitro	  chromatin	  template.	  The	  robustness	  of	  the	  assays	  had	  enabled	  investigators	  to	  isolate	  not	  only	  the	  subunits,	  but	  also	  identify	  the	  domain	  or	  the	  specific	  amino	  acid	  residues	  within	  the	  subunits,	  that	  are	  required	  for	  an	  activity.	  These	  studies	  provided	  insight	  into	  the	  mechanistic	  details	  of	  how	  PRC1	  and	  PRC2	  may	  influence	  their	  target	  genes	  in	  the	  nucleus.	  	  	   Nonetheless,	  the	  caveat	  to	  the	  biochemical	  assays	  is	  that	  they	  often	  involve	  non-­‐physiological	  conditions.	  For	  instance,	  an	  assay	  may	  involve	  non-­‐physiological	  salt	  conditions,	  which	  may	  generate	  protein	  behaviors	  that	  are	  non-­‐existent	  in	  vivo.	  Hence,	  their	  relevance	  must	  at	  least	  be	  tested	  in	  a	  cellular	  system	  with	  molecular	  assays.	  	  	   In	  a	  cellular	  system,	  transcriptional	  silencing	  of	  PcG	  protein-­‐bound	  genes	  is	  used	  as	  the	  readout	  for	  PcG	  function.	  Chromatin	  immunoprecipitation	  (ChIP)	  experiments	  followed	  by	  quantitative	  PCR	  (qPCR)	  or	  high	  throughput	  sequencing	  analyses	  are	  routinely	  used	  to	  identify	  the	  genes	  that	  are	  bound	  by	  a	  PcG	  protein	  of	  interest.	  Investigators	  perturb	  the	  system	  by	  depleting,	  overexpressing	  or	  mutating	  the	  PcG	  protein	  and	  assay	  for	  gene	  expression	  changes.	  As	  PcG	  proteins	  exist	  as	  multi-­‐subunit	  complexes	  in	  vivo,	  the	  depletion	  or	  overexpression	  of	  a	  PcG	  protein	  often	  affect	  other	  components	  of	  the	  complex	  (for	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example,	  see	  Ref.	  30)	  Hence,	  it	  is	  not	  possible	  to	  establish	  direct	  relationship	  between	  an	  activity	  and	  gene	  repression	  through	  these	  experiments.	  With	  the	  knowledge	  gained	  from	  biochemical	  and	  structural	  studies,	  once	  can	  selectively	  mutate	  the	  key	  residues	  required	  for	  the	  activity	  without	  disrupting	  the	  complex,	  thereby	  isolating	  the	  effect	  of	  the	  activity	  on	  PcG	  function.	  	  The	  test	  for	  the	  relevance	  of	  a	  biochemical	  activity	  in	  cells	  may	  or	  may	  not	  be	  straightforward.	  In	  the	  case	  of	  PRC2,	  its	  histone	  methyltransferase	  (HMTase)	  activity,	  which	  catalyzes	  the	  tri-­‐methylation	  of	  histone	  H3	  lysine	  27	  (H3K27me3),	  was	  readily	  assayed	  for	  in	  cells	  using	  antibodies	  and	  found	  to	  be	  associated	  with	  PcG	  repression31.	  	  Furthermore,	  the	  SET	  domain	  of	  E(z),	  which	  catalyzes	  the	  modification,	  is	  conserved	  and	  well-­‐described	  from	  previous	  studies.	  Through	  selective	  mutations	  at	  the	  critical	  residues	  that	  were	  identified	  by	  homology	  to	  other	  HMTase	  proteins,	  catalytic	  dead	  PRC2	  mutants	  were	  generated	  and	  found	  to	  have	  PcG	  phenotypes.	  Thus,	  for	  PRC2,	  the	  activity-­‐to-­‐function	  relationship	  was	  rapidly	  established.	  Non-­‐enzymatic	  activities,	  however,	  are	  more	  challenging	  to	  assay	  for	  in	  cells.	  Thus,	  it	  can	  be	  complicated	  to	  determine	  if	  they	  take	  place	  
in	  vivo	  and	  /or	  have	  biological	  functions.	  This	  is	  especially	  so	  if	  they	  involve	  protein	  regions	  with	  no	  apparent	  homology	  to	  other	  known	  proteins.	  The	  polynucleosome	  compaction	  activity	  of	  PRC1,	  which	  depends	  on	  an	  intrinsically	  unfolded	  region	  of	  CBX2,	  is	  one	  such	  example,	  which	  we	  will	  discuss	  in	  greater	  detail	  in	  the	  next	  section.	  	  Overall,	  we	  have	  gained	  much	  knowledge	  about	  the	  PcG	  system	  since	  the	  identification	  of	  the	  first	  PcG	  gene,	  Pc,	  in	  the	  year	  19478.	  This	  was	  through	  biochemical,	  molecular	  and	  genetic	  studies	  that	  provided	  complementary	  information.	  	  In	  the	  following	  section	  we	  describe	  three	  examples	  of	  PRC1	  activities	  and	  our	  current	  understanding	  of	  how	  they	  may	  contribute	  to	  the	  role	  of	  PRC1	  as	  an	  epigenetic	  gene	  repressor.	  Our	  focus	  is	  on	  the	  mammalian	  PRC1,	  though	  the	  activities	  are	  conserved	  in	  the	  fly	  PRC1.	  We	  will	  also	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highlight	  a	  key	  gap	  in	  the	  prevailing	  knowledge,	  which	  we	  aim	  to	  address	  with	  the	  research	  work	  presented	  in	  this	  dissertation.	  	  	  
Mechanisms	  of	  gene	  repression	  by	  PRC1	  	   PRC1	  consists	  of	  four	  core	  components,	  which	  are	  conserved	  between	  fly	  and	  mammals:	  an	  SCE	  homolog,	  a	  PSC	  homolog,	  a	  PC	  homolog	  and	  a	  PH	  homolog	  (Figure	  1.2)32,33.	  	  The	  subunits	  have	  distinct	  biochemical	  activities,	  which	  imply	  that	  the	  complex	  may	  repress	  its	  target	  genes	  through	  multiple	  mechanisms.	  It	  was	  observed	  that	  genes	  that	  are	  bound	  by	  all	  four	  PRC1	  core	  subunits	  in	  flies	  fall	  into	  two	  broad	  categories:	  Class	  I	  genes,	  which	  include	  the	  Hox	  genes,	  require	  all	  four	  components	  for	  repression,	  while	  Class	  II	  genes	  depend	  only	  on	  PSC	  and	  PH34.	  This	  indicates	  that	  there	  may	  be	  differential	  and	  synergistic	  regulation	  at	  different	  target	  genes.	  Here,	  we	  review	  the	  following	  three	  activities	  of	  PRC1:	  1. Histone	  H2A	  mono-­‐ubiquitination	  by	  the	  SCE/PSC	  homologs	  2. Chromatin	  organization	  by	  the	  PH	  homologs	  3. Nucleosomal-­‐level	  compaction	  by	  fly	  PSC	  and	  mammalian	  CBX2	  	  
1. Histone	  H2A	  mono-­‐ubiquitination	  by	  the	  SCE/PSC	  homologs	  	   Wang	  et.	  al	  (2004)	  discovered	  that	  the	  RING1B	  (or	  RING1A)/BMI-­‐1	  complex	  purified	  form	  HeLa	  cells	  is	  a	  E3	  ubiquitin	  ligase	  enzyme	  that	  mono-­‐ubiquitylates	  histone	  H2AK11935.	  This	  catalytic	  activity	  is	  conserved	  in	  the	  homologous	  fly	  SCE/PSC	  complex.	  The	  mono-­‐ubiquitynated	  histone	  H2A	  (H2AUb)	  is	  localized	  at	  the	  promoters	  of	  PRC1	  target	  genes	  in	  HeLa	  and	  fly	  S2	  cells.	  The	  depletion	  of	  Ring1B	  or	  SCE	  leads	  to	  loss	  of	  H2AUb	  and	  ectopic	  expression	  of	  the	  target	  genes.	  In	  addition,	  H2AUb	  is	  enriched	  on	  the	  inactive	  X-­‐chromosome36-­‐38.These	  observations	  suggested	  that	  H2AUb	  is	  involved	  in	  stable	  gene	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repression.	  Notably,	  the	  RING1B/BMI-­‐1	  enzymatic	  module	  is	  not	  exclusive	  to	  the	  canonical	  PRC1,	  but	  is	  also	  present	  in	  several	  PRC1-­‐like	  complexes	  such	  as	  BCOR	  and	  E2F6	  in	  mammals,	  and	  dRAF	  in	  flies	  (Figure	  1.2)16,39.	  	   The	  role	  of	  H2AUb	  in	  PRC1-­‐mediated	  repression	  is	  unclear.	  H2AUb	  was	  thought	  to	  be	  required	  for	  restraining	  poised	  RNA	  polymerases,	  at	  least	  on	  bivalent	  genes	  in	  mouse	  embryonic	  stem	  cells	  (mESCs)40.	  However,	  there	  is	  increasing	  evidence	  showing	  that	  it	  is	  mainly	  involved	  in	  PcG	  protein	  recruitment	  in	  mammals.	  Through	  using	  a	  de	  novo	  targeting	  assay	  in	  mESCs,	  two	  groups	  observed	  that	  H2AUb	  is	  required	  for	  PRC2,	  and	  thus	  H3K27me3,	  localization	  on	  target	  genes41,42.	  The	  H3K27me3	  in	  turn	  recruits	  canonical	  PRC1	  via	  interactions	  with	  its	  chromodomain-­‐containing	  subunit.	  As	  canonical	  PRC1	  also	  has	  the	  H2A	  ubiquitylating	  activity,	  it	  was	  proposed	  that	  this	  cascade	  of	  events	  forms	  a	  feedback	  loop	  that	  reinforces	  PRC1	  and	  PRC2	  binding	  to	  create	  a	  stable	  repressive	  domain.	  	  	   The	  protein	  complex	  that	  deposits	  the	  initiating	  H2AUb	  modifications,	  however,	  is	  a	  variant	  PRC1	  that	  contains	  Rybp	  and/or	  Kdm2b41,43.	  Unlike	  the	  canonical	  PRC1,	  the	  variant	  complex	  does	  not	  contain	  the	  PC	  and	  PH	  homolog	  subunits.	  It	  may	  also	  contain	  an	  alternative	  PSC	  homolog,	  PCGF1	  (Figure	  1.2).	  This	  is	  consistent	  with	  a	  previous	  finding	  where	  the	  depletion	  of	  a	  canonical	  PRC1	  component	  Bmi-­‐1	  does	  not	  affect	  H3K27me344.	  	  	   The	  variant	  PRC1	  does	  not	  appear	  to	  be	  directly	  involved	  in	  the	  classically	  defined	  functions	  of	  PRC1.	  In	  mESCs,	  genes	  that	  bound	  by	  the	  variant	  complex	  are	  moderately	  expressed;	  in	  contrast,	  those	  bound	  by	  the	  canonical	  PRC1	  are	  repressed45.	  In	  addition,	  the	  target	  genes	  of	  the	  variant	  complex	  are	  mainly	  metabolic	  and	  cell-­‐cycle	  regulators,	  whereas	  those	  of	  the	  canonical	  complex	  are	  lineage-­‐specific	  developmental	  regulators.	  Thus,	  it	  was	  unclear	  whether	  the	  H2A	  ubiquitylating	  activity	  of	  the	  RING1B/BMI-­‐1	  module	  is	  a	  critical	  function	  of	  canonical	  PRC1.	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   Two	  groups	  addressed	  this	  question	  by	  generating	  catalytic	  dead	  mutants	  of	  Ring1B	  and	  SCE	  in	  mammals	  and	  flies,	  respectively30,46.	  The	  targeted	  impairment	  of	  the	  E3	  ligase	  activity	  was	  achieved	  through	  an	  I53A	  substitution,	  which	  was	  shown	  by	  X-­‐ray	  crystallography	  to	  lie	  in	  the	  interface	  that	  binds	  the	  E2	  ubiquitin-­‐conjugating	  enzyme47.	  In	  both	  mice	  and	  flies,	  the	  catalytic	  function	  of	  Ring1B	  is	  dispensable	  for	  the	  repression	  of	  Hox	  genes	  and	  for	  proper	  anterior-­‐posterior	  patterning.	  Therefore,	  H2AUb	  is	  not	  required	  for	  the	  classic	  PcG	  function.	  The	  mutation,	  however,	  is	  embryonic	  lethal,	  which	  indicates	  H2AUb	  has	  other	  regulatory	  roles	  that	  remain	  to	  be	  explored.	  	  	   The	  study	  of	  histone	  H2A	  mono-­‐ubiquitination	  by	  Ring1B	  is	  thus	  an	  example	  of	  how	  PcG	  and	  non-­‐PcG	  functions	  of	  a	  protein	  can	  be	  dissected	  through	  combining	  biochemical,	  molecular	  and	  genetic	  approaches	  	  
	  
2. Chromatin	  organization	  by	  the	  PH	  homologs	  The	  fly	  PH	  and	  all	  its	  mammalian	  homologs	  have	  a	  sterile	  alpha	  motif	  (SAM)	  domain	  that	  has	  self-­‐polymerizing	  activity.	  A	  crystal	  structure	  of	  the	  PH-­‐SAM	  domain	  showed	  that	  it	  forms	  a	  helical	  polymer,	  which	  resembles	  that	  formed	  by	  another	  known	  transcriptional	  repressor	  TEL48.	  The	  similarities	  prompted	  a	  model	  where	  gene	  repression	  can	  be	  achieved	  through	  protein-­‐protein	  interactions	  that	  structurally	  organize	  the	  chromatin	  in	  space.	  It	  was	  later	  observed	  that	  mouse	  PRC1	  is	  able	  to	  recruit	  nucleosomal	  arrays	  in	  trans	  and	  inhibit	  chromatin	  remodeling	  on	  the	  recruited	  array.	  This	  activity	  is	  dependent	  on	  the	  Ph	  subunit49.	  	  This	  generated	  further	  interest	  in	  the	  model	  where	  higher	  order	  chromatin	  organization	  is	  involved	  in	  gene	  repression.	  	  The	  hypothesis	  was	  tested	  in	  cells	  by	  assaying	  chromatin	  for	  long-­‐range	  interactions	  and	  organizational	  features	  that	  are	  dependent	  on	  PRC1.	  Through	  information	  collected	  from	  conventional	  immunofluorescence	  imaging,	  super-­‐resolution	  STORM	  imaging,	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chromosome	  conformation	  capture	  assays	  and	  chromatin	  polymer	  modeling,	  it	  was	  found	  that	  chromatin	  with	  PRC1	  binding	  do	  form	  subnuclear	  clusters	  with	  a	  unique	  compact	  packaging	  configuration50,51.	  The	  depletion	  of	  Ph	  and	  mutation	  the	  SAM	  domain	  that	  prevent	  polymerization	  both	  disrupt	  the	  clusters	  and	  abrogate	  chromatin	  interactions,	  which	  often	  coincide	  with	  ectopic	  expression	  of	  PRC1	  target	  genes51,52.	  It	  is,	  however,	  unclear	  how	  transcription	  is	  inhibited	  within	  these	  higher	  order	  structures.	  They	  may	  be	  involved	  in	  excluding	  the	  transcriptional	  machinery	  from	  the	  chromatin,	  isolating	  the	  repressed	  regions	  from	  neighboring	  active	  genes	  to	  prevent	  ‘bystander’	  transcriptional	  activation,	  or	  stabilizing	  local	  PRC1	  binding	  by	  mass	  action	  to	  enable	  robust	  silencing.	  Nonetheless,	  the	  molecular	  assays	  in	  cells	  show	  that	  Ph	  polymerization	  is	  important	  in	  vivo	  and	  is	  required	  for	  gene	  repression	  by	  PRC1.	  	  Finally,	  a	  Phc2-­‐SAM	  mutant	  mouse	  model	  was	  generated	  and	  found	  to	  have	  the	  classic	  PcG	  phenotype	  of	  anterior-­‐to-­‐posterior	  transformation50.	  The	  mouse	  embryonic	  fibroblasts	  derived	  from	  the	  mutant	  mice	  have	  Hox	  gene	  mis-­‐expression.	  	  Therefore,	  the	  biochemical,	  molecular	  and	  genetic	  experiments	  have	  altogether	  showed	  that	  chromatin	  organization	  through	  protein-­‐protein	  interactions	  is	  an	  important	  feature	  in	  PRC1-­‐mediated	  gene	  repression	  and	  PRC1	  function	  during	  development.	  
	  
3. Nucleosomal-­‐level	  compaction	  by	  fly	  PSC	  and	  mammalian	  CBX2	  
In	  the	  year	  1999,	  PRC1	  was	  successfully	  purified	  from	  fly	  embryos.	  It	  was	  able	  to	  prevent	  ATP-­‐dependent	  chromatin	  remodeling	  by	  the	  human	  SWI/SNF	  complex	  on	  a	  plasmid	  template	  containing	  assembled	  nucleosomes32.	  This	  provided	  the	  molecular	  evidence	  for	  the	  genetic	  interactions	  between	  the	  PcG	  and	  trxG	  genes,	  which	  had	  suggested	  that	  PcG	  and	  trxG	  complexes	  have	  direct	  antagonistic	  effects	  on	  the	  Hox	  genes.	  It	  was	  later	  found	  that	  the	  complex	  is	  able	  to	  inhibit	  transcription	  from	  a	  chromatin	  template	  in	  vitro,	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again	  providing	  molecular	  evidence	  for	  the	  function	  of	  PRC1	  as	  a	  transcriptional	  regulator53.	  The	  two	  biochemical	  activities	  correlated	  well	  with	  a	  third	  in	  vitro	  observation,	  that	  is	  the	  ability	  of	  PRC1	  to	  compact	  polynucleosome	  arrays:	  following	  incubation	  with	  PRC1,	  the	  conformation	  of	  a	  polynucleosome	  array,	  when	  viewed	  by	  electron	  microscopy,	  becomes	  converted	  from	  an	  extended	  beads-­‐on-­‐a-­‐string	  structure	  into	  a	  series	  of	  dense	  globules	  consisting	  of	  multiple	  adjacent	  nucleosomes54.	  Based	  on	  these	  activities,	  it	  was	  hypothesized	  that	  the	  fly	  PRC1	  could	  stably	  repress	  its	  target	  genes	  through	  creating	  a	  compact	  chromatin	  environment	  that	  is	  refractory	  to	  transcriptional	  activation.	  	  
The	  inhibition	  of	  chromatin	  remodeling,	  repression	  of	  in	  vitro	  transcription,	  and	  polynucleosome	  compaction	  activities	  require	  only	  the	  PSC	  subunit	  of	  the	  fly	  PSC;	  PSC	  alone	  has	  activity	  levels	  that	  are	  similar	  to	  that	  of	  the	  reconstituted	  complex54.	  Through	  examining	  the	  phenotypes	  of	  a	  series	  of	  Psc	  mutants	  that	  have	  different	  extents	  of	  C-­‐terminal	  truncations	  in	  PSC,	  and	  the	  activities	  of	  the	  PSC	  variants	  the	  alleles	  encode,	  the	  functional	  domain	  in	  PSC	  was	  mapped	  to	  a	  large	  region	  near	  its	  C-­‐terminal	  that	  has	  no	  predicted	  structure	  or	  known	  homology	  to	  other	  proteins55.	  	  The	  analysis	  of	  the	  fly	  mutants,	  whose	  severity	  of	  phenotype	  increases	  with	  the	  extent	  of	  truncation	  in	  PSC,	  which	  in	  turn	  correlated	  with	  increased	  loss	  of	  in	  vitro	  activity,	  provided	  support	  for	  the	  biological	  relevance	  of	  the	  three	  in	  vitro	  activities	  of	  PRC1	  described	  above.	  However,	  a	  caveat	  to	  this	  interpretation	  is	  that	  the	  PSC	  truncations	  also	  could	  affect	  the	  complex	  non-­‐specifically,	  such	  as	  compromising	  the	  stability	  of	  the	  PSC	  protein.	  	  Thus,	  the	  fly	  phenotypes	  cannot	  be	  specifically	  linked	  to	  the	  loss	  of	  an	  active	  domain	  in	  PSC.	  	  
Reconstituted	  mouse	  PRC1,	  like	  its	  fly	  counterpart,	  is	  also	  able	  to	  prevent	  ATPase-­‐dependent	  chromatin	  remodeling	  and	  compact	  polynucleosomes56.	  The	  conservation	  of	  the	  activities	  across	  species	  provided	  further	  support	  for	  their	  biological	  relevance.	  The	  active	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component	  of	  the	  mouse	  complex,	  however,	  is	  CBX2	  (previously	  known	  as	  M33),	  which	  is	  the	  homolog	  to	  the	  fly	  PC.	  The	  murine	  homologs	  to	  PSC,	  which	  are	  Bmi-­‐1	  and	  Mel-­‐18,	  are	  inactive	  in	  these	  respects.	  The	  active	  region	  within	  CBX2,	  called	  ‘compaction	  domain’	  for	  its	  ability	  to	  compact	  polynucleosomes,	  was	  mapped	  and	  compared	  to	  the	  compaction	  domain	  of	  PSC.	  Both	  regions	  appear	  to	  be	  intrinsically	  disordered	  and	  have	  an	  over-­‐representation	  of	  the	  basic	  residues	  lysine	  and	  arginine.	  This	  suggested	  that	  an	  extended	  region	  with	  high	  positive	  charge	  is	  required	  for	  the	  activities.	  	  
Grau	  et.	  al	  tested	  the	  charge	  hypothesis	  by	  creating	  a	  series	  of	  CBX2	  charge	  variants	  and	  assaying	  for	  their	  in	  vitro	  activity	  levels56.	  CBX2	  variants	  of	  reduced	  positive	  charge	  had	  different	  numbers	  of	  lysine-­‐to-­‐alanine	  and	  arginine-­‐to-­‐alanine	  amino	  acid	  substitutions	  in	  the	  compaction	  domain,	  while	  CBX2	  variants	  of	  increased	  positive	  charge	  had	  aspartic	  acid-­‐to-­‐alanine	  and	  glutamic	  acid-­‐to-­‐alanine	  substitutions	  in	  the	  same	  region.	  The	  mutations	  did	  not	  prevent	  the	  CBX2	  variants	  from	  being	  incorporated	  into	  PRC1.	  Grau	  et.	  al	  observed	  an	  excellent	  correlation	  between	  charge	  and	  activity	  levels	  of	  the	  CBX2	  variant,	  whether	  in	  isolation	  or	  when	  incorporated	  into	  PRC1.	  More	  importantly,	  they	  found	  that	  the	  charge	  requirement	  is	  conserved	  across	  PcG	  proteins	  from	  other	  organisms,	  which	  is	  an	  indicator	  that	  this	  feature	  of	  PcG	  proteins	  could	  be	  relevant	  for	  their	  function	  in	  vivo.	  An	  independent	  study	  reported	  a	  similar	  finding63.	  Nonetheless,	  mutant	  alleles	  that	  specifically	  affect	  charge	  in	  PSC	  have	  not	  been	  isolated	  in	  flies,	  presumably	  because	  the	  probability	  of	  simultaneously	  mutating	  multiple	  lysine	  or	  arginine	  residues	  by	  chance	  is	  very	  small.	  
Despite	  the	  seemingly	  straightforward	  connection	  between	  polynucleosome	  compaction,	  which	  correlates	  well	  with	  the	  repression	  of	  in	  vitro	  transcription	  and	  chromatin	  remodeling,	  to	  gene	  repression,	  its	  biological	  relevance	  remained	  untested.	  This	  is	  because	  the	  nature	  of	  an	  equivalent	  compact	  chromatin	  state	  in	  the	  nucleus	  is	  unknown,	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and	  there	  is	  no	  obvious	  assay	  for	  it.	  Implicit	  to	  this	  model	  for	  repression	  is	  that	  DNA	  becomes	  inaccessible	  to	  transcriptional	  activators	  when	  it	  is	  under	  repression	  by	  PRC1.	  There	  had	  been	  attempts	  to	  test	  for	  reduced	  accessibility	  in	  vivo	  in	  flies,	  but	  the	  interpretation	  of	  the	  results	  was	  not	  straightforward.	  	  
The	  approaches	  to	  measuring	  accessibility	  of	  DNA	  typically	  involve	  measuring	  the	  activity	  of	  a	  heterologous	  DNA	  binding	  protein	  (‘probe’)	  on	  a	  region	  of	  interest	  as	  readout.	  The	  approaches	  fall	  into	  two	  broad	  categories:	  the	  first	  measures	  the	  accessibility	  of	  endogenous	  sequences	  by	  treating	  isolated	  nuclei	  with	  the	  probes,	  while	  the	  second	  measures	  the	  accessibility	  of	  transgenes	  in	  the	  genome	  using	  exogenously	  expressed	  probes	  
in	  vivo.	  The	  assays	  aimed	  to	  determine	  whether	  there	  are	  differences	  in	  the	  measured	  accessibility	  in	  PcG	  target	  genes	  or	  PcG	  regulated	  regions	  in	  a	  manner	  that	  is	  dependent	  on	  the	  PcG	  proteins.	  This	  was	  done	  by	  comparing	  the	  accessibility	  of	  a	  same	  region	  between	  wild	  type	  and	  PcG	  mutants,	  or	  between	  two	  cell	  types	  where	  the	  gene	  of	  interest	  is	  expressed	  in	  one	  and	  repressed	  in	  the	  other.	  	  
An	  example	  of	  the	  first	  type	  of	  assay	  is	  the	  study	  by	  Schlossherr	  et.	  al	  57.	  In	  this	  study,	  the	  authors	  used	  DNA	  cutting	  by	  a	  series	  of	  restriction	  endonucleases	  (RE)	  as	  the	  output	  for	  accessibility	  at	  the	  Antp	  and	  Abd-­‐B	  genes.	  They	  observed	  that	  Antp	  was	  more	  accessible	  in	  wing	  discs	  where	  it	  is	  expressed,	  compared	  to	  the	  eye-­‐antennal	  discs,	  where	  it	  was	  repressed.	  	  The	  authors,	  however,	  noted	  that	  the	  magnitude	  of	  the	  differences	  was	  small	  and	  they	  were	  unable	  to	  determine	  if	  the	  increased	  accessibility	  in	  the	  wing	  discs	  is	  a	  reflection	  of	  its	  actively	  transcribed	  state.	  Moreover,	  they	  did	  not	  observed	  a	  difference	  in	  the	  accessibility	  of	  the	  Abd-­‐B	  gene	  between	  wild	  type	  and	  Pc	  mutant	  embryos.	  Hence,	  it	  is	  unclear	  whether	  accessibility	  as	  measured	  by	  RE	  activity	  is	  informative	  of	  a	  PcG-­‐mediated	  function.	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Several	  studies	  adopted	  the	  second	  type	  of	  approach	  to	  determine	  DNA	  accessibility,	  that	  is	  to	  measure	  the	  accessibility	  of	  transgene	  sequences	  that	  are	  inserted	  into	  known	  PcG-­‐regulated	  regions	  using	  exogenously	  expressed	  probes58-­‐60.	  In	  flies,	  the	  transgene	  is	  typically	  inserted	  into	  BX-­‐C.	  These	  studies	  collectively	  showed	  that	  there	  is	  reduced	  accessibility	  that	  is	  associated	  with	  PcG	  repression	  and	  is	  dependent	  on	  PcG	  proteins.	  The	  magnitude	  of	  change	  is	  two-­‐fold	  or	  less,	  which	  is	  consistent	  with	  the	  report	  by	  Schlossherr	  
et.	  al	  in	  their	  study	  with	  endogenous	  PRC1	  targets58.	  It	  was	  shown	  that	  altering	  transcription	  alone	  does	  not	  lead	  to	  changes	  in	  the	  accessibility.	  Hence,	  these	  results	  suggest	  that	  PcG	  protein	  binding	  and	  repression	  is	  accompanied	  by	  reduced	  access	  to	  the	  target	  DNA.	  However,	  the	  accessibility	  changes	  appear	  to	  be	  sensitive	  to	  the	  characteristic	  of	  the	  transgene	  insert.	  The	  site	  of	  the	  insertion,	  the	  number	  of	  binding	  sites	  for	  the	  probe	  on	  the	  transgene,	  and	  the	  distance	  between	  the	  probe	  binding	  sites	  and	  the	  region	  whose	  accessibility	  is	  being	  measured	  all	  appear	  to	  influence	  the	  accessibility	  measurement.	  Hence,	  it	  is	  unclear	  how	  the	  transgene	  behaviors	  are	  representative	  of	  endogenous	  PcG	  targets,	  which	  are	  diverse	  in	  their	  genomic	  features	  such	  as	  domain	  size	  and	  nucleotide	  composition.	  	  
The	  earlier	  studies	  measured	  the	  accessibility	  of	  single	  loci.	  More	  recently,	  two	  groups	  attempted	  to	  provide	  a	  genome-­‐wide	  view	  of	  the	  PcG	  regulated	  regions61,62.	  Bell	  et.	  
al	  utilized	  DNA	  methylation	  by	  the	  enzyme	  M.	  SssI	  as	  readout	  for	  accessibility.	  They	  observed	  that	  the	  average	  M.	  SssI	  methylation	  level	  in	  H3K27me3-­‐decorated	  regions	  is	  lower	  compared	  to	  regions	  without	  H3K27me3.	  The	  difference	  of	  the	  means,	  again,	  is	  small	  and	  there	  is	  a	  large	  overlap	  in	  the	  range	  of	  measured	  accessibilities	  between	  regions	  with	  and	  without	  H3K27me3.	  Therefore,	  it	  appears	  that	  PcG	  associated	  regions	  as	  a	  whole	  have	  lower	  accessibility	  in	  the	  genome	  but	  the	  accessibility	  at	  individual	  sites	  is	  highly	  contextual.	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In	  the	  second	  study,	  Deal	  et.	  al	  determined	  the	  genome-­‐wide	  nucleosome	  turnover	  rates62.	  Heterochromatic	  regions,	  which	  are	  stably	  repressed,	  have	  low	  nucleosome	  turnover	  rates;	  thus,	  it	  was	  predicted	  that	  PcG	  repressed	  regions	  would	  have	  lower	  turnover	  rates	  as	  well.	  Surprisingly,	  the	  nucleosome	  in	  PcG	  binding	  sites,	  together	  with	  trxG	  binding	  sites,	  promoters,	  active	  gene	  bodies	  and	  replication	  of	  origins,	  have	  turnover	  rates	  that	  are	  higher	  than	  the	  genome	  average.	  This	  challenged	  the	  conventional	  view	  that	  PcG	  repressed	  regions	  are	  inert	  like	  the	  heterochromatic	  regions.	  	  Therefore,	  there	  is	  no	  strong	  evidence	  from	  chromatin	  studies	  that	  support	  or	  refute	  the	  model	  for	  gene	  repression	  through	  chromatin	  compaction	  by	  PRC1.	  Given	  the	  technical	  challenges	  of	  assaying	  for	  a	  compact	  chromatin	  state	  at	  the	  molecular	  level,	  we	  adopted	  a	  genetic	  approach	  to	  test	  the	  model	  in	  vivo.	  An	  overview	  of	  this	  work	  is	  provided	  in	  the	  next	  section.	  	  
DISSERTATION	  OVERVIEW	  The	  overarching	  hypothesis	  of	  our	  study	  is	  that	  the	  in	  vitro	  activity	  of	  polynucleosome	  compaction	  is	  a	  mechanism	  by	  which	  PRC1	  performs	  its	  function	  as	  an	  epigenetic	  transcriptional	  repressor	  in	  vivo.	  We	  tested	  the	  hypothesis	  via	  two	  different	  approaches,	  presented	  in	  Chapters	  2	  and	  3,	  respectively.	  	  In	  Chapter	  2,	  we	  tested	  whether	  the	  compaction	  activity	  is	  required	  for	  the	  transcriptional	  repression	  of	  PRC1	  target	  genes	  in	  cells.	  We	  generated	  mESC	  lines	  that	  express	  CBX2	  variants	  whose	  in	  vitro	  activities	  were	  characterized	  by	  Grau	  et.	  al,	  and	  assayed	  for	  gene	  expression	  changes56.	  We	  observed	  that	  the	  inactive	  CBX2	  variant	  failed	  to	  repress	  gene	  expression,	  while	  an	  active	  CBX2	  variant	  has	  repressive	  activities	  that	  are	  similar	  to	  wild	  type.	  We	  showed	  that	  the	  inactive	  CBX2	  variant	  is	  able	  to	  form	  PRC1	  and	  localize	  appropriately	  at	  PRC1	  target	  genes	  on	  the	  chromatin.	  Thus,	  we	  conclude	  that	  the	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loss	  of	  repressive	  function	  is	  due	  to	  the	  loss	  of	  compaction	  activity	  in	  this	  CBX2	  variant.	  Hence,	  the	  compaction	  activity	  is	  required	  for	  the	  transcriptional	  repression	  of	  PRC1	  target	  genes	  in	  cells.	  In	  Chapter	  3,	  we	  tested	  whether	  the	  compaction	  domain	  of	  CBX2	  is	  required	  for	  PRC1	  function	  during	  development.	  The	  classic	  PcG	  function	  is	  defined	  by	  its	  role	  in	  maintaining	  Hox	  gene	  repression	  through	  embryogenesis,	  which	  is	  important	  for	  the	  patterning	  of	  the	  anterior-­‐posterior	  axis.	  Hence,	  we	  generated	  mouse	  mutants	  with	  two	  different	  knock-­‐in	  alleles	  of	  Cbx2	  with	  mutations	  in	  the	  compaction	  domain,	  and	  examined	  their	  axial	  skeletons	  for	  anterior-­‐posterior	  transformations.	  These	  mice	  exhibit	  posterior	  transformation	  phenotypes	  that	  mimic	  the	  phenotypes	  of	  Cbx2-­‐/-­‐	  mice,	  indicating	  that	  our	  
Cbx2	  mutant	  alleles	  are	  loss-­‐of-­‐function	  alleles.	  Hence,	  we	  conclude	  that	  the	  compaction	  domain	  is	  required	  for	  PRC1	  function	  during	  development.	  Overall,	  our	  studies	  indicate	  that	  the	  compaction	  activity	  is	  integral	  to	  PRC1	  function	  
in	  vivo.	  In	  Chapter	  4,	  we	  discuss	  the	  implications	  of	  these	  results	  and	  suggest	  some	  future	  research	  directions	  for	  understanding	  the	  roles	  of	  the	  PcG	  proteins	  and	  chromatin	  in	  heritable	  gene	  repression.
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  CHAPTER	  2	  
CBX2	  with	  compaction	  activity	  is	  required	  
for	  gene	  repression	  in	  cells	  
	  
Contributions:	  
Sharmistha	  Kundu	  (Kingston	  lab)	  generated	  the	  ChIP-­‐seq	  data	  in	  Figure	  2.1B.	  John	  Seavitt,	  (MGH	  Gene	  Targeting	  Facility)	  provided	  technical	  help	  in	  generating	  the	  doxycycline-­‐inducible	  mouse	  embryonic	  stem	  cell	  lines.	  Peggy	  Wang	  and	  Ruslan	  Sadreyev	  (Molbio	  Bioinformatics	  Core)	  performed	  the	  ChIP-­‐seq	  and	  RNA-­‐seq	  analyses	  in	  Figures	  2.2	  and	  2.3.	  Andrej	  Savol	  (Molbio	  Bioinformatics	  Core)	  generated	  Figure	  2.2E.	  Sharmistha	  Kundu	  performed	  the	  ChIP	  experiments	  in	  Figure	  2.5.	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ABSTRACT	  
Polycomb	  group	  (PcG)	  proteins	  are	  developmental	  regulators	  that	  maintain	  their	  target	  genes	  in	  the	  repressive	  state.	  The	  molecular	  mechanisms	  by	  which	  they	  achieve	  repression	  remain	  to	  be	  elucidated.	  Polycomb	  repressive	  complex	  1	  (PRC1)	  is	  able	  to	  compact	  polynucleosomes	  in	  vitro,	  but	  the	  relevance	  of	  this	  activity	  to	  its	  function	  in	  vivo	  is	  unknown.	  For	  mammalian	  PRC1,	  the	  activity	  is	  mapped	  to	  a	  basic	  region	  in	  its	  CBX2	  subunit.	  Mutations	  that	  reduce	  charge	  in	  this	  region	  disrupt	  the	  compaction	  activity	  of	  the	  complex.	  We	  tested	  the	  hypothesis	  that	  the	  compaction	  activity	  is	  important	  for	  PRC1-­‐mediated	  gene	  repression	  in	  cells.	  We	  compared	  the	  gene	  expression	  patterns	  in	  mouse	  embryonic	  stem	  cell	  lines	  expressing	  CBX2	  variants	  whose	  in	  vitro	  activities	  were	  characterized.	  We	  observed	  that	  the	  inactive	  CBX2	  variant	  failed	  to	  repress	  gene	  expression,	  while	  an	  active	  CBX2	  variant	  has	  repressive	  activities	  that	  are	  similar	  to	  wild	  type.	  We	  showed	  that	  the	  inactive	  CBX2	  variant	  is	  able	  to	  form	  PRC1	  and	  localize	  appropriately	  at	  PRC1	  target	  genes	  on	  the	  chromatin.	  In	  addition,	  we	  found	  that	  another	  CBX	  homolog	  CBX7	  and	  the	  Polycomb	  –associated	  histone	  modifications	  H3K27me3	  and	  H2AK119Ub	  are	  insufficient	  for	  full	  repression	  at	  some	  genes	  in	  the	  absence	  of	  CBX2.	  Thus,	  we	  conclude	  that	  the	  loss	  of	  repressive	  function	  is	  due	  to	  the	  loss	  of	  compaction	  activity	  in	  the	  inactive	  CBX2	  variant.	  Our	  results	  support	  the	  hypothesis	  that	  chromatin	  compaction	  is	  relevant	  to	  PRC1	  function	  in	  vivo.
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INTRODUCTION	  
The	  Polycomb	  group	  (PcG)	  genes	  were	  first	  identified	  through	  genetic	  studies	  in	  flies.	  They	  were	  identified	  because	  they	  produced	  an	  interesting	  mutant	  phenotype	  where	  a	  particular	  body	  segment	  assumed	  the	  identity	  of	  another,	  i.e.	  homeotic	  transformation.	  The	  PcG	  genes	  maintain	  the	  repression	  of	  Hox	  genes	  through	  embryogenesis	  for	  proper	  patterning	  of	  the	  anterior-­‐posterior	  axis.	  In	  addition,	  they	  regulate	  many	  other	  developmental	  genes.	  The	  PcG	  genes	  and	  the	  Hox	  genes	  are	  widely	  conserved	  from	  fly	  through	  mammals.	  	  Mutations	  in	  the	  PcG	  genes	  in	  mice	  also	  result	  in	  homeotic	  transformation	  phenotypes	  that	  are	  analogous	  to	  those	  observed	  in	  the	  fly	  mutants,	  suggesting	  that	  the	  gene	  regulatory	  roles	  of	  PcG	  genes	  are	  conserved.	  	  
Several	  lines	  of	  evidence	  indicated	  the	  PcG	  proteins	  interact	  with	  chromatin.	  The	  fly	  PC	  protein	  has	  a	  chromodomain	  that	  was	  also	  present	  in	  Heterochromatin	  protein	  1	  (HP1),	  which	  associates	  with	  heterochromatin1.	  Secondly,	  mutations	  in	  trithorax	  group	  (trxG)	  genes	  were	  found	  to	  suppress	  PcG	  phenotypes2.	  Several	  of	  the	  trxG	  genes	  encode	  ATP-­‐dependent	  chromatin	  remodelers	  that	  move	  nucleosomes	  to	  maintain	  active	  transcription;	  this	  indicated	  PcG	  gene	  products	  may	  antagonize	  chromatin	  remodeling.	  Moreover,	  several	  PcG	  proteins,	  e.g.	  PC,	  PSC	  and	  PH	  were	  observed	  to	  bind	  to	  polytene	  chromosomes	  at	  sites	  that	  included	  	  the	  Hox	  gene	  clusters	  ANT-­‐C	  and	  BX-­‐C3,4.	  	  
In	  order	  to	  gain	  mechanistic	  understanding	  of	  PcG-­‐mediated	  gene	  repression,	  PcG	  proteins	  have	  been	  purified	  and	  subjected	  to	  assays	  that	  investigate	  their	  interactions	  with	  the	  nucleosome	  or	  a	  chromatin	  template.	  The	  proteins	  form	  two	  broad	  classes	  of	  complexes:	  PRC1	  and	  PRC2.	  This	  study	  focuses	  on	  PRC1.	  The	  core	  components	  of	  the	  fly	  PRC1	  are	  Polycomb	  (PC),	  Polyhomeotic	  (PH),	  Posterior	  sex	  combs	  (PSC)	  and	  Sex	  comb	  extra	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(SCE).	  PRC1	  and	  its	  core	  components	  are	  conserved	  in	  mammals	  but	  with	  added	  complexity;	  there	  are	  two	  to	  six	  homologs	  for	  each	  of	  the	  components	  in	  mammals	  (Figure	  1.2).	  The	  homologs	  can	  substitute	  for	  one	  another	  for	  PRC1	  formation5;	  however,	  they	  are	  not	  equivalent	  in	  their	  biochemical	  activities.	  They	  also	  have	  different	  but	  overlapping	  temporal	  and	  spatial	  expression	  patterns	  during	  development	  and	  in	  the	  organism.	  Therefore,	  PcG-­‐mediated	  gene	  repression	  appears	  to	  be	  much	  more	  complex	  in	  mammals	  than	  in	  flies.	  	  
The	  biochemical	  activities	  of	  each	  core	  PRC1	  component	  have	  been	  characterized	  and	  they	  form	  the	  basis	  for	  models	  of	  how	  PRC1	  maintain	  gene	  repression.	  	  SCE,	  when	  in	  complex	  with	  PSC,	  mono-­‐ubiquitylates	  histone	  H2A	  (H2AUb)6,7.	  This	  activity	  is	  conserved	  in	  specific	  mammalian	  Ring1/PCGF	  homolog	  combinations.	  H2AUb	  was	  associated	  with	  RNA	  polymerase	  pausing	  and	  the	  recruitment	  of	  PRC2	  for	  gene	  repression	  in	  cells8	  However,	  recent	  studies	  with	  SCE	  and	  Ring1B	  catalytic	  mutants	  in	  flies	  and	  mice,	  respectively,	  indicate	  that	  it	  is	  unlikely	  to	  be	  directly	  involved	  in	  PRC1-­‐dependent	  repression9,10.	  PH	  and	  all	  three	  mammalian	  Phc	  proteins	  are	  able	  to	  self-­‐assemble	  into	  oligomers	  via	  their	  SAM	  domains.	  This	  activity	  was	  demonstrated	  to	  be	  important	  for	  higher	  order	  chromatin	  folding	  and	  PRC1	  gene	  repression	  in	  mice	  and	  in	  fly	  cells11,12.	  	  PC	  and	  the	  CBX	  homologs	  contain	  a	  chromodomain	  that	  binds	  to	  the	  histone	  modification	  H3K27me3.	  They	  are	  therefore	  thought	  to	  play	  a	  role	  in	  targeting	  PRC1	  to	  genomic	  regions	  delineated	  by	  H3K27me3,	  which	  is	  shown	  to	  be	  important	  for	  gene	  repression13.	  The	  CBX	  proteins	  are	  also	  able	  to	  bind	  H3K9me.	  	  Different	  CBX	  homologs	  show	  varying	  affinities	  for	  either	  histone	  mark	  that	  can	  be	  modulated	  by	  post-­‐translational	  modifications	  on	  the	  protein	  itself	  
14-­‐16.	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An	  in	  vitro	  reconstituted	  fly	  PRC1	  containing	  the	  core	  components	  without	  PH	  has	  the	  ability	  to	  inhibit	  chromatin	  remodeling	  and	  to	  create	  compact	  structures	  on	  nucleosomal	  arrays17,18.	  These	  two	  activities	  correlate	  very	  well,	  and	  this	  gave	  rise	  to	  a	  model	  where	  PRC1	  creates	  a	  localized	  chromatin	  structure	  that	  is	  refractory	  to	  chromatin	  remodeling	  and	  transcription	  in	  the	  nucleus.	  However,	  general	  DNA	  accessibility	  is	  not	  markedly	  reduced	  at	  PcG-­‐repressed	  regions	  in	  vivo19-­‐21.	  	  
The	  PSC	  subunit	  alone	  is	  sufficient	  for	  the	  two	  activities18.	  The	  functional	  domain	  in	  PSC	  is	  a	  large	  region	  near	  its	  C-­‐terminus	  that	  has	  no	  predicted	  structure	  or	  known	  homology	  to	  other	  proteins22.	  A	  study	  of	  PSC	  truncation	  mutants	  hinted	  at	  the	  biological	  relevance	  of	  the	  two	  in	  vitro	  activities.	  The	  severity	  of	  their	  phenotypes	  correlated	  with	  the	  extent	  of	  the	  truncations	  from	  their	  C-­‐termini,	  suggesting	  that	  an	  increased	  loss	  of	  the	  functional	  domain	  contributed	  to	  concomitant	  loss	  of	  PRC1	  function.	  	  
Another	  indication	  that	  the	  in	  vitro	  activities	  are	  relevant	  is	  that	  they	  are	  conserved	  in	  the	  in	  vitro	  reconstituted	  mouse	  PRC123.	  The	  activities,	  however,	  are	  found	  in	  the	  homolog	  of	  PC,	  CBX2,	  instead	  of	  the	  homolog	  to	  PSC,	  which	  is	  Bmi-­‐1.	  The	  functional	  domain	  in	  CBX2	  was	  identified,	  and	  like	  that	  for	  PSC,	  it	  has	  no	  predicted	  structure	  or	  known	  homology	  domains.	  A	  comparison	  of	  the	  two	  functional	  domains	  revealed	  a	  bias	  in	  amino	  acid	  composition	  for	  the	  basic	  residues	  lysine	  (K)	  and	  arginine	  (R).	  These	  gave	  the	  two	  proteins	  high	  overall	  positive	  charge.	  To	  test	  whether	  the	  K	  and	  R	  residues	  are	  important,	  Grau	  et.	  al	  delineated	  two	  regions	  in	  the	  functional	  domain	  and	  mutated	  every	  other	  K	  and	  R	  residue	  to	  A	  (K-­‐to-­‐A,	  and	  R-­‐to-­‐A	  ).	  They	  found	  the	  mutations	  abrogated	  the	  activities,	  and	  partial	  mutations	  led	  to	  partial	  loss	  of	  activity.	  	  In	  contrast,	  aspartic	  acid-­‐to-­‐alanine	  (D-­‐to-­‐A)	  and	  glutamic	  acid-­‐to-­‐alanine	  (E-­‐to-­‐A)	  mutations	  that	  increase	  charge	  did	  not	  affect	  the	  activities.	  Therefore,	  there	  appears	  to	  be	  a	  correlation	  between	  charge	  in	  CBX2	  and	  its	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activities.	  However,	  positive	  charge	  is	  not	  the	  sole	  requirement,	  	  as	  non-­‐PcG	  proteins	  of	  similar	  charge	  to	  CBX2	  did	  not	  have	  such	  activities.	  Lastly,	  Grau	  et.	  al	  found	  that	  high	  overall	  positive	  charge	  is	  a	  good	  predictor	  for	  activity	  in	  putative	  PRC1	  components	  in	  other	  organisms,	  including	  zebrafish,	  frog	  and	  worm.	  This	  has	  two	  implications:	  firstly,	  the	  chromatin	  remodeling	  inhibition	  and	  chromatin	  compaction	  activities	  are	  widely	  conserved;	  secondly,	  the	  molecular	  basis	  for	  the	  activities	  is	  also	  likely	  to	  be	  conserved.	  An	  independent	  study	  by	  Beh	  et.	  al	  reported	  a	  similar	  finding24.	  	  
Therefore,	  we	  hypothesize	  that	  K	  and	  R	  residues	  in	  CBX2	  that	  confer	  it	  its	  compaction	  activities	  are	  important	  for	  PcG	  gene	  repression	  in	  cells.	  We	  test	  the	  hypothesis	  by	  comparing	  gene	  expression	  changes	  in	  cell	  lines	  that	  express	  wild	  type	  or	  CBX2	  charge	  mutants	  previously	  characterized	  by	  Grau	  et.	  al.	  	  
	  
RESULTS	  
CBX2	  is	  expressed	  and	  binds	  to	  PRC1	  target	  genes	  in	  mESCs	  
We	  needed	  a	  cell	  culture	  system	  to	  investigate	  whether	  the	  K	  and	  R	  residues	  in	  the	  compaction	  domain	  of	  CBX2	  are	  required	  for	  repression	  of	  PRC1	  target	  genes.	  	  There	  are	  five	  CBX	  homologs	  that	  are	  expressed	  in	  a	  cell-­‐type	  specific	  manner,	  namely	  CBX2,	  4,	  6,	  7	  and	  825.	  In	  mouse	  embryonic	  stem	  cells	  (mESCs),	  CBX2,	  6	  and	  7	  are	  expressed.	  However,	  only	  CBX2	  and	  7	  are	  associated	  with	  PRC1.	  The	  expression	  level	  of	  CBX2	  is	  low	  compared	  to	  that	  of	  CBX7	  in	  mESCs.	  CBX2	  depletion	  does	  not	  affect	  mESC	  self-­‐renewal,	  unlike	  CBX7	  which	  is	  important	  for	  both	  self-­‐renewal	  and	  pluripotency25,26.	  Given	  that	  Cbx2-­‐/-­‐	  mESCs	  are	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stable	  in	  culture,	  we	  reasoned	  that	  we	  could	  express	  CBX2	  variants	  in	  them	  to	  assess	  their	  effects	  on	  gene	  expression.	  	  
Earlier	  studies	  have	  shown	  that	  CBX2	  is	  expressed	  and	  binds	  to	  known	  Polycomb	  target	  genes	  in	  mESCs,	  where	  Ring1B	  and	  the	  PRC2	  components	  Eed	  and	  Suz12	  also	  bind27,28.	  We	  wanted	  to	  verify	  this	  to	  ensure	  that	  CBX2	  may	  have	  PRC1-­‐associated	  roles	  in	  mESCs.	  To	  confirm	  that	  CBX2	  is	  present	  in	  wild	  type	  mESCs,	  we	  analyzed	  four	  common	  mESC	  lines	  by	  western	  blot	  analysis.	  We	  detected	  a	  band	  for	  CBX2	  in	  all	  four	  wild	  type	  lines	  but	  not	  in	  the	  Cbx2-­‐/-­‐	  mESC	  line,	  which	  we	  used	  as	  a	  negative	  control	  for	  the	  specificity	  of	  the	  antibody	  (Figure	  2.1A).	  To	  verify	  that	  CBX2	  binds	  to	  chromatin	  in	  the	  context	  of	  PRC1,	  we	  performed	  ChIP-­‐seq	  analyses	  on	  mESCs	  for	  CBX2,	  Ring1B,	  Phc1	  and	  CBX7.	  The	  CBX2	  binding	  sites	  coincide	  with	  those	  for	  the	  other	  three	  proteins	  (Figure	  2.1B).	  The	  antibody	  used	  for	  ChIP	  did	  not	  give	  enrichment	  signal	  in	  Cbx2-­‐/-­‐	  mESCs	  (see	  Figure	  2.2D),	  indicating	  that	  the	  antibody	  used	  for	  CBX2-­‐ChIP	  is	  specific	  for	  CBX2.	  	  	  
These	  data	  indicate	  that	  CBX2	  is	  expressed	  in	  mESCs	  and	  forms	  PRC1	  that	  localizes	  onto	  chromatin.	  Hence,	  we	  conclude	  that	  mESCs	  are	  an	  appropriate	  system	  for	  comparing	  the	  effect	  of	  wild	  type	  (WT)	  and	  mutant	  CBX2	  on	  gene	  repression.	  Notably,	  CBX7	  is	  also	  present	  at	  CBX2	  binding	  sites,	  indicating	  that	  there	  are	  at	  least	  two	  types	  of	  CBX-­‐containing	  PRC1	  in	  mESCs.	  
Generation	  of	  cell	  lines	  that	  express	  WT	  and	  mutant	  CBX2	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Figure	  2.1	  	  CBX2	  is	  expressed	  and	  binds	  to	  PRC1	  target	  genes	  in	  mESCs.	  
A.	  Western	  blot	  shows	  the	  expression	  of	  CBX2	  in	  four	  common	  mESC	  lines.	  Lysate	  from	  Cbx2-­‐/-­‐	  mESCs	  and	  exogenous	  HA-­‐tagged	  CBX2	  were	  used	  as	  negative	  and	  positive	  controls,	  respectively,	  for	  the	  speciEicity	  of	  the	  CBX2	  antibody.	  This	  panel	  also	  shows	  the	  presence	  of	  other	  PRC1	  components,	  CBX7,	  Phc1	  and	  Ring1B,	  in	  these	  cells.	  H3	  is	  used	  as	  loading	  control	  for	  the	  lysates.	  	  B.	  Genome	  browser	  tracks	  of	  ChIP-­‐seq	  data	  for	  CBX2	  and	  other	  PRC1	  subunits	  at	  	  two	  known	  PRC1	  target	  regions.	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required	  for	  its	  in	  vitro	  activities	  (Figure	  2.2A).	  The	  mutations	  reduce	  the	  positive	  charge	  on	  the	  protein.	  In	  contrast,	  the	  DEA-­‐CBX2	  has	  aspartic	  acid-­‐to-­‐alanine	  (D-­‐to-­‐A)	  and	  glutamic	  acid-­‐to-­‐alanine	  (E-­‐to-­‐A)	  substitutions	  in	  the	  same	  regions,	  which	  increase	  the	  positive	  charge.	  Both	  KRA-­‐CBX2	  and	  DEA-­‐CBX2	  were	  previously	  characterized	  biochemically23:	  compared	  to	  WT-­‐CBX2,	  KRA-­‐CBX2	  was	  unable	  to	  inhibit	  chromatin	  remodeling	  and	  compact	  nucleosomal	  arrays,	  while	  DEA-­‐CBX2	  has	  activity	  levels	  similar	  to	  WT-­‐CBX2.	  	  	  
We	  were	  able	  to	  determine	  the	  conditions	  that	  are	  required	  for	  the	  mESC	  lines	  to	  express	  CBX2	  to	  similar	  levels	  (Figure	  2.2B).	  We	  did	  this	  for	  two	  independent	  WT-­‐CBX2	  lines,	  two	  independent	  KRA-­‐CBX2	  lines	  and	  one	  DEA-­‐CBX2	  line,	  which	  were	  all	  used	  in	  our	  gene	  expression	  studies	  reported	  below.	  	  The	  presence	  of	  mutant	  CBX2	  proteins	  does	  not	  affect	  the	  protein	  levels	  of	  other	  PRC1	  components,	  as	  shown	  for	  CBX7	  and	  Phc1	  by	  western	  blot	  analysis	  (Figure	  2.2B).	  
Complex	  formation	  and	  targeting	  of	  KRA-­‐	  and	  WT-­‐CBX2	  
To	  test	  whether	  KRA-­‐CBX2	  is	  incorporated	  into	  PRC1	  complex	  in	  the	  cells,	  we	  immunoprecipitated	  Ring1B	  and	  assayed	  for	  CBX2	  by	  western	  blot	  analysis.	  KRA-­‐CBX2	  interacts	  with	  Ring1B,	  as	  does	  the	  re-­‐introduced	  WT-­‐CBX2	  (Figure	  2.2C).	  Thus,	  we	  conclude	  that	  KRA-­‐CBX2	  can	  interact	  with	  other	  PRC1	  subunits	  for	  complex	  assembly.	  This	  is	  consistent	  with	  previous	  findings	  that	  the	  amino	  acid	  substitutions	  do	  not	  affect	  CBX2-­‐Ring1B	  interaction,	  which	  occurs	  through	  its	  C-­‐box	  domain23.	  	  
To	  determine	  whether	  KRA-­‐CBX2	  localizes	  to	  bona	  fide	  PRC1	  target	  genes,	  we	  performed	  ChIP-­‐seq	  analysis	  for	  KRA-­‐CBX2	  and	  compared	  it	  to	  that	  for	  WT-­‐CBX2.	  We	  observed	  that	  the	  ChIP	  enrichment	  signals	  for	  KRA-­‐CBX2	  coincide	  to	  a	  high	  degree	  with	  those	  for	  WT-­‐CBX2	  at	  known	  PRC1	  target	  genes	  (Figure	  2.2D):	  263	  out	  of	  the	  285	  genes	  
33
CLUSTAL 2.1 multiple sequence alignment 
 
 
WT-CBX2         MEELSSVGEQVFAAECILSKRLRKGKLEYLVKWRGWSSKHNSWEPEENILDPRLLLAFQK 60 
DEA-CBX2        MEELSSVGEQVFAAECILSKRLRKGKLEYLVKWRGWSSKHNSWEPEENILDPRLLLAFQK 60 
KRA-CBX2        MEELSSVGEQVFAAECILSKRLRKGKLEYLVKWRGWSSKHNSWEPEENILDPRLLLAFQK 60 
                ************************************************************ 
 
WT-CBX2         KEHEKEVQNRKRGKRPRGRPRKHTATSSCSRRSKLKEPDAPSKSKSSSSSSSSTSSSSSS 120 
DEA-CBX2        KEHEKEVQNRKRGKRPRGRPRKHTATSSCSRRSKLKEPDAPSKSKSSSSSSSSTSSSSSS 120 
KRA-CBX2        KEHEKEVQNRKRGKRPRGRPRKHTATSSCSRRSKLKEPDAPSKSKSSSSSSSSTSSSSSS 120 
                ************************************************************ 
 
WT-CBX2         DEEEDDSDLDSKRGPRGRETHPVPQKKAQILVAKPELKDPIRKKRGRKPLPPEQKAARRP 180 
DEA-CBX2        DEEEDDSDLDSKRGPRGRETHPVPQKKAQILVAKPALKDPIRKKRGRKPLPPAQKAARRP 180 
KRA-CBX2        DEEEDDSDLDSARGPAGRETHPVPQAKAQILVAAPELKDPIAKARGAKPLPPEQAAARAP 180 
                *********** *** ********* ******* * ***** * ** ***** * *** * 
 
WT-CBX2         VSLAKVLKTTRKDLGTSAAKLPPPLSAPVAGLAALKAHTKEACGGPSTMATPENLASLMK 240 
DEA-CBX2        VSLAKVLKTTRKDLGTSAAKLPPPLSAPVAGLAALKAHTKAACGGPSTMATPENLASLMK 240 
KRA-CBX2        VSLAKVLATTRADLGTSAAKLPPPLSAPVAGLAALAAHTKEACGGPSTMATPENLASLMA 240 
                ******* *** *********************** **** ******************  
 
WT-CBX2         GMAGSPSRGGIWQSSIVHYMNRMSQSQVQAASRLALKAQATNKCGLGLDLKVRTQKGGEL 300 
DEA-CBX2        GMAGSPSRGGIWQSSIVHYMNRMSQSQVQAASRLALKAQATNKCGLGLALKVRTQKGGEL 300 
KRA-CBX2        GMAGSPSRGGIWQSSIVHYMNAMSQSQVQAASRLALAAQATNKCGLGLDLAVRTQAGGEL 300 
                ********************* ************** *********** * **** **** 
 
WT-CBX2         GGSPAGGKVPKAPGGGAAEQQRGNHSGSPGAQLAPTQELSLQVLDLQSVKNGVPGVGLLA 360 
DEA-CBX2        GGSPAGGKVPKAPGGGAAAQQRGNHSGSPGAQLAPTQELSLQVLALQSVKNGVPGVGLLA 360 
KRA-CBX2        GGSPAGGKVPAAPGGGAAEQQRGNHSGSPGAQLAPTQELSLQVLDLQSVANGVPGVGLLA 360 
                ********** ******* ************************* **** ********** 
 
WT-CBX2         RHAPAKAIPATNPATGKGPGSGPTGANMTNAPTDNNKGEKLTCKATALPAPSVKRDTVKS 420 
DEA-CBX2        RHAPAKAIPATNPATGKGPGSGPTGANMTNAPTDNNKGAKLTCKATALPAPSVKRDTVKS 420 
KRA-CBX2        RHAPAAAIPATNPATGKGPGSGPTGANMTNAPTDNNAGEKLTCAATALPAPSVKADTVKS 420 
                ***** ****************************** * **** ********** ***** 
 
WT-CBX2         VAASGGQEGHTAPGEGRKPPALSELSTGEENSSSDSDPDSTSLPSAAQNLSVAIQTSQDW 480 
DEA-CBX2        VAASGGQEGHTAPGEGRKPPALSELSTGEENSSSDSDPDSTSLPSAAQNLSVAIQTSQDW 480 
KRA-CBX2        VAASGGQEGHTAPGEGRKPPALSELSTGEENSSSDSDPDSTSLPSAAQNLSVAIQTSQDW 480 
                ************************************************************ 
 
WT-CBX2         KPTRSLIEHVFVTDVTANLITVTVKESPTSVGFFNLRHY 519 
DEA-CBX2        KPTRSLIEHVFVTDVTANLITVTVKESPTSVGFFNLRHY 519 
KRA-CBX2        KPTRSLIEHVFVTDVTANLITVTVKESPTSVGFFNLRHY 519 
                ***************************************!
CHD	  	  	  :	  Chromodomain.	  
AT	  	  	  	  	  	  :	  AT-­‐hook.	  
R1,2	  	  	  :	  Regions	  required	  for	  the	  in	  vitro	  ac?vi?es.	  
WT +++" +"+"++"
+++++" +++++"DEA 




No CBX2 protein. 
Expresses WT, KRA-, or DEA-CBX2.  
- dox 
+ dox 
No CBX2 protein. 
Expresses WT, RA-, or DEA-CBX2.  
Dox-­‐inducible	  Cbx2-­‐/-­‐	  mESC	  A	  
Figure	  2.2	  	  WT-­‐	  and	  KRA-­‐CBX2	  are	  expressed	  similarly,	  interact	  with	  Ring1B	  and	  bind	  to	  






















































































































































































Figure	  2.2	  (Continued)	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with	  KRA-­‐CBX2	  binding	  are	  WT-­‐CBX2	  bound	  genes	  (92%	  overlap).	  	  Of	  the	  WT-­‐CBX2	  bound	  genes,	  78%	  of	  them	  are	  genes	  with	  endogenous	  CBX2	  binding,	  as	  determined	  from	  ChIP-­‐seq	  experiments	  with	  WT	  mESCs.	  Therefore,	  we	  concluded	  that	  KRA-­‐CBX2,	  like	  the	  reintroduced	  WT-­‐CBX2,	  is	  able	  to	  localize	  appropriately	  to	  PRC1	  target	  genes.	  	  
We	  noted	  that	  the	  ChIP	  signal	  for	  KRA-­‐CBX2	  is	  weaker	  compared	  to	  that	  for	  WT-­‐CBX2.	  Given	  that	  crosslinking	  between	  protein	  and	  DNA	  occurs	  via	  the	  primary	  amine	  group	  on	  lysine	  residues,	  we	  expect	  KRA-­‐CBX2	  to	  crosslink	  less	  efficiently	  than	  the	  WT	  protein	  due	  to	  the	  K-­‐to-­‐A	  substitutions	  introduced.	  To	  test	  whether	  the	  ChIP	  enrichment	  signals	  for	  KRA-­‐CBX2	  are	  overall	  lower	  than	  those	  for	  WT-­‐CBX2,	  we	  plotted	  the	  peak	  densities	  for	  KRA	  against	  the	  peak	  densities	  for	  WT	  for	  every	  peak	  that	  is	  called	  from	  the	  WT-­‐CBX2	  ChIP-­‐seq	  data	  set.	  The	  two	  correlated	  linearly,	  and	  the	  best-­‐fit	  line	  has	  a	  slope	  of	  0.4	  (Figure	  2.2E).	  This	  indicates	  that	  the	  KRA	  peaks	  densities	  are	  generally	  about	  half	  of	  those	  of	  the	  WT	  peaks.	  We	  later	  observed	  the	  same	  with	  our	  ChIP-­‐qPCR	  experiments	  (see	  Figure	  2.5A).	  We	  observed	  that	  the	  peaks	  that	  are	  called	  from	  the	  KRA-­‐CBX2	  ChIP-­‐seq	  data	  set	  are	  mainly	  the	  peaks	  with	  high	  densities	  in	  the	  WT-­‐CBX2	  data	  set	  (Figure	  2.2E).	  This	  suggests	  that	  only	  genomic	  regions	  with	  high	  CBX2	  binding	  showed	  sufficient	  enrichment	  above	  noise	  in	  the	  KRA-­‐CBX2	  ChIP-­‐seq	  experiment	  to	  be	  called	  as	  peaks.	  These	  observations	  are	  consistent	  with	  the	  explanation	  that	  poor	  crosslinking	  with	  KRA-­‐CBX2	  leads	  to	  the	  weaker	  overall	  ChIP	  enrichment	  compared	  to	  WT.	  However,	  we	  note	  that	  these	  observations	  do	  not	  rule	  out	  poorer	  binding	  or	  occupancy	  efficiencies	  for	  KRA-­‐CBX2	  compared	  to	  WT-­‐CBX2.	  	  
We	  conclude	  that	  in	  our	  cell	  lines,	  the	  KRA-­‐CBX2	  forms	  PRC1	  and	  binds	  to	  PRC1	  target	  genes.	  Thus,	  we	  can	  assay	  for	  the	  effects	  of	  the	  mutations	  on	  transcriptional	  regulation.
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Tight	  regulation	  of	  WT-­‐	  and	  DEA-­‐CBX2	  levels,	  but	  not	  for	  KRA-­‐CBX2	  
We	  noted	  an	  interesting	  observation	  while	  performing	  the	  doxycycline	  titration	  experiments	  to	  determine	  the	  conditions	  required	  for	  the	  cell	  lines	  to	  express	  CBX2	  to	  similar	  levels.	  We	  observed	  the	  KRA-­‐CBX2	  lines	  showed	  increased	  CBX2	  protein	  levels	  with	  increasing	  doxycycline	  as	  expected,	  but	  the	  WT	  and	  DEA-­‐CBX2	  lines	  appeared	  to	  fail	  to	  respond	  to	  increasing	  doxycycline	  (Figure	  2.3A,	  B,	  C).	  	  This	  held	  true	  for	  independently	  derived	  mESC	  clones.	  We	  suspected	  that	  the	  WT-­‐	  and	  DEA-­‐CBX2	  proteins	  could	  not	  be	  expressed	  at	  high	  levels	  in	  the	  cells	  because	  of	  their	  repressive	  activities.	  Thus,	  we	  followed	  the	  protein	  levels	  after	  the	  addition	  of	  doxycycline	  over	  a	  time	  period	  of	  48	  hours	  to	  determine	  if	  there	  is	  a	  burst	  of	  expression	  that	  is	  rapidly	  down	  regulated.	  Indeed	  this	  was	  what	  we	  observed	  (Figure	  2.3D).	  When	  the	  cells	  were	  treated	  with	  high	  concentrations	  of	  doxycycline,	  CBX2	  was	  made	  but	  was	  quickly	  lost	  by	  48	  hours	  after	  induction.	  On	  the	  other	  hand,	  when	  the	  cells	  were	  treated	  with	  low	  concentrations	  of	  doxycycline,	  CBX2	  levels	  remained	  relatively	  stable.	  The	  mRNA	  levels	  of	  Cbx2	  correlated	  with	  the	  protein	  levels,	  indicating	  that	  protein	  loss	  is	  due	  to	  downregulation	  of	  transcription	  of	  the	  transgene	  (Figure	  2.3E).	  The	  tight	  regulation	  of	  WT-­‐and	  DEA-­‐CBX2	  levels	  is	  reminiscent	  of	  dosage	  sensitivity	  Polycomb	  group	  mutants	  in	  flies	  and	  mice,	  where	  both	  haploinsufficiency	  and	  overexpression	  of	  the	  Polycomb	  group	  genes	  lead	  to	  developmental	  abnormalities29-­‐31.	  	  
These	  observations	  indicate	  that	  KRA-­‐	  and	  WT-­‐CBX2	  are	  different	  with	  respect	  to	  their	  tolerable	  levels	  in	  mESCs.	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Figure	  2.3	  	  The	  expressions	  of	  WT-­‐	  and	  DEA-­‐CBX2	  ,	  but	  not	  KRA-­‐	  CBX2,	  are	  tightly	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Figure	  2.3	  (Continued)	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Effect	  of	  charge	  mutations	  on	  gene	  expression	  	  
To	  investigate	  the	  effect	  of	  the	  charge	  mutations	  in	  CBX2	  on	  gene	  expression,	  we	  performed	  RNA-­‐seq	  of	  the	  cell	  lines	  before	  and	  after	  doxycycline	  treatment	  that	  induces	  CBX2	  expression.	  	  
We	  wanted	  to	  have	  set(s)	  of	  genes	  that	  may	  be	  regulated	  by	  CBX2	  on	  which	  we	  will	  perform	  differential	  expression	  analyses.	  To	  do	  this	  we	  identified	  genes	  that	  have	  CBX2	  binding	  from	  our	  WT-­‐CBX2	  and	  KRA-­‐CBX2	  ChIP	  seq	  datasets	  and	  created	  three	  lists:	  genes	  with	  WT-­‐CBX2	  binding,	  genes	  with	  KRA-­‐CBX2	  binding,	  and	  genes	  that	  are	  found	  in	  both	  lists.	  From	  these,	  we	  selected	  genes	  that	  had	  detectable	  transcript	  levels	  in	  at	  least	  one	  sample	  from	  our	  RNA-­‐seq	  data.	  The	  resulting	  gene	  lists	  had	  130,	  67	  and	  59	  genes,	  respectively	  (Figure	  2.4	  Venn	  diagram).	  For	  these	  genes	  we	  calculated	  the	  fold	  change	  in	  mRNA	  levels	  as	  a	  ratio	  of	  post-­‐induction	  mRNA	  counts	  to	  pre-­‐induction	  counts	  (Fold	  Change	  =	  +doxycycline/	  -­‐	  doxycycline).	  By	  this	  metric,	  genes	  with	  a	  negative	  fold	  change	  values	  would	  be	  genes	  that	  become	  repressed	  following	  CBX2	  expression,	  and	  vice	  versa.	  We	  did	  this	  for	  the	  five	  mESC	  lines	  shown	  in	  Figure	  2.2B,	  and	  an	  additional	  sample	  where	  KRA.1	  was	  treated	  with	  more	  doxycycline	  to	  express	  KRA-­‐CBX2	  at	  a	  higher	  level.	  The	  analyses	  are	  presented	  in	  heat	  maps	  where	  red	  represents	  down	  regulation	  and	  blue	  for	  upregulation	  (Figure	  2.4A).	  	  
We	  first	  focused	  our	  analysis	  on	  the	  genes	  with	  both	  WT-­‐	  and	  KRA-­‐CBX2	  binding.	  We	  found	  that	  re-­‐introducing	  WT	  CBX2	  resulted	  in	  the	  repression	  of	  many	  of	  these	  genes	  (Figure	  2.4A,	  left	  panel,	  left	  two	  columns).	  The	  repression	  is	  also	  evident	  when	  screen	  shots	  of	  RNA-­‐seq	  tracks	  of	  affected	  genes	  were	  examined	  (Figure	  2.4B,	  blue	  tracks).	  Notably,	  non-­‐PRC1	  target	  genes	  do	  not	  exhibit	  this	  decrease.	  In	  comparing	  the	  effects	  of	  re-­‐introducing	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Figure	  2.4	  (Continued)	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the	  CBX2	  mutants	  to	  WT,	  we	  observed	  that	  the	  target	  gene	  set	  as	  a	  whole	  was	  affected	  less	  by	  KRA-­‐CBX2	  (Figure	  2.4A,	  left	  panel,	  right	  three	  columns).	  In	  contrast,	  the	  expression	  of	  DEA-­‐CBX2	  had	  effected	  repression	  similar	  to	  WT-­‐CBX2	  (Figure	  2.4A,	  left	  panel,	  third	  column	  from	  left).	  Again,	  these	  effects	  on	  target	  gene	  expression	  are	  evident	  when	  the	  RNA	  seq	  tracks	  of	  individual	  affected	  genes	  were	  examined	  (Figure	  2.4B).	  	  The	  effects	  on	  gene	  repression	  were	  also	  verified	  by	  reverse	  transcription-­‐qPCR	  on	  the	  cell	  lines	  before	  and	  after	  doxycycline	  treatment	  (Figure	  2.4C).	  Therefore,	  we	  conclude	  that	  WT-­‐CBX2	  is	  required	  for	  the	  repression	  of	  a	  subset	  of	  genes	  that	  it	  binds.	  KRA-­‐CBX2	  has	  less	  repressive	  activity	  on	  these	  genes	  compared	  to	  WT-­‐CBX2,	  but	  DEA-­‐CBX2	  has	  similar	  activity	  to	  WT-­‐CBX2.	  	  
We	  performed	  hierarchical	  clustering	  on	  the	  gene	  expression	  changes	  in	  the	  cell	  lines	  to	  determine	  their	  degree	  of	  similarity.	  The	  WT-­‐	  and	  DEA-­‐CBX2	  expressing	  lines	  clustered	  together,	  while	  the	  KRA-­‐CBX2	  lines	  clustered	  together,	  away	  from	  the	  WT	  and	  DEA-­‐CBX2	  lines	  (Figure	  2.4A,	  left	  panel).	  	  	  
We	  repeated	  the	  analysis	  on	  the	  genes	  bound	  by	  WT-­‐CBX2	  and	  the	  genes	  bound	  by	  KRA-­‐CBX2.	  We	  saw	  the	  same	  results	  with	  both	  lists,	  in	  that	  there	  was	  less	  repression	  by	  KRA-­‐CBX2	  compared	  to	  WT-­‐	  and	  DEA-­‐CBX2,	  and	  the	  KRA-­‐lines	  clustered	  separately	  from	  the	  WT-­‐	  and	  DEA-­‐CBX2	  lines	  (Figure	  2.4A,	  middle	  and	  right	  panels).	  Finally,	  we	  measured	  the	  degree	  of	  similarity	  among	  the	  cell	  lines	  using	  Pearson	  correlation	  test.	  We	  found	  that	  the	  WT-­‐	  and	  DEA-­‐CBX2	  lines	  show	  higher	  correlation	  with	  each	  other	  than	  with	  the	  KRA-­‐CBX2	  lines	  (Figure	  2.4D),	  which	  is	  consistent	  with	  the	  hierarchical	  clustering	  analyses.	  	  
We	  conclude	  that	  gene	  repressive	  activity	  is	  decreased	  in	  KRA-­‐CBX2,	  but	  is	  unaffected	  in	  DEA-­‐CBX2.	  Therefore,	  mutations	  that	  affect	  the	  in	  vitro	  activities	  of	  CBX2	  also	  affect	  its	  function	  in	  vivo.	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PRC1	  subunits	  and	  histone	  modifications	  on	  chromatin	  are	  unaffected	  by	  KRA-­‐CBX2	  
Although	  the	  majority	  of	  the	  peaks	  from	  the	  KRA-­‐CBX2	  ChIP-­‐seq	  data	  overlapped	  with	  those	  from	  the	  WT-­‐CBX2	  data	  set,	  we	  wanted	  to	  know	  if	  the	  differential	  impact	  of	  WT-­‐	  and	  KRA-­‐CBX2	  on	  gene	  expression	  might	  be	  caused	  by	  differences	  in	  binding	  specifically	  at	  the	  affected	  genes.	  In	  addition,	  we	  also	  wanted	  to	  know	  whether	  the	  other	  PRC1	  components	  and	  the	  histone	  modifications	  associated	  with	  PcG	  could	  have	  been	  affected	  by	  KRA-­‐CBX2.	  Thus,	  we	  performed	  ChIP	  experiments	  for	  CBX2,	  CBX7,	  Ring1B,	  H2AUb	  and	  H3K27me3	  and	  assayed	  for	  enrichment	  of	  CBX2-­‐dependent	  and	  CBX2-­‐independent	  regions	  by	  qPCR.	  	  
From	  our	  CBX2-­‐ChIP-­‐qPCR	  experiments,	  we	  observed	  that	  KRA-­‐CBX2	  is	  able	  to	  bind	  to	  both	  genes	  that	  are	  dependent	  and	  independent	  of	  WT-­‐CBX2	  for	  repression,	  similar	  to	  WT-­‐CBX2	  (Figure	  2.5A).	  Therefore,	  the	  lack	  of	  repression	  by	  KRA-­‐CBX2	  is	  not	  due	  to	  its	  absence	  at	  the	  affected	  genes.	  Notably,	  the	  ChIP	  enrichment	  for	  KRA-­‐CBX2	  is	  about	  half	  of	  that	  for	  WT-­‐CBX2	  which	  is	  consistent	  with	  our	  ChIP-­‐seq	  analysis	  described	  earlier	  (Figure	  2.2E).	  	  
The	  lack	  of	  repression	  by	  KRA-­‐CBX2	  could	  be	  due	  to	  interference	  with	  the	  PRC1	  complex	  on	  the	  chromatin.	  As	  Ring1B	  is	  a	  central	  component	  of	  all	  PRC1	  family	  complexes,	  we	  took	  it	  as	  a	  representative	  of	  all	  PRC1	  complexes	  and	  determined	  whether	  its	  binding	  on	  chromatin	  is	  affected.	  We	  observed	  that	  re-­‐introducing	  the	  WT-­‐	  or	  KRA-­‐CBX2	  does	  not	  affect	  Ring1B	  binding	  compared	  to	  their	  respective	  null	  states	  (Figure	  2.5B).	  This	  implies	  that	  CBX2-­‐mediated	  repression	  is	  not	  due	  to	  increased	  recruitment	  of	  other	  PcG	  proteins	  to	  the	  target	  genes.	  It	  also	  implies	  that	  KRA-­‐CBX2	  does	  not	  interfere	  with	  the	  binding	  of	  these	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Figure	  2.5	  	  CBX2-­‐dependent	  repression	  is	  not	  correlated	  with	  Ring1B,	  CBX7,	  H2AK119Ub	  



















































































































































































































































































































































































































































































































































Figure	  2.5	  (Continued)	  
47
proteins.	  	  Therefore,	  we	  conclude	  that	  CBX2,	  whether	  WT	  or	  KRA,	  does	  not	  affect	  Ring1B	  on	  the	  chromatin.	  	  
CBX7	  is	  the	  dominant	  CBX	  homolog	  that	  is	  expressed	  in	  mESCs.	  We	  wanted	  to	  know	  whether	  CBX7	  binds	  differentially	  at	  genes	  that	  are	  dependent	  and	  independent	  of	  CBX2	  for	  repression,	  which	  could	  imply	  distinct	  functions	  for	  different	  CBX-­‐containing	  PRC1	  complexes.	  By	  CBX7-­‐ChIPqPCR,	  we	  observed	  that	  CBX7	  is	  present	  at	  both	  CBX2-­‐	  dependent	  and	  independent	  genes,	  and	  that	  its	  binding	  is	  independent	  of	  CBX2	  (Figure	  2.5C,	  compare	  the	  blue	  open	  and	  solid	  bars).	  CBX7	  alone	  is	  thus	  insufficient	  for	  the	  full	  repression	  of	  CBX2-­‐dependent	  genes.	  This	  implies	  that	  CBX7	  and	  CBX2	  are	  not	  fully	  redundant.	  We	  also	  observed	  that	  KRA-­‐CBX2	  does	  not	  affect	  CBX7	  binding	  (Figure	  2.5C,	  compare	  the	  red	  open	  and	  solid	  bars).	  Hence,	  we	  conclude	  that	  CBX7	  or	  CBX7-­‐containing	  PRC1	  is	  insufficient	  for	  full	  repression	  of	  genes	  that	  require	  CBX2	  for	  repression.	  	  
Finally,	  CBX2-­‐dependent	  repression	  might	  be	  associated	  with	  H2AUb	  andH3K27me3,	  the	  two	  histone	  modifications	  that	  coincide	  with	  PcG	  repressed	  regions	  in	  the	  genome.	  We	  found	  that	  re-­‐introducing	  WT-­‐CBX2	  does	  not	  increase	  the	  levels	  of	  H2AUb	  (Figure	  2.5D,	  compare	  blue	  open	  and	  solid	  bars).	  This	  implies	  that	  CBX2-­‐mediated	  repression	  is	  independent	  of	  H2AUb;	  it	  also	  implies	  that	  H2AUb	  without	  CBX2	  is	  insufficient	  for	  the	  full	  repression	  of	  some	  genes.	  We	  also	  noted	  that	  KRA-­‐CBX2	  does	  not	  interfere	  with	  H2AUb	  levels,	  indicating	  that	  the	  mutant	  CBX2	  does	  not	  disrupt	  Ring1B	  catalytic	  activity	  (Figure	  2.5D,	  compare	  red	  open	  and	  solid	  bars).	  	  Similarly,	  the	  re-­‐introduction	  of	  WT-­‐CBX2	  does	  not	  increase	  H3K27me3	  levels	  (Figure	  2.5E,	  compare	  blue	  open	  and	  solid	  bars).	  This	  suggests	  that	  CBX2-­‐dependent	  genes	  are	  not	  fully	  silenced	  without	  CBX2	  even	  when	  H3K27me3	  is	  present	  at	  wild	  type	  levels.	  Again,	  KRA-­‐CBX2	  does	  not	  interfere	  with	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H3K27me3	  levels.	  Based	  on	  these	  observations,	  we	  conclude	  that	  repression	  by	  CBX2	  is	  independent	  of	  Polycomb-­‐associated	  histone	  modifications.	  
Taken	  together,	  CBX2	  seems	  to	  be	  the	  direct	  effector	  of	  silencing	  at	  a	  subset	  of	  genes.	  Mutations	  in	  the	  CBX2	  compaction	  domain	  inhibit	  its	  gene	  silencing	  activity.	  	  
	  
DISCUSSION	  
In	  summary,	  we	  observed	  that	  behaviors	  of	  WT-­‐,	  KRA-­‐	  and	  DEA-­‐CBX2	  are	  different	  in	  a	  cellular	  context,	  and	  appeared	  to	  be	  associated	  with	  their	  in	  vitro	  activities.	  WT-­‐	  and	  DEA-­‐,	  both	  of	  which	  are	  active	  in	  vitro,	  are	  able	  to	  repress	  PRC1	  target	  genes,	  and	  their	  protein	  levels	  are	  tightly	  regulated	  in	  the	  cells.	  In	  contrast,	  KRA-­‐CBX2,	  which	  is	  inactive	  in	  
vitro,	  is	  unable	  to	  repress	  CBX2	  target	  genes,	  and	  can	  be	  tolerated	  at	  much	  higher	  levels;	  this	  corroborates	  that	  it	  is	  biologically	  inactive.	  Our	  results	  indicated	  that	  the	  differences	  between	  WT-­‐	  and	  KRA-­‐CBX2	  are	  not	  due	  to	  the	  loss	  of	  complex	  formation,	  chromatin	  binding	  or	  mis-­‐targeting	  with	  KRA-­‐CBX2.	  There	  are	  no	  significant	  changes	  in	  the	  binding	  of	  other	  PRC1	  components	  or	  Polycomb-­‐associated	  histone	  modifications	  on	  the	  target	  genes	  whether	  in	  the	  presence	  of	  WT-­‐	  or	  KRA-­‐CBX2.	  This	  suggests	  that	  the	  lack	  of	  gene	  repression	  by	  KRA-­‐CBX2	  is	  due	  to	  the	  absence	  of	  an	  activity	  that	  directly	  affects	  the	  target	  genes.	  The	  dominant	  CBX	  homolog	  in	  mESCs,	  CBX7,	  is	  inactive	  in	  vitro	  and	  does	  not	  fully	  repress	  PRC1	  targets	  that	  are	  CBX2-­‐dependent.	  Hence,	  our	  observations	  support	  the	  hypothesis	  that	  chromatin	  compaction,	  as	  exerted	  by	  CBX2,	  is	  a	  mechanism	  by	  which	  PRC1	  achieves	  gene	  repression.	  
We	  observed	  in	  our	  study	  that	  the	  number	  of	  genes	  that	  became	  repressed	  in	  Cbx2-­‐/-­‐	  mESCs	  following	  the	  re-­‐introduction	  of	  WT-­‐CBX2	  is	  small,	  and	  there	  were	  no	  change	  in	  the	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expression	  of	  the	  Hox	  genes.	  Moreover,	  the	  magnitude	  of	  down-­‐regulation	  is	  also	  modest	  with	  most	  target	  genes	  showing	  less	  than	  two-­‐fold	  change.	  This	  observation	  is	  consistent	  with	  a	  previous	  finding	  that	  CBX2	  is	  not	  essential	  for	  the	  role	  of	  PRC1	  in	  the	  mESC	  state25.	  This	  led	  us	  to	  ask	  whether	  the	  difference	  in	  the	  WT-­‐	  and	  KRA-­‐CBX2	  repressive	  activities	  has	  significance	  in	  biological	  functions;	  it	  is	  known	  that	  biological	  systems	  can	  tolerate	  a	  small	  range	  of	  gene	  expression	  levels	  without	  any	  impact.	  	  
Cbx2	  expression	  is	  low	  in	  mESCs,	  and	  increases	  as	  the	  cells	  undergo	  differentiation	  (Ref.	  25;	  also	  our	  data	  not	  shown).	  This	  suggests	  that	  we	  may	  see	  a	  larger	  difference	  between	  WT-­‐	  and	  KRA-­‐CBX2	  activity	  in	  a	  differentiated	  cell	  type.	  We	  differentiated	  our	  mESC	  lines	  using	  several	  differentiation	  protocols,	  and	  found	  that	  the	  differentiated	  cells	  often	  fail	  to	  respond	  to	  doxycycline	  induction	  for	  CBX2	  expression.	  The	  phenomenon	  is	  unlikely	  to	  be	  specific	  to	  WT-­‐	  and	  KRA-­‐CBX2,	  as	  others	  and	  we	  had	  experienced	  a	  similar	  challenge	  with	  unrelated	  doxycycline	  –inducible	  cell	  lines.	  Therefore,	  we	  subsequently	  developed	  a	  new	  system	  to	  further	  address	  the	  impact	  of	  the	  mutations	  in	  the	  compaction	  domain	  of	  CBX2,	  as	  described	  below.	  
	  
CONCLUSIONS	  AND	  NEXT	  STEPS	  
Through	  comparing	  mESCs	  that	  express	  WT-­‐	  or	  KRA-­‐CBX2,	  we	  were	  able	  to	  conclude	  that	  mutations	  in	  the	  compaction	  domain	  disrupt	  gene	  repression	  by	  CBX2.	  The	  magnitude	  of	  the	  effects,	  however,	  is	  small,	  which	  prompted	  us	  to	  compare	  WT-­‐	  and	  KRA-­‐CBX2	  in	  a	  different	  system.	  	  
Two	  independently	  generated	  Cbx2-­‐/-­‐	  mice	  had	  been	  studied	  and	  have	  a	  range	  of	  phenotypes,	  including	  anterior-­‐to-­‐posterior	  transformations	  that	  defined	  the	  Polycomb	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group	  mutants32,33.	  We	  reasoned	  that	  we	  would	  generate	  mutant	  mice	  that	  express	  KRA-­‐CBX2	  and	  compare	  phenotypes	  to	  the	  Cbx2-­‐/-­‐	  phenotypes.	  With	  the	  mutant	  mice	  we	  will	  also	  be	  able	  to	  study	  WT-­‐	  and	  KRA-­‐CBX2	  in	  the	  context	  of	  the	  other	  CBX	  homologs	  that	  are	  expressed	  during	  development.	  This	  is	  interesting	  because	  the	  compaction	  domain	  that	  is	  described	  here	  is	  unique	  to	  CBX2	  amongst	  the	  other	  CBX	  homologs.	  This	  work	  is	  described	  in	  the	  next	  research	  chapter.	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MATERIALS	  AND	  METHODS	  
Cell	  culture	  
	   Cbx2-­‐/-­‐	  and	  its	  derivative	  doxycycline-­‐inducible	  mESC	  lines	  were	  cultured	  on	  DR4	  feeders	  in	  mESC	  media,	  containing	  DMEM	  (Gibco	  11995),	  supplemented	  with	  15%	  FBS	  (Tet-­‐System	  Approved	  FBS,	  ES	  Cell	  Qualified;	  ClonTech	  Laboratories	  631157),	  1000U/mL	  LIF	  (Millipore),	  non-­‐essential	  amino	  acids,	  GlutaMax	  ,	  penicillin/streptomycin	  ,	  2-­‐β-­‐mercaptoethanol	  .	  V6.5,	  CJ7	  and	  J1	  mESCs	  were	  cultured	  on	  feeders	  (PMEF-­‐N,	  Fischer	  Scientific)	  in	  mESC	  media	  prepared	  as	  above,	  except	  that	  the	  FBS	  is	  ES-­‐certified	  serum	  from	  Hyclone	  (Thermofischer	  Scientific	  16141079).	  E14	  were	  culture	  on	  0.2%	  gelatin-­‐coated	  plate	  in	  mESC	  media	  supplemented	  with	  Hyclone	  serum.	  	  
Generation	  of	  doxycycline-­‐inducible	  mESC	  lines	  	  
	   The	  cell	  lines	  were	  generated	  using	  Tet-­‐On®	  3G	  Inducible	  Expression	  System	  (EF1alpha	  Version)	  and	  Tet-­‐On®	  3G	  Vector	  Set	  (Bicistronic	  Version)	  (Clontech	  631167,	  631161)	  according	  to	  the	  manufacturer’s	  protocol.	  Briefly,	  the	  Cbx2-­‐/-­‐	  cells	  were	  transfected	  with	  the	  pEF1alpha-­‐Tet3G	  plasmid	  and	  puromycin	  linear	  selection	  marker	  and	  selected	  for	  puromycin	  resistance.	  To	  test	  their	  responsiveness	  to	  doxycycline,	  individual	  clones	  were	  transfected	  with	  pTRE3G-­‐Luc	  and	  assayed	  for	  luciferase	  activity.	  A	  responsive	  clone	  was	  chosen	  and	  transfected	  with	  the	  pTRE3G	  plasmid	  containing	  a	  Kozak	  sequence	  followed	  by	  the	  coding	  sequence	  for	  HA-­‐tagged	  WT,	  KRA	  or	  DEA-­‐CBX2	  in	  MCS1,	  and	  the	  coding	  sequence	  for	  GFP	  in	  MCS2,	  along	  with	  linear	  hygromycin	  selection	  marker.	  Hygromycin-­‐resistant	  clones	  were	  treated	  with	  doxycycline	  and	  screened	  for	  GFP	  expression	  by	  imaging	  and	  for	  expression	  of	  CBX2	  by	  Western	  blot.	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Western	  blot	  
	   Whole	  cell	  lysates	  were	  prepared	  by	  lysing	  cells	  in	  RIPA	  buffer	  (50mM	  Tris-­‐HCl	  pH	  8.0,	  0.1%	  SDS,	  0.5%	  sodium	  deoxycholate,	  1%	  NP40,	  150mM	  NaCl),	  separated	  on	  4-­‐12%	  bis-­‐Tris	  gels,	  transferred	  onto	  nitrocellulose	  membranes	  and	  blotted	  for	  PRC1	  components	  using	  the	  antibodies	  listed	  in	  the	  Appendix,	  Table	  S1.	  TBP	  or	  H3	  protein	  levels	  were	  used	  as	  loading	  controls.	  Relative	  protein	  levels	  were	  quantified	  using	  ImageJ.	  	  
Chromatin	  Immunoprecipitation	  (ChIP)	  
	   ChIP	  experiments	  were	  performed	  using	  the	  antibodies	  listed	  in	  the	  Appendix	  using	  standard	  protocols.	  3x10^6	  cells	  were	  used	  for	  each	  ChIP	  experiment.	  ChIP	  enrichments	  were	  assessed	  via	  quantitative	  PCR	  analysis	  (ChIP-­‐qPCR)	  or	  high	  throughput	  sequencing	  (ChIP-­‐seq).	  	  
	   For	  ChIP-­‐qPCR,	  the	  sequences	  of	  the	  primers	  are	  listed	  in	  the	  Appendix,	  Table	  S3.	  	  
	   For	  ChIP-­‐seq,	  the	  enriched	  DNA	  and	  input	  DNA	  were	  made	  into	  sequencing	  libraries	  as	  previously	  described34,	  and	  sequenced	  on	  Illumina	  HiSeq	  2000	  instrument,	  resulting	  in	  approximately	  30	  million	  of	  50bp	  reads	  per	  sample.	  Reads	  were	  aligned	  against	  the	  mm9	  reference	  genome	  using	  BWA35.	  Alignments	  were	  filtered	  for	  uniquely	  mapped	  reads	  and	  alignment	  duplicates	  were	  removed.	  Input-­‐normalized	  coverage	  tracks	  were	  generated	  using	  SPP36.To	  determine	  regions	  of	  ChIP-­‐Seq	  tag	  enrichment,	  we	  analyzed	  tag	  counts	  in	  a	  1kb	  window	  over	  the	  chromosome	  length	  with	  the	  step	  of	  200bp.	  Statistical	  significance	  of	  enrichment	  of	  ChIP	  vs.	  input	  was	  estimated	  using	  negative	  binomial	  distribution,	  with	  the	  estimate	  of	  the	  mean	  based	  on	  the	  tag	  counts	  in	  input,	  and	  the	  size	  parameter	  (s)	  selected	  based	  on	  manual	  inspection	  of	  resulting	  peak	  calls.	  Adjacent	  enriched	  windows	  separated	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by	  1kb	  or	  less	  were	  merged	  to	  generate	  a	  list	  of	  regions	  with	  significant	  enrichment. 
Co-­‐immunoprecipitation	  
Nuclear	  lysates	  and	  immunoprecipitation	  were	  prepared	  and	  carried	  out	  as	  described	  in	  Hashimoto	  et	  al	  with	  the	  following	  modifications:	  Lysates	  from	  8x10^6	  cells	  were	  used	  per	  IP	  without	  pre-­‐clearing,	  Protein	  A	  Dynabeads	  (Life	  Technologies,	  100-­‐02D)	  were	  used	  to	  capture	  the	  antibody-­‐antigen	  complex,	  and	  the	  proteins	  were	  eluted	  by	  heating	  at	  70°C	  in	  LDS	  for	  10	  minutes.	  The	  antibodies	  used	  are	  listed	  in	  the	  Appendix.	  	  
Gene	  expression	  analyses	  	  
	   RNA-­‐seq:	  Total	  RNA	  was	  extracted	  from	  cells	  with	  Trizol,	  DNaseI-­‐treated	  and	  purified	  using	  Direct-­‐zol™	  RNA	  MiniPrep	  (Zymo).	  mRNA	  was	  purified	  from	  the	  RNA	  and	  made	  into	  cDNA	  libraries	  using	  TruSeq	  total	  RNA	  kit	  (Illumina).	  Sequencing	  libraries	  were	  prepared	  and	  sequenced	  as	  above.	  Two	  or	  three	  biological	  replicates	  were	  used	  per	  sample.	  The	  reads	  were	  aligned	  to	  the	  mouse	  transcriptome	  (mm9	  RefSeq	  annotation)	  using	  TopHat37.	  Gene	  expression	  counts	  were	  calculated	  using	  HTSeq	  v.0.6.038.	  Calculation	  of	  expression	  values	  and	  differential	  expression	  analysis	  were	  performed	  using	  edgeR39,	  with	  a	  filter	  for	  genes	  with	  average	  read	  counts	  of	  logCPM	  >1from	  all	  biological	  replicates.	  Library	  size-­‐normalized	  bigwig	  files	  for	  IGV	  genome	  browser	  tracks	  were	  generated	  using	  SPP.	  
	   To	  generate	  a	  list	  of	  candidate	  CBX2	  target	  genes,	  we	  selected	  genes	  with	  CBX2	  binding	  based	  on	  our	  CBX2	  ChIP-­‐seq	  data	  from	  WT-­‐	  and	  KRA-­‐CBX2	  expressing	  mESCs	  and	  have	  log	  fold	  change	  values	  (logFC)	  with	  adjusted	  P-­‐value	  <0.1,	  regardless	  of	  the	  magnitude	  of	  fold	  change.	  These	  genes	  and	  their	  logFC	  were	  used	  to	  generate	  the	  heat	  maps	  with	  hierarchical	  clustering	  using	  the	  heat	  map.2(	  )	  function	  in	  R.	  	  The	  Pearson	  correlations	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scores	  were	  based	  on	  logFC	  values	  and	  calculated	  using	  the	  cor(	  )	  function	  in	  R.	  	  
	   Reverse-­‐transcription	  quantitative	  PCR	  (RT-­‐qPCR):	  Total	  RNA	  was	  prepared	  as	  above	  and	  reverse	  transcribed	  using	  SuperScript®	  VILO™	  cDNA	  Synthesis	  Kit	  (Life	  Technologies,	  11754-­‐050).	  qPCR	  was	  performed	  using	  the	  Taqman	  probes	  indicated	  in	  the	  Appendix,	  Table	  S2.	  B2M	  levels	  were	  used	  as	  the	  internal	  control	  for	  cDNA	  content.	  The	  expression	  level	  of	  a	  gene	  in	  each	  +dox	  sample	  is	  presented	  as	  a	  relative	  value	  to	  its	  expression	  level	  in	  the	  corresponding	  no	  dox	  sample.	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The	  Polycomb	  group	  proteins	  are	  important	  epigenetic	  regulators	  that	  are	  required	  for	  cell	  fate	  stability.	  They	  are	  conserved	  throughout	  the	  animal	  and	  plant	  kingdoms,	  and	  function	  through	  maintaining	  the	  repression	  of	  their	  target	  genes.	  The	  Polycomb	  group	  mutants	  (PcG)	  in	  flies	  were	  initially	  identified	  based	  on	  a	  homeotic	  transformation	  phenotype,	  where	  the	  heterozygous	  mutant	  males	  exhibited	  ectopic	  sex	  combs	  on	  their	  second	  and	  third	  sets	  of	  legs.	  The	  homozygous	  mutants	  die	  early	  during	  development	  and	  the	  embryos	  generally	  have	  segmentation	  defects1,2.	  The	  phenotypes	  indicated	  that	  the	  anterior-­‐posterior	  body	  axis	  was	  disrupted	  during	  development	  in	  the	  PcG	  mutants.	  	  
The	  Hox	  genes	  are	  important	  determinants	  of	  the	  anterior-­‐posterior	  axis	  in	  most	  metazoans.	  Their	  expression	  patterns	  along	  the	  axis	  determine	  the	  ordered	  identities	  of	  the	  body	  segments	  of	  the	  organism3.	  Their	  expression	  patterns	  are	  initiated	  by	  early	  developmental	  regulators	  and	  are	  maintained	  through	  development	  to	  adulthood.	  The	  homeotic	  phenotypes	  in	  the	  PcG	  mutants	  arise	  from	  ectopic	  expression	  of	  the	  Hox	  genes	  in	  the	  developing	  embryo4,5.	  The	  PcG	  gene	  products	  form	  multi-­‐subunit	  complexes	  that	  bind	  to	  chromatin	  for	  transcriptional	  repression.	  	  
The	  mammalian	  homologs	  of	  the	  PcG	  genes	  were	  identified	  based	  on	  the	  sequence	  identities	  of	  the	  proteins	  they	  encode.	  There	  are	  multiple	  mammalian	  paralogs	  for	  each	  fly	  Polycomb	  group	  gene6.	  The	  paralogs	  have	  distinct	  and	  overlapping	  functions7,8.	  Here,	  we	  focus	  on	  the	  mammalian	  homologs	  to	  the	  fly	  PC,	  referred	  to	  as	  the	  CBX	  proteins.	  CBX2	  was	  previously	  shown	  to	  inhibit	  chromatin	  remodeling	  and	  compact	  polynucleosomes	  in	  vitro9.	  	  
There	  are	  five	  PC	  homologs	  in	  the	  mouse	  genome:	  CBX2,	  CBX4,	  CBX6,	  CBX7	  and	  CBX8.	  They	  were	  identified	  by	  virtue	  of	  their	  sequence	  identities	  to	  the	  chromodomain	  and	  C-­‐box	  domain	  in	  the	  fly	  PC.	  With	  the	  exception	  of	  CBX6,	  the	  four	  CBX	  proteins	  were	  shown	  to	  bind	  H3K27me3	  and	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H3K9me3	  peptide	  sequences	  via	  their	  chromodomains10,	  interact	  with	  Ring1B	  for	  PRC1	  formation	  via	  their	  C-­‐box	  domains11,	  and	  localize	  on	  chromatin	  at	  known	  PRC1	  target	  genes12-­‐15.	  Hence,	  they	  are	  bona	  fide	  subunits	  of	  the	  mammalian	  PRC1.	  Nonetheless,	  they	  have	  common	  and	  distinct	  characteristics	  as	  described	  below.	  Thus,	  depending	  on	  which	  CBX	  protein	  is	  incorporated	  into	  PRC1,	  the	  activity	  of	  the	  complex	  is	  likely	  to	  vary.	  It	  is	  unclear	  how	  this	  variation	  governs	  the	  roles	  of	  PRC1	  in	  mammalian	  development,	  and	  what	  features	  might	  be	  unique	  to	  the	  mammalian	  developmental	  process	  compared	  to	  flies.	  	  
Aside	  from	  the	  chromodomain	  at	  the	  N-­‐terminus,	  an	  AT-­‐hook	  or	  AT-­‐hook	  like	  motif	  next	  to	  the	  chromodomain	  and	  the	  C-­‐box	  at	  the	  C-­‐terminus,	  there	  is	  little	  conservation	  in	  the	  sequence	  and	  length	  in	  the	  middle	  portion	  of	  the	  CBX	  proteins16	  (Figure	  3.1A).	  This	  variation	  is	  thought	  to	  confer	  unique	  functionalities	  in	  the	  different	  homologs.	  	  
Indeed,	  the	  various	  CBX	  proteins	  differ	  in	  their	  abilities	  to	  repress	  chromatin	  remodeling	  and	  compact	  polynucleosomes	  in	  vitro9	  (Figure	  3.1B).	  There	  appears	  to	  be	  a	  correlation	  between	  the	  length	  of	  the	  variable	  portion,	  the	  amount	  of	  positive	  charge	  in	  the	  protein,	  and	  the	  in	  vitro	  activity	  levels.	  Specifically,	  the	  variable	  portion	  of	  CBX2	  is	  the	  longest	  and	  has	  the	  highest	  positive	  charge,	  which	  correlate	  with	  the	  protein’s	  high	  in	  vitro	  activity.	  In	  contrast,	  it	  is	  the	  shortest	  in	  CBX7,	  which	  also	  is	  the	  least	  positively	  charged	  CBX	  protein	  and	  lacks	  in	  vitro	  activity.	  CBX8	  has	  intermediate	  amounts	  of	  positive	  charge	  and	  a	  corresponding	  intermediate	  level	  of	  activity.	  	  



















CBX2' +32.5' Yes' Mouse'
CBX4' Not'reported'
CBX6' +16.1' Yes'' Frog'
CBX7' E7.7' No' Zebraﬁsh'
CBX8' +21.3' Yes' Zebraﬁsh'
A	  
B	  
Figure	  3.1	  	  Conserved	  and	  variable	  features	  of	  the	  CBX	  proteins.	  	  
A.	  Illustration	  of	  the	  protein	  structures	  of	  CBX	  and	  PC	  homologs	  drawn	  to	  scale.	  The	  region	  in	  CBX2	  that	  is	  required	  for	  its	  in	  vitro	  polynucleosome	  compaction	  activity	  is	  indicated.	  Image	  is	  adapted	  from	  Senthilkumar	  and	  Mishra	  (2009).	  B.	  The	  charge	  levels	  and	  compaction	  activities	  of	  CBX	  proteins	  from	  various	  organisms.	  Information	  is	  from	  Grau	  et.	  al	  (2012).	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support	  the	  notion	  that	  PRC1-­‐containing	  different	  CBX	  homologs	  have	  different	  roles,	  the	  functional	  significance	  of	  the	  differences	  remains	  to	  be	  tested.	  	  
The	  expression	  of	  CBX2,	  CBX4,	  CBX7	  and	  CBX8	  are	  temporally	  regulated	  during	  mESC	  and	  hematopoietic	  stem	  cell	  (HSC)	  differentiation.	  In	  mESCs,	  the	  expression	  of	  CBX7	  is	  the	  highest	  and	  is	  necessary	  for	  self-­‐renewal.	  As	  mESCs	  undergo	  differentiation,	  CBX7	  is	  down-­‐regulated	  while	  CBX2,	  4	  and	  8	  are	  up-­‐regulated15.	  Even	  though	  CBX2,	  4	  and	  8	  are	  expressed	  at	  the	  same	  developmental	  stages,	  they	  are	  required	  for	  the	  specification	  of	  different	  cell	  fates.	  For	  example,	  CBX2	  and	  CBX4	  bind	  distinct	  sets	  of	  target	  genes	  in	  embryoid	  bodies,	  and	  their	  depletion	  in	  teratomas	  leads	  to	  an	  overrepresentation	  of	  cells	  from	  the	  endodermal	  and	  mesodermal	  lineages,	  respectively.	  	  Interestingly,	  CBX8	  is	  required	  for	  activation	  of	  developmental	  regulators	  in	  the	  early	  differentiation	  steps,	  which	  runs	  contrary	  to	  the	  conventional	  role	  of	  PRC1	  as	  transcriptional	  repressors15.	  Similarly	  for	  mouse	  HSCs,	  only	  CBX7	  is	  required	  for	  self-­‐renewal,	  while	  CBX2,	  4	  and	  8	  are	  required	  for	  proper	  differentiation.	  CBX2	  is	  specifically	  necessary	  for	  lymphopoiesis19,20.	  Hence,	  CBX7	  appears	  to	  be	  associated	  with	  sustained	  cell	  proliferation	  and	  cell	  fate	  plasticity,	  while	  CBX2,	  4	  and	  8	  are	  associated	  with	  cell	  fate	  restriction,	  at	  least	  in	  mice.	  There	  is	  evidence	  suggesting	  that	  the	  human	  CBX2	  and	  CBX4	  have	  functions	  that	  are	  contrary	  to	  their	  mouse	  counterparts21-­‐23.	  	  	  
The	  knockout	  mice	  for	  all	  the	  CBX	  homologs	  have	  been	  generated	  and	  examined24-­‐29.	  In	  contrast	  to	  flies,	  in	  which	  homozygous	  Pc	  null	  is	  embryonic	  lethal,	  the	  Cbx	  knockout	  mice	  are	  able	  to	  complete	  embryogenesis,	  suggesting	  that	  there	  is	  at	  least	  some	  redundancy	  in	  function	  among	  the	  CBX	  proteins	  during	  development.	  	  
Interestingly,	  only	  the	  Cbx2-­‐/-­‐	  mice	  exhibit	  the	  classic	  homeotic	  transformation	  phenotype	  that	  characterized	  the	  initial	  fly	  PcG	  mutants24,25.	  This	  suggests	  that	  CBX2	  has	  a	  unique	  activity	  that	  is	  required	  for	  maintaining	  Hox	  gene	  repression	  that	  cannot	  be	  compensated	  for	  by	  the	  other	  CBX	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homologs.	  It	  is	  unknown	  whether	  the	  lack	  of	  compensation	  is	  due	  to	  the	  absence	  of	  a	  specific	  activity	  in	  the	  other	  homologs	  or	  failure	  to	  invoke	  their	  expression	  at	  specific	  stages	  of	  embryogenesis.	  The	  Cbx2-­‐/-­‐	  mice	  also	  exhibit	  other	  phenotypes,	  including	  male-­‐to-­‐female	  sex	  reversal25.	  This	  phenotype	  was	  reported	  for	  a	  human	  patient	  who	  had	  two	  somatic	  point	  mutations	  in	  Cbx2.	  The	  mutations	  are	  not	  within	  the	  compaction	  domain	  defined	  in	  our	  in	  vitro	  assays,	  nor	  did	  the	  patient	  display	  skeletal	  abnormalities30.	  This	  suggests	  that	  the	  protein	  regions	  involved	  in	  Hox	  gene	  regulation	  and	  sex-­‐determination	  are	  distinct	  in	  CBX2.	  In	  contrast	  to	  Cbx2-­‐/-­‐	  mice,	  the	  Cbx4-­‐/-­‐	  mice	  have	  hematopoietic	  system	  defects31,	  while	  the	  Cbx7-­‐/-­‐	  and	  Cbx8-­‐/-­‐	  mice	  do	  not	  have	  obvious	  developmental	  abnormalities26,32.	  	  







Generation	  of	  Cbx223KRA	  mutant	  mice	  	  
To	  determine	  whether	  K-­‐to-­‐A	  and	  R-­‐to-­‐A	  mutations	  in	  the	  compaction	  domain	  would	  negatively	  impact	  PRC1	  function	  during	  embryogenesis,	  we	  generated	  a	  targeting	  construct	  to	  knock-­‐in	  the	  mutations	  into	  the	  endogenous	  Cbx2	  locus	  (Figure	  3.2A).	  The	  predicted	  gene	  product	  from	  this	  allele	  is	  the	  same	  KRA-­‐CBX2	  variant	  that	  was	  investigated	  in	  Chapter	  2.	  It	  will	  be	  referred	  to	  as	  CBX223KRA	  from	  here	  onwards	  due	  to	  the	  23	  amino	  acid	  substitutions	  introduced.	  	  
The	  construct	  was	  electroporated	  into	  V6.5	  mESCs,	  which	  is	  a	  C57BL/6	  x	  129S4/SvJae	  F1	  hybrid	  line;	  the	  genetic	  background	  of	  the	  resulting	  mice	  will	  be	  a	  point	  of	  consideration	  in	  the	  phenotypic	  analyses	  later.	  	  We	  screened	  for	  homologous	  recombination	  events	  at	  the	  endogenous	  locus	  by	  PCR	  with	  the	  primer	  pairs	  indicated	  in	  Figure	  3.2A.	  The	  targeted	  and	  the	  wild	  type	  alleles	  give	  PCR	  products	  of	  different	  sizes,	  thereby	  allowing	  us	  to	  identify	  mESC	  clones	  with	  successful	  targeting.	  The	  targeted	  allele	  is	  denoted	  Cbx223KRAneo	  as	  the	  neomycin	  selection	  cassette	  (neoR)	  is	  present	  in	  its	  intron	  4.	  An	  example	  of	  the	  PCR	  products	  after	  gel	  electrophoresis	  is	  shown.	  We	  recovered	  one	  targeted	  mESC	  clone.	  	  
The	  steps	  to	  obtain	  Cbx223KRA	  mutant	  mice	  are	  summarized	  in	  Figure	  3.2B.	  Briefly,	  the	  targeted	  mESC	  clone	  was	  injected	  into	  host	  blastocysts	  to	  generate	  chimeric	  mice,	  which	  were	  then	  crossed	  with	  C57BL/6	  mice	  to	  test	  for	  germ	  line	  transmission	  of	  Cbx223KRAneo.	  We	  recovered	  four	  chimeric	  founders	  with	  germ	  line	  transmission.	  	  	  






































































































Heterozygous	  F2	  progeny	  from	  this	  cross	  were	  screened	  for	  the	  removal	  of	  neoR	  by	  PCR	  with	  the	  indicated	  primer	  pairs	  (Figure	  3.2C).	  An	  example	  of	  the	  PCR	  products	  after	  gel	  electrophoresis	  is	  shown.	  We	  denote	  the	  targeted	  allele	  after	  neoR	  removal	  Cbx223KRA.	  Only	  Cbx223KRA/+	  mice	  were	  used	  in	  subsequent	  crosses.	  We	  noted	  that	  neoR	  removal	  could	  be	  incomplete	  in	  the	  germ	  line	  of	  these	  mice	  and	  this	  cannot	  be	  detected	  by	  genotyping	  with	  tail	  tip	  genomic	  DNA.	  Therefore,	  we	  always	  tested	  the	  F3	  progeny	  from	  these	  crosses	  for	  the	  presence	  of	  neoR	  .	  Only	  F3	  mice	  that	  were	  free	  of	  neoR	  were	  retained	  for	  further	  breeding.	  	  
The	  Cbx223KRA/+	  F2	  mice	  were	  intercrossed,	  and	  the	  F3	  progeny	  were	  genotyped	  using	  a	  melt	  curve	  analysis	  approach	  (see	  Materials	  and	  Methods).	  We	  were	  able	  to	  obtain	  live	  Cbx223KRA/+and	  
Cbx223KRA/23KRA	  animals	  from	  these	  crosses.	  	  
Generation	  of	  Cbx213KRA	  mutant	  mice	  
The	  in	  vitro	  assays	  with	  CBX2	  variants	  indicated	  that	  a	  smaller	  number	  of	  K-­‐to-­‐A	  and	  R-­‐to-­‐A	  substitutions	  also	  negatively	  impacted	  CBX2	  activity	  levels9.	  We	  wanted	  to	  know	  if	  a	  smaller	  number	  of	  mutations	  (fewer	  than	  23)	  would	  also	  disrupt	  PRC1	  function	  during	  development.	  We	  chose	  to	  test	  CBX213KRA	  because	  of	  its	  in	  vitro	  activity	  levels,	  which	  are	  intermediate	  between	  CBX2WT	  and	  CBX223KRA.	  All	  the	  13	  amino	  acid	  substitutions	  in	  CBX213KRA	  are	  in	  region	  1	  of	  the	  biochemically	  defined	  compaction	  domain.	  It	  appears	  that	  this	  region	  is	  critical	  for	  CBX2	  activity,	  as	  a	  similar	  number	  of	  mutations	  in	  region	  2	  of	  the	  compaction	  domain	  by	  themselves	  had	  no	  impact	  on	  the	  activity	  but	  enhance	  the	  loss	  of	  activity	  in	  the	  presence	  of	  the	  mutations	  in	  region	  1.	  	  
To	  generate	  a	  knock-­‐in	  Cbx213KRA	  allele,	  we	  used	  a	  CRIPSR-­‐Cas9-­‐mediated	  targeting	  approach	  as	  illustrated	  in	  Figure	  3.3A.	  A	  pair	  of	  single-­‐guide	  RNAs	  (sgRNAs),	  mRNA	  encoding	  the	  Cas9	  nickase,	  and	  a	  plasmid	  containing	  the	  donor	  sequence	  for	  homologous	  recombination	  were	  injected	  into	  mouse	  zygotes	  (C57BL/6	  inbred	  strain).	  The	  schematics	  of	  the	  recognition	  sites	  of	  the	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Figure	  3.3	  	  Generation	  of	  Cbx213KRA	  mutant	  mice.	  	  
A.	  The	  approach	  for	  generating	  Cbx213KRA	  mutant	  mice	  via	  zygotic	  injection	  of	  the	  CRISPR-­‐Cas9n	  system	  and	  a	  DNA	  donor.	  Image	  is	  adapted	  from	  http://jaxmice.jax.org.	  B.	  Schematics	  of	  the	  endogenous	  Cbx2	  locus	  and	  the	  composition	  of	  the	  DNA	  donor	  used	  for	  knocking	  in	  the	  K-­‐to-­‐A	  and	  R-­‐to-­‐A	  mutation	  sequence.	  The	  relative	  positions	  on	  gene	  of	  the	  recognition	  sites	  of	  the	  sgRNA	  pair,	  the	  sites	  encoding	  the	  mutations,	  and	  the	  restriction	  sites	  for	  RFLP	  analysis	  are	  indicated.	  C.	  The	  endogenous	  WT	  allele	  and	  the	  expected	  targeted	  allele	  after	  homologous	  recombination.	  The	  binding	  locations	  of	  the	  primers	  used	  in	  the	  PCR-­‐RFLP	  screening	  assay	  are	  indicated	  by	  blue	  arrowheads.	  An	  example	  of	  the	  gel	  image	  after	  RFLP	  and	  the	  fragment	  sizes	  that	  are	  expected	  from	  each	  allele.	  Fragments	  unique	  to	  the	  mutant	  and	  WT	  allele	  are	  marked	  with	  red	  and	  blue	  asterisks.	  respectively.	  In	  this	  example,	  the	  three	  mice	  that	  arose	  from	  injected	  zygotes	  had	  RFLP	  fragments	  from	  both	  the	  mutant	  and	  WT	  alleles.	  This	  indicates	  that	  one	  of	  their	  Cbx2	  allele	  had	  undergone	  the	  anticipated	  homologous	  recombination	  event.	  	  D.	  Schematic	  illustration	  of	  the	  expected	  gene	  products	  from	  the	  Cbx2	  mutant	  alleles	  in	  mice	  generated	  for	  this	  study.	  The	  amino	  acid	  sequence	  in	  their	  compaction	  domains	  are	  shown.	  E.	  An	  example	  of	  the	  	  melt	  curve	  proPiles	  of	  	  WT,	  heterozygous	  and	  	  homozygous	  mutants	  (bottom	  panel,	  shown	  for	  the	  Cbx213KRA	  mice).	  The	  binding	  sites	  of	  the	  primers	  used	  in	  this	  analysis	  are	  shown	  in	  the	  top	  panel.	  The	  middle	  panel	  are	  melt	  curves	  from	  control	  plasmids.	  The	  proPiles	  for	  Cbx223KRA	  and	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Figure	  3.3	  (Continued)	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sgRNAs	  and	  the	  donor	  are	  shown	  in	  Figure	  3.3B.	  In	  addition	  to	  the	  differences	  in	  coding	  sequence,	  the	  endogenous	  Cbx2	  and	  donor	  sequences	  also	  differ	  in	  the	  presence	  or	  absence	  of	  the	  XmaI	  and	  HindIII	  restriction	  sites,	  which	  allows	  the	  two	  sequences	  to	  be	  distinguished	  by	  restriction	  fragment	  length	  polymorphism	  (RFLP).	  	  
Mice	  born	  from	  the	  injected	  zygotes	  were	  screened	  for	  homologous	  recombination	  events	  via	  PCR	  with	  the	  indicated	  primer	  pair	  and	  RFLP	  with	  XmaI	  and	  HindIII	  (Figure	  3.3C).	  Cutting	  by	  HindIII	  and	  resistance	  to	  cutting	  by	  XmaI	  would	  indicate	  that	  homologous	  recombination	  has	  taken	  place.	  An	  example	  of	  this	  analysis	  is	  shown	  in	  the	  gel	  image	  shown	  in	  Figure	  3.3C.	  
Based	  on	  the	  RFLP	  results,	  three	  mice	  were	  identified	  to	  have	  homologous	  recombination	  events	  in	  their	  genomes.	  Exon	  5	  of	  the	  Cbx2	  gene	  from	  these	  animals	  were	  cloned	  and	  sequenced	  so	  that	  they	  can	  be	  characterized	  in	  detailed,	  e.g.	  to	  identify	  small	  internal	  insertions	  or	  deletions	  that	  would	  not	  be	  detected	  by	  PCR-­‐RFLP.	  All	  three	  mice	  were	  found	  to	  have	  more	  than	  two	  types	  of	  Cbx2	  alleles	  at	  the	  endogenous	  locus,	  suggesting	  that	  they	  are	  mosaic.	  Each	  type	  of	  mutant	  allele	  is	  likely	  to	  have	  arisen	  from	  independent	  CRISPR-­‐mediated	  cutting	  events	  in	  the	  developing	  embryo.	  	  
The	  mosaic	  founders	  were	  crossed	  to	  C57BL/6	  mice	  to	  test	  for	  germ	  line	  transmission	  and	  to	  segregate	  the	  mutant	  alleles.	  We	  recovered	  several	  mutant	  alleles	  among	  the	  progeny,	  but	  two	  are	  of	  particular	  interest:	  Cbx213KRA,	  which	  is	  encoded	  by	  the	  donor	  sequence,	  and	  a	  novel	  Cbx26KRA,	  that	  presumably	  arose	  from	  an	  incomplete	  homologous	  recombination	  event.	  Cbx26KRA	  would	  give	  amino	  acid	  substitutions	  in	  the	  8th-­‐13th	  targeted	  residues;	  thus	  it	  has	  half	  the	  number	  of	  mutations	  in	  Cbx213KRA,	  and	  a	  quarter	  of	  the	  mutations	  in	  Cbx223KRA	  (Figure	  3.3D).	  	  	  
Cbx213KRA/+	  and	  Cbx26KRA/+	  siblings	  were	  intercrossed	  to	  produce	  wild	  type,	  heterozygous,	  and	  homozygous	  progeny	  of	  the	  respective	  mutant	  alleles	  for	  experimentation.	  The	  animals	  were	  genotyped	  using	  the	  melt	  curve	  analysis	  approach.	  An	  example	  of	  the	  melt	  curve	  profiles	  is	  shown	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in	  Figure	  3.3E.	  We	  were	  able	  to	  obtain	  live	  Cbx213KRA/+,	  Cbx213KRA/13KRA	  and	  Cbx26KRA/+,	  Cbx26KRA/6KRA	  animals.	  	  
Expression	  of	  the	  engineered	  Cbx2	  alleles	  and	  the	  activities	  of	  their	  products	  in	  vitro	  	  
To	  assess	  whether	  the	  targeted	  mutant	  alleles	  were	  expressed	  in	  vivo,	  we	  compared	  the	  CBX2	  protein	  levels	  in	  E10.5	  embryos	  that	  are	  homozygous	  mutant	  with	  their	  wild	  type	  littermates	  by	  Western	  blot	  analysis.	  We	  observed	  that	  CBX223KRA	  and	  CBX213KRA	  protein	  levels	  are	  similar	  to	  wild	  type	  levels,,	  while	  CBX26KRA	  is	  present	  at	  66%	  of	  wild	  type	  levels	  	  (Figures	  3.3A,	  B).	  We	  repeated	  the	  experiment	  with	  additional	  Cbx26KRA/6KRA	  samples	  and	  obtained	  similar	  results	  (data	  not	  shown).	  The	  protein	  levels	  in	  Cbx26KRA/+	  embryos,	  however,	  are	  similar	  to	  wild	  type.	  	  This	  indicates	  that	  the	  Cbx223KRA	  and	  Cbx213KRA	  alleles	  are	  expressed	  normally	  but	  Cbx26KRA	  is	  expressed	  at	  a	  reduced	  level.	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Figure	  3.4	  	  The	  expression	  of	  the	  CBX223KRA,	  CBX213KRA	  and	  CBX26KRA	  	  in	  vivo	  and	  their	  in	  




for	  Cbx4	  (data	  not	  shown).	  Therefore,	  we	  conclude	  that	  the	  expressions	  of	  the	  other	  Cbx	  homologs	  are	  not	  affected	  in	  the	  mutants.	  	  
CBX26KRA	  is	  a	  novel	  CBX2	  variant	  whose	  in	  vitro	  activity	  level	  was	  undetermined.	  In	  order	  to	  be	  able	  to	  associate	  the	  phenotypes	  of	  the	  Cbx26KRA	  mutants	  with	  the	  activity	  of	  the	  protein,	  we	  tested	  CBX26KRA	  for	  its	  ability	  to	  inhibit	  chromatin	  remodeling	  in	  vitro.	  Based	  on	  previous	  studies	  we	  would	  expect	  CBX26KRA	  to	  have	  activity	  levels	  that	  are	  intermediate	  between	  CBX2WT	  and	  CBX213KRA,	  in	  accordance	  to	  its	  positive	  charge.	  Indeed,	  this	  was	  what	  we	  observed	  (Figure	  3.4C).	  CBX223KRA	  is	  the	  least	  active	  among	  the	  protein	  variants	  tested,	  which	  is	  consistent	  with	  previous	  findings	  9.	  	  
Therefore,	  we	  have	  at	  least	  two	  mutant	  mouse	  lines,	  Cbx223KRA	  and	  Cbx213KRA,	  that	  express	  CBX2	  variants	  with	  different	  extents	  of	  K-­‐to-­‐A	  and	  R-­‐to-­‐A	  mutations	  in	  the	  compaction	  domain.	  The	  
Cbx26KRA	  allele	  has	  lower	  CBX2	  protein	  levels.	  Given	  that	  PcG	  proteins	  have	  dose-­‐dependent	  effects,	  results	  from	  the	  Cbx26KRA	  mutants	  will	  have	  to	  be	  interpreted	  with	  caution.	  The	  CBX2	  variants	  from	  these	  alleles	  have	  in	  vitro	  activity	  levels	  that	  correspond	  to	  the	  number	  of	  mutations	  introduced.	  We	  proceeded	  to	  examine	  the	  mutant	  mice	  for	  loss-­‐of-­‐function	  PcG	  phenotypes	  to	  determine	  the	  contribution	  of	  the	  compaction	  domain	  to	  PRC1	  function	  in	  the	  animals.	  	  
Posterior	  transformation	  in	  the	  skeleton	  of	  Cbx223KRA/23KRA	  mice	  
Posteriorization,	  or	  posterior	  transformation,	  describes	  a	  morphological	  change	  where	  a	  more	  anterior	  body	  segment	  assumes	  the	  identity	  of	  a	  more	  posterior	  segment.	  Posteriorization	  is	  a	  phenotype	  for	  gain-­‐of-­‐function	  in	  the	  Hox	  genes,	  which	  in	  turn	  can	  be	  caused	  by	  loss-­‐of-­‐function	  in	  the	  PcG	  genes.	  	  In	  mice,	  posteriorization	  is	  identified	  by	  examining	  the	  axial	  skeleton.	  The	  mouse	  vertebrae	  are	  divided	  into	  five	  distinct	  regions,	  namely	  the	  cervical,	  thoracic,	  sacral,	  lumbar	  and	  caudal	  regions.	  Bones	  from	  each	  segment	  have	  unique	  morphologies	  and	  are	  present	  in	  defined	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numbers	  with	  small	  variation	  among	  different	  genetic	  backgrounds.	  Posteriorization	  in	  mice	  would	  thus	  manifest	  as	  changes	  in	  the	  vertebrae	  pattern.	  Therefore,	  we	  stained	  the	  skeletons	  of	  young	  adult	  mice	  of	  the	  Cbx223KR/23KRA	  ,	  Cbx223KR/+	  and	  Cbx2+/+	  genotypes	  for	  examination.	  	  
We	  found	  that	  the	  vertebrae	  of	  the	  Cbx223KRA/23KRA	  animals	  have	  morphological	  changes	  at	  several	  positions	  along	  the	  anterior-­‐posterior	  axis.	  The	  changes	  are	  all	  posterior	  transformations,	  which	  are	  consistent	  with	  loss	  of	  Hox	  gene	  repression	  by	  PcG	  proteins	  during	  development	  .	  These	  changes	  included:	  (1)	  C7-­‐to-­‐T1:	  partial	  transformation	  of	  the	  seventh	  cervical	  vertebra	  to	  the	  first	  thoracic	  vertebra,	  as	  characterized	  by	  ectopic	  ribs	  at	  C7,	  which	  were	  often	  asymmetrical	  in	  length	  and	  shape.	  In	  two	  of	  the	  nine	  Cbx223KRA/23KRA	  skeletons	  examined,	  the	  C7	  rib	  on	  one	  side	  is	  a	  full	  rib	  that	  fuses	  to	  the	  sternum	  while	  the	  C7	  rib	  on	  the	  other	  side	  fuses	  to	  the	  rib	  associated	  with	  T1	  (Figure	  3.5A,	  B);	  (2)	  T1-­‐to-­‐T2:	  transformation	  of	  the	  first	  thoracic	  vertebra	  to	  the	  second	  thoracic	  vertebra,	  as	  evidenced	  by	  the	  presence	  of	  a	  spinous	  process	  on	  T1	  usually	  restricted	  to	  T2	  (Figure	  3.5A,	  B);	  (3)	  T7-­‐to-­‐T8:	  unilateral	  or	  bilateral	  transformation	  of	  the	  seventh	  thoracic	  vertebra	  to	  the	  eight	  vertebra,	  which	  led	  to	  six	  vertebrosternal	  ribs	  instead	  of	  the	  expected	  seven	  in	  wild	  type	  mice.	  In	  some	  mutants	  the	  seventh	  rib	  (R7)	  misattached	  to	  a	  more	  posterior	  position	  on	  the	  sternum	  (Figure	  3.5D);	  (4)	  T13-­‐to-­‐L1:	  the	  transformation	  of	  the	  thirteenth	  thoracic	  vertebra	  to	  the	  first	  lumbar	  vertebra,	  as	  characterized	  by	  the	  unilateral	  degeneration	  of	  the	  floating	  rib	  normally	  on	  T13	  (Figure	  3.5E,	  F);	  	  (5)	  L6-­‐to-­‐S1:	  the	  transformation	  of	  the	  sixth	  lumbar	  vertebra	  to	  the	  first	  sacral	  vertebra,	  which	  is	  ,	  identified	  as	  the	  association	  of	  the	  ilium	  with	  L6	  instead	  of	  S1	  (Figure	  3.5E).	  	  
We	  compared	  the	  transformations	  in	  the	  Cbx223KRA/23KRA	  mice	  to	  those	  previously	  reported	  for	  the	  Cbx2-­‐/-­‐,	  Phc2-­‐/-­‐	  and	  Bmi1-­‐/-­‐	  mice	  (Table	  3.1)7,24,33,34.	  We	  note	  that	  the	  reported	  penetrance	  of	  the	  transformations	  may	  not	  be	  directly	  comparable	  among	  the	  different	  mutants	  as	  the	  phenotypes	  could	  be	  scored	  by	  different	  criteria.	  Furthermore,	  the	  mice	  are	  in	  dissimilar	  genetic	  backgrounds.	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Figure	  3.5	  	  Posterior	  transformations	  in	  Cbx223KRA	  and	  Cbx213KRA	  mutant	  mice.	  	  
A.	  Lateral	  views	  of	  the	  cervical	  vertebrae	  and	  the	  3irst	  two	  thoracic	  vertebrae.	  The	  ectopic	  cervical	  ribs	  (asterisks)	  and	  spinous	  processes	  on	  T1	  (open	  arrow	  heads)	  on	  the	  mutants	  are	  evidences	  for	  posteriorization	  in	  the	  axial	  skeleton.	  B.	  Disarticulated	  C7,	  T1	  and	  T2	  bones	  from	  Cbx223KRA/23KRA	  and	  matching	  WT	  control	  animals.	  The	  transformed	  bones	  from	  the	  mutants	  have	  intermediate	  morphologies.	  Mutants	  exhibit	  longer	  cervical	  ribs	  (black	  arrow	  heads)	  than	  the	  rib	  anlanges	  in	  WT	  controls.	  The	  spinous	  process	  on	  T1	  (open	  arrow	  head)	  and	  a	  spurious	  rib	  extending	  from	  the	  rib	  on	  T1	  (asterisk)	  are	  marked.	  C.	  Disarticulated	  C7	  bones	  from	  Cbx213KRA/13KRA	  and	  matching	  control	  animals.	  The	  cervical	  ribs	  in	  the	  mutants	  smaller	  compared	  to	  those	  in	  Cbx223KRA/23KRA	  (Panel	  B).	  D.	  	  Sternal	  defects.	  R7	  in	  mutants	  are	  often	  mis-­‐attached	  or	  un-­‐attached	  to	  the	  sternum	  (asterisks).	  Black	  arrow	  heads	  depict	  the	  expected	  positions	  of	  splits	  in	  the	  sternum	  segment.	  The	  absence	  of	  the	  split	  leads	  to	  3ive	  sternum	  segments	  instead	  of	  six.	  	  E.	  Transformations	  in	  the	  lumbar	  and	  sacral	  vertebrae.	  T13-­‐to-­‐L6	  transformations	  are	  marked	  with	  asterisks.	  F.	  Disarticulated	  T13	  bones	  from	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The	  transformations	  observed	  in	  Cbx223KRA/23KRA	  overlap	  with	  those	  found	  in	  Cbx2-­‐/-­‐	  (Table	  3.1).	  This	  indicates	  that	  the	  Cbx223KRA23KRA	  resembles	  Cbx2-­‐/-­‐.	  The	  transformations	  are	  partially	  penetrant	  in	  Cbx223KRA/23KRA	  mice;	  in	  contrast,	  they	  were	  reported	  to	  be	  fully	  penetrant	  in	  the	  Cbx2-­‐/-­‐	  mice.	  	  This	  may	  suggest	  that	  Cbx223KRA	  is	  hypomorphic,	  which	  is	  consistent	  with	  our	  molecular	  data	  from	  Chapter	  2,	  where	  we	  showed	  that	  the	  K-­‐to-­‐A	  and	  R-­‐to-­‐A	  mutations	  do	  not	  prevent	  CBX223KRA	  from	  being	  incorporated	  into	  PRC1	  and	  binding	  chromatin.	  This	  could	  also	  explain	  the	  absence	  of	  the	  exocipital-­‐C1	  fusion	  and	  C1-­‐to-­‐C2	  transformations	  which	  were	  reported	  for	  the	  Cbx2-­‐/-­‐	  mice.	  Nevertheless,	  the	  phenotypic	  variations	  could	  also	  be	  due	  to	  the	  differences	  in	  genetic	  backgrounds	  between	  our	  mutant	  line	  and	  the	  two	  Cbx2-­‐/-­‐	  mouse	  lines.	  	  
Based	  on	  this	  analysis,	  we	  conclude	  that	  the	  mutations	  in	  the	  compaction	  domain	  of	  CBX2	  mimic	  loss-­‐of-­‐function	  in	  Cbx2.	  These	  observations	  support	  our	  hypothesis	  that	  activity	  in	  the	  compaction	  domain	  is	  important	  for	  CBX2	  activity	  during	  embryogenesis.	  	  
Posterior	  transformation	  in	  the	  skeleton	  of	  Cbx213KRA/13KRA	  mice	  
The	  in	  vitro	  activity	  level	  of	  CBX213KRA	  is	  between	  that	  of	  CBX2WT	  and	  CBX223KRA	  (Figure	  3.4C).	  We	  wanted	  to	  know	  if	  the	  Cbx213KRA/13KRA	  mice	  have	  transformation	  phenotypes,	  and	  if	  so,	  are	  they	  less	  severe	  compared	  to	  the	  Cbx223KRA/23KRA	  mice,	  as	  the	  biochemical	  data	  would	  predict.	  Thus,	  we	  similarly	  analyzed	  skeleton	  preparations	  of	  Cbx213KRA/13KRA,	  Cbx213KRA/+	  and	  Cbx2+/+	  animals.	  	  	  
We	  found	  that	  the	  Cbx213KRA/13KRA	  mice	  exhibited	  four	  out	  of	  five	  of	  the	  posterior	  transformations	  observed	  in	  the	  Cbx223KRA/23KRA	  mice	  (Table	  3.2).	  They	  did	  not	  have	  additional	  axial	  skeletal	  changes	  that	  were	  not	  seen	  in	  the	  Cbx223KRAmutants.	  Thus,	  the	  Cbx213KRA	  and	  Cbx223KRA	  alleles	  lead	  to	  similar	  abnormalities	  in	  the	  axial	  skeleton.	  	  
To	  determine	  whether	  there	  is	  a	  difference	  in	  the	  severity	  of	  the	  phenotypes	  between	  the	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Cbx213KRA	  and	  Cbx223KRA	  mutants,	  we	  compared	  the	  extent	  of	  morphological	  change	  and	  the	  frequency	  of	  occurrence	  of	  each	  transformation,	  taking	  into	  consideration	  that	  the	  two	  lines	  are	  in	  dissimilar	  genetic	  backgrounds.	  	  
The	  C7-­‐to-­‐T1	  transformations	  are	  more	  dramatic	  in	  Cbx223KRA/23KRA	  than	  in	  Cbx213KRA/13KRA	  .	  	  For	  the	  Cbx223KRA/23KRA,	  	  the	  ectopic	  cervical	  ribs	  are	  longer	  and	  in	  some	  instances	  become	  articulated	  to	  the	  sternum	  or	  T1	  rib	  (Figure	  3.5B,	  panels	  iv	  and	  vi).	  	  In	  contrast,	  the	  cervical	  ribs	  in	  
Cbx213KRA/13KRA	  resemble	  nubbins	  (Figure	  3.5C,	  panel	  ii).	  Moreover,	  two	  Cbx223KRA/23KRA	  animals	  (not	  the	  ones	  with	  the	  cervical	  ribs	  attached	  to	  the	  sternum)	  have	  additional	  defects	  in	  their	  cervical	  vertebra,	  which	  are	  	  C2-­‐C3	  and	  C4-­‐C5	  fusions,	  respectively.	  Only	  one	  Cbx213KRA/23KRA	  has	  an	  additional	  cervical	  vertebra	  defect,	  which	  was	  a	  missing	  C3.	  	  We	  noted	  that	  the	  Cbx223KRA/23KRA	  and	  
Cbx213KRA/13KRA	  may	  not	  be	  directly	  comparable	  for	  transformations	  in	  the	  cervical	  region	  because	  of	  differences	  in	  genetic	  background.	  We	  observed	  that	  the	  wild	  type	  littermates	  of	  the	  Cbx223KRA	  strain	  have	  tiny	  rib	  anlages	  at	  C7	  (Figure	  3.5B,	  panel	  i).	  This	  is	  presumably	  due	  to	  its	  hybrid	  genetic	  background35.	  In	  contrast,	  the	  wild	  type	  littermates	  of	  the	  Cbx213KRA/13KRA	  animals	  examined	  do	  not	  have	  extraneous	  bones	  associated	  with	  C7	  as	  expected	  (Figure	  3.5C,	  panel	  i).	  Despite	  the	  differences	  between	  their	  wild-­‐type	  littermates,	  the	  abnormalities	  in	  the	  cervical	  vertebrae	  of	  Cbx223KRA/23KRA	  	  are	  clearly	  more	  severe	  than	  those	  in	  Cbx213KRA/13KRA.	  Going	  forward,	  we	  will	  be	  measuring	  the	  length	  of	  the	  C7	  ribs	  in	  the	  animals	  to	  obtain	  a	  quantitative	  description	  of	  the	  phenotype.	  	  
For	  the	  T1-­‐to-­‐T2	  transformation,	  the	  frequency	  of	  occurrence	  is	  higher	  in	  the	  
Cbx223KRA/23KRARA	  mutants	  than	  in	  the	  Cbx213KRA/23KRA	  mutants	  (56%	  vs.	  22%).	  Notably	  this	  transformation	  was	  not	  found	  in	  the	  wild	  type	  animals	  from	  either	  genetic	  background.	  It	  was	  observed	  in	  one	  Cbx223KRA/+	  but	  not	  in	  any	  of	  the	  Cbx213KRA/+	  examined.	  	  The	  T13-­‐to-­‐L13	  transformation	  was	  found	  only	  in	  Cbx223KR/23KRAA	  but	  not	  in	  Cbx213KRA/13KRA.	  There	  is	  no	  difference	  in	  the	  wild	  type	  and	  heterozygous	  mutants	  from	  the	  two	  strains.	  Based	  on	  these	  two	  phenotypes,	  the	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Cbx223KRA	  mutation	  is	  more	  severe	  than	  the	  Cbx213KRA	  mutation.	  	  
The	  L6-­‐to-­‐S1	  transformation	  can	  occur	  unilaterally,	  where	  the	  L6	  vertebra	  assumes	  both	  lumbar	  and	  sacral	  characteristics	  (Figure	  3.5E,	  panel	  iv),	  or	  bilaterally,	  where	  the	  L6	  appears	  identical	  to	  S1	  (Figure	  3.5E,	  panels	  ii	  and	  iii).	  For	  Cbx223KRA/23KRA,	  this	  transformation	  is	  predominantly	  bilateral.	  For	  Cbx213KRA/13KRA,	  the	  frequencies	  for	  both	  types	  of	  changes	  are	  similar.	  Overall,	  taking	  into	  consideration	  both	  unilateral	  and	  bilateral	  changes,	  the	  frequency	  of	  the	  L6-­‐to-­‐S1	  phenotype	  has	  higher	  penetrance	  in	  Cbx223KRA/23KRA	  than	  in	  Cbx213KRA/13KRA	  (89%	  vs.	  55%).	  Similarly,	  the	  mis-­‐attachment	  of	  R7	  can	  be	  unilateral	  (Figure	  3.5D,	  panels	  ii,	  iv,	  v)	  or	  bilateral	  (Figure	  3.5D,	  panel	  iii).	  For	  Cbx213KRA/13KRA,	  the	  frequency	  of	  this	  change	  being	  bilateral	  is	  higher	  than	  it	  being	  unilateral	  (44%	  vs.	  22%).	  In	  contrast,	  only	  unilateral	  changes	  were	  found	  in	  Cbx213KRA/13KRA.	  .	  Again,	  the	  overall	  frequency	  of	  this	  phenotype	  is	  higher	  in	  Cbx223KRA/23KRA	  than	  in	  the	  Cbx213KRA/13KRA	  (66%	  vs.	  33%).	  Thus,	  the	  Cbx223KRA	  mutation	  is	  also	  more	  severe	  based	  on	  these	  two	  phenotypes.	  	  
Therefore,	  we	  conclude	  that	  the	  skeletal	  abnormalities	  collectively	  indicate	  that	  the	  
Cbx223KRA	  mutation	  causes	  more	  severe	  posterior	  transformations	  than	  the	  Cbx213KRA	  mutation.	  This	  correlates	  with	  Cbx223KRA	  being	  less	  active	  than	  Cbx213KRA	  in	  our	  in	  vitro	  assays.	  
We	  want	  to	  highlight	  that	  the	  posterior	  transformations	  in	  the	  Cbx223KRA	  and	  Cbx213KRA	  mutants	  are	  highly	  similar,	  albeit	  with	  different	  degrees	  of	  severity.	  This	  similarity	  is	  despite	  the	  two	  strains	  having	  different	  genetic	  backgrounds	  and	  were	  generated	  using	  distinct	  approaches	  and	  targeting	  constructs.	  This	  suggests	  that	  an	  intact	  compaction	  domain	  is	  essential	  for	  PRC1	  functions	  as	  Hox	  gene	  regulators	  during	  development.	  	  
Posterior	  transformation	  in	  the	  skeleton	  of	  Cbx26KRA/6KRA	  mice	  
We	  also	  analyzed	  the	  skeleton	  preparations	  of	  Cbx26KRA/6KRA,	  Cbx26KRA/+and	  	  Cbx2+/+	  animals.	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As	  CBX26KRA	  is	  more	  active	  than	  CBX213KRA	  in	  vitro,	  we	  predicted	  that	  the	  Cbx26KRA	  mutants	  to	  have	  less	  severe	  homeotic	  phenotypes	  than	  the	  Cbx213KRA	  mutants.	  However,	  contrary	  to	  our	  predictions,	  not	  only	  did	  the	  Cbx26KRA/6KRA	  animals	  have	  all	  the	  homeotic	  transformations	  observed	  in	  the	  
Cbx213KRA13KRA	  animals,	  the	  frequencies	  of	  occurrence	  were	  also	  higher	  (Table	  3.2).	  A	  possible	  explanation	  for	  this	  could	  be	  the	  lower	  level	  of	  CBX2	  protein	  in	  the	  Cbx26KRA	  animals	  (see	  Figure	  3.4B).	  However,	  this	  does	  not	  explain	  why	  the	  transformations	  are	  also	  observed	  more	  frequently	  in	  the	  Cbx26KRA/+	  animals	  than	  in	  the	  Cbx213KRA/+	  animals.	  Curiously,	  two	  out	  of	  the	  nine	  wild	  type	  control	  animals	  have	  C7-­‐to-­‐T1	  and	  T1-­‐to-­‐T2	  transformations,	  respectively,	  that	  resemble	  the	  phenotypes	  of	  Cbx223KRA/23KRA.	  In	  addition,	  six	  out	  of	  seven	  of	  the	  wild	  type	  animals	  have	  small	  cervical	  ribs,	  similar	  to	  those	  observed	  for	  the	  wild	  type	  littermates	  for	  the	  Cbx223KRA	  strain	  (Table	  3.3).	  We	  expected	  the	  wild	  type	  controls	  for	  the	  Cbx26KRA	  and	  Cbx213KRA	  strains	  to	  be	  the	  same	  because	  they	  are	  in	  the	  same	  genetic	  background	  (C57BL/6).	  This	  led	  us	  to	  hypothesize	  that	  there	  is	  background	  mutation	  in	  the	  Cbx26KRA	  strain	  that	  could	  be	  contributing	  to	  the	  phenotype.	  	  To	  test	  this	  hypothesis,	  we	  are	  collecting	  Cbx26KRA/6KRA	  animals	  from	  a	  different	  founder	  animal	  for	  analysis.	  Hence,	  we	  are	  hitherto	  unable	  to	  conclude	  whether	  the	  Cbx26KRA	  mutation	  leads	  to	  similar	  or	  more	  severe	  homeotic	  phenotypes	  compared	  to	  Cbx213KRA.	  
Survival,	  growth	  and	  fertility	  of	  the	  Cbx223KRA,	  Cbx213KRA	  and	  Cbx26KRA	  mutants	  
In	  addition	  to	  sternal	  defects	  and	  posterior	  transformation	  in	  the	  axial	  skeleton,	  which	  are	  the	  classic	  PcG	  phenotypes,	  the	  Cbx2-­‐/-­‐	  mice	  have	  additional	  phenotypes	  as	  described	  below.	  We	  examined	  our	  mutant	  mice	  for	  these	  abnormalities	  to	  determine	  if	  they	  are	  similarly	  affected	  as	  the	  
Cbx2-­‐/-­‐.	  	  



































































































































































	   	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  














































The	  number	  of	  progeny	  from	  successive	  heterozygote	  crosses	  is	  shown	  in	  Figure	  3.6A.	  The	  pups	  were	  counted	  when	  they	  were	  born,	  genotyped	  between	  postnatal	  day	  5	  and	  7	  (P5-­‐7)	  and	  examined	  again	  at	  weaning	  (P21).	  We	  observed	  	  no	  significant	  under-­‐representation	  of	  the	  homozygous	  progeny	  for	  all	  three	  mutant	  alleles.	  
Reduced	  body	  weight:	  Cbx2-­‐/-­‐	  mice	  exhibit	  growth	  retardation	  -­‐	  a	  few	  days	  after	  birth	  they	  weigh	  75%	  less	  compared	  to	  wild	  type	  littermates.	  However,	  these	  phenotypes	  were	  not	  observed	  in	  Cbx223KRA,	  Cbx213KRA	  and	  Cbx26KRA	  homozygous	  mice	  (Figure	  3.6B).	  Therefore,	  we	  conclude	  that	  the	  mutations	  in	  the	  compaction	  domain	  do	  not	  affect	  growth	  of	  the	  animals.	  	   	  
Sex-­‐reversal:	  The	  Cbx2	  gene	  was	  shown	  to	  be	  important	  for	  sex	  determination	  in	  mice	  and	  humans	  (katoh	  1998,	  Lauber	  2009).	  An	  individual	  with	  mutations	  in	  the	  Cbx2	  gene	  can	  be	  genotypically	  XY	  but	  have	  female	  external	  genitalia.	  In	  mice,	  Cbx2-­‐/-­‐	  XY	  and	  XX	  animals	  are	  sterile.	  For	  all	  the	  Cbx223KRA,	  Cbx213KRA	  and	  Cbx26KRA	  homozygous	  male	  and	  female	  animals	  tested,	  we	  observed	  that	  they	  have	  external	  genitalia	  that	  matched	  their	  chromosomal	  sex.	  Both	  male	  and	  female	  homozygous	  mutants	  are	  also	  fertile	  and	  able	  to	  give	  viable	  offspring.	  Hence,	  we	  conclude	  that	  the	  K-­‐to-­‐A	  and	  R-­‐to-­‐A	  mutations	  do	  not	  affect	  the	  role	  of	  Cbx2	  in	  sex	  determination.	  	  
Abnormalities	  in	  soft	  tissue	  organs:	  Finally,	  we	  performed	  histopathology	  examination	  on	  the	  homozygous	  mutant	  mice.	  Emphasis	  was	  given	  to	  the	  colon,	  spleen,	  thymus	  and	  gonads,	  given	  that	  the	  Cbx2-­‐/-­‐	  mice	  develop	  abnormalities	  in	  these	  organs.	  We	  observed	  no	  obvious	  defects	  in	  the	  organs	  of	  our	  mutant	  animals.	  	  






































































Outcome	   Expected	  #	   Observed	  #	  
+/+	   42	   38	  
23KRA/+	   84	   90	  
23KRA/23KRA	   42	   40	   P	  value:	  	   0.64	  TOTAL	   168	   168	  
Outcome	   Expected	  #	   Observed	  #	  
+/+	   54.75	   59	  
13KRA/+	   109.5	   109	  
13KRA/13KRA	   54.75	   51	  TOTAL	   219	   219	   P	  value:	  	   0.74	  
Outcome	   Expected	  #	   Observed	  #	  
+/+	   43.25	   51	  
6KRA/+	   86.5	   82	  
6KRA/6KRA	   43.25	   40	  TOTAL	   173	   173	   P	  value:	  	   0.39	  
A	  
B	  
Figure	  3.6	  	  No	  lethality	  or	  growth	  retardation	  in	  the	  Cbx223KRA,	  Cbx213KRA,	  Cbx26KRA	  mutants.	  	  
A.	  Chi-­‐square	  test	  on	  the	  number	  of	  progeny	  from	  heterozygous	  intercrosses	  of	  the	  mutants.	  B.	  The	  weight	  of	  the	  homozygous	  mutants	  in	  comparison	  to	  their	  heterozygous	  and	  WT	  littermates	  at	  the	  indicated	  ages.	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requirement	  for	  an	  intact	  compaction	  domain	  to	  PcG	  function	  in	  patterning	  the	  anterior-­‐posterior	  axis.	  
	  
DISCUSSION	  	  
In	  summary,	  we	  generated	  two	  mutant	  mice	  with	  the	  knock-­‐in	  alleles	  Cbx223KRA	  and	  
Cbx213KRA,	  respectively,	  which	  express	  CBX2	  variants	  with	  different	  number	  of	  mutations	  in	  the	  compaction	  domain.	  We	  observed	  that	  both	  Cbx223KRA/23KRA	  and	  Cbx213KRA/13KRA	  animals	  have	  posterior	  transformation	  phenotypes	  that	  are	  similar	  to	  those	  in	  Cbx2-­‐/-­‐	  animals,	  indicating	  that	  the	  mutations	  lead	  to	  loss	  of	  function	  in	  CBX2.	  The	  phenotype	  appears	  to	  be	  more	  severe	  in	  
Cbx223KRA/23KRA	  than	  in	  Cbx213KRA/13KRA,	  and	  this	  corresponds	  to	  the	  in	  vitro	  activity	  levels	  of	  their	  respective	  protein	  products.	  Our	  mutants	  exhibited	  the	  PcG	  phenotype	  of	  the	  Cbx2-­‐/-­‐	  animals,	  but	  not	  the	  other	  phenotypes.	  This	  indicates	  that	  the	  mutations	  affected	  a	  specific	  activity	  in	  CBX2,	  which	  is	  consistent	  with	  our	  molecular	  analyses	  in	  the	  previous	  chapter	  which	  indicated	  that	  the	  mutations	  neither	  affected	  CBX2	  incorporation	  into	  PRC1	  nor	  its	  localization	  to	  chromatin.	  This	  alleviated	  concerns	  that	  the	  introduction	  a	  relatively	  large	  number	  of	  amino	  acid	  substitutions	  (23	  and	  13,	  respectively)	  may	  affect	  the	  protein	  and	  the	  PcG	  system	  non-­‐specifically.	  	  
Given	  the	  extensive	  knowledge	  of	  the	  field	  on	  PcG	  mutants	  and	  homeotic	  transformation	  phenotypes,	  the	  posterior	  transformations	  in	  our	  mutants	  are	  almost	  certainly	  due	  ectopic	  Hox	  gene	  expression.	  Nonetheless,	  we	  have	  not	  directly	  demonstrated	  this.	  Thus,	  a	  future	  experiment	  would	  be	  to	  compare	  Hox	  gene	  expression	  patterns	  in	  mutant	  and	  wild	  type	  embryos	  by	  whole	  mount	  in	  situ	  hybridization	  analyses.	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We	  anticipated	  that	  the	  effects	  of	  the	  mutations	  on	  gene	  expression	  would	  be	  larger	  in	  differentiated	  cell	  types	  compared	  to	  what	  was	  observed	  in	  mESCs	  in	  the	  previous	  chapter.	  A	  cellular	  system	  in	  which	  transcriptional	  regulation	  is	  significantly	  perturbed	  by	  the	  mutations	  would	  be	  invaluable	  for	  future	  studies	  that	  aim	  to	  determine	  the	  chromatin	  changes	  that	  accompany	  gene	  repression	  by	  CBX2.	  To	  identify	  such	  a	  cellular	  system,	  we	  have	  performed	  gene	  expressions	  analyses	  on	  tissues	  isolated	  from	  mutant	  and	  wild	  type	  embryos,	  and	  primary	  cell	  lines	  that	  were	  derived	  from	  the	  embryos.	  	  Specifically,	  we	  performed	  RNA-­‐seq	  experiments	  on	  the	  fore-­‐	  and	  hindlimb	  buds	  of	  E10.5	  Cbx213KRA/13KRA	  and	  wild	  type	  embryos.	  The	  choice	  of	  material	  was	  based	  on	  the	  high	  levels	  of	  Cbx2	  expression	  in	  these	  tissues36.	  	  However,	  we	  did	  not	  observe	  obvious	  differences	  in	  the	  gene	  expression	  patterns	  between	  the	  mutant	  and	  wild	  type	  samples	  (data	  not	  shown).	  	  As	  CBX2	  is	  expressed	  in	  primary	  fibroblasts,	  we	  also	  compared	  fibroblasts	  derived	  from	  
Cbx213KRA/13KRA	  and	  wild	  type	  embryos	  for	  the	  expression	  of	  selected	  Hox	  genes	  and	  Cdkn2a	  (a	  PRC1	  target)	  by	  reverse	  transcription-­‐qPCR.	  We	  also	  did	  not	  detect	  significant	  differences	  between	  the	  mutant	  and	  wild	  type	  cells	  (data	  not	  shown).	  Therefore,	  we	  have	  yet	  to	  directly	  demonstrate	  that	  mutating	  the	  compaction	  domain	  of	  CBX2	  would	  lead	  to	  loss	  of	  repression	  at	  PRC1	  target	  genes	  in	  differentiated	  cells.	  	  




CONCLUSIONS	  AND	  FUTURE	  DIRECTIONS	   	  
Through	  the	  Cbx2	  mutant	  mice	  generated,	  we	  were	  able	  to	  link	  the	  requirement	  for	  an	  intact	  compaction	  domain	  to	  the	  genetically	  defined	  PcG	  function	  during	  embryogenesis.	  The	  same	  residues	  in	  CBX2	  are	  required	  for	  chromatin	  remodeling	  inhibition	  and	  polynucleosome	  compaction	  in	  vitro,	  and	  for	  repression	  of	  PRC1	  targets	  in	  mESCs.	  Taken	  together,	  our	  observations	  indicate	  that	  the	  in	  vitro	  activities	  of	  CBX2	  could	  be	  one	  of	  the	  mechanisms	  by	  which	  PRC1	  achieve	  stable	  gene	  silencing	  in	  vivo.	  This	  leads	  to	  several	  immediate	  questions,	  including	  the	  following:	  	  
1. Is	  there	  a	  chromatin	  state	  in	  the	  nucleus	  that	  is	  analogous	  to	  the	  compacted	  polynucleosomes	  seen	  under	  electron	  microscopy?	  How	  might	  we	  assay	  for	  this	  state	  and	  how	  might	  it	  prevent	  transcription?	  2. Are	  the	  identities	  of	  the	  K	  and	  R	  residues	  or	  the	  positive	  charge	  they	  carry	  that	  are	  the	  critical	  features	  for	  CBX2	  function?	  In	  other	  words,	  is	  the	  nature	  of	  the	  CBX2	  and	  nucleosome	  contacts	  driven	  by	  specific	  interactions	  between	  chemical	  groups,	  or	  by	  non-­‐specific	  electrostatic	  interactions?	  	  3. How	  might	  CBX2	  be	  involved	  in	  propagating	  the	  repressed	  state	  through	  cellular	  divisions?	  	  
We	  discuss	  how	  we	  might	  consider	  these	  questions	  in	  the	  next	  chapter.	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MATERIALS	  AND	  METHODS	  
All	  animal	  procedures	  were	  performed	  according	  to	  NIH	  guidelines	  and	  approved	  by	  the	  Committee	  on	  Animal	  Care	  at	  Massachusetts	  General	  Hospital	  and	  Harvard	  University.	  	  
Generation	  of	  Cbx223KRA	  targeting	  construct	  
The	  targeting	  construct	  was	  assembled	  from	  the	  following	  components	  into	  a	  pUC19	  vector	  backbone:	  gBlock	  encoding	  the	  K-­‐to-­‐A	  and	  R-­‐to-­‐A	  mutations	  (Integrated	  DNA	  Technologies,	  IDT);	  homologous	  arms	  PCR	  amplified	  from	  a	  BAC	  clone	  (RP23-­‐272P15);	  thymidine	  kinase	  selection	  cassette	  PCR	  amplified	  from	  the	  plasmid	  PL253	  (ATCC,	  PTA-­‐4998);	  loxP-­‐flanked	  neomycin	  selection	  cassette	  amplified	  from	  a	  standard	  plasmid.	  We	  verified	  the	  construct	  by	  sequencing.	  	  
Production	  of	  sgRNA	  and	  donor	  DNA	  for	  CRISPR-­‐mediated	  gene	  targeting	  
sgRNAs	  (sgRNA-­‐L:	  GCCTTCTGTTCTGGGGGTAGAGG;	  sgRNA-­‐R:	  GAGACCCGTCAGCCTGGC	  CAAGG)	  were	  designed	  using	  Zinc	  Finger	  Targeter	  (ZiFiT)37,38,	  synthesized	  as	  DNA	  oligonucleotides	  (IDT),	  annealed,	  phosphorylated	  and	  cloned	  into	  pX335(Addgene	  plasmid	  #	  42335).	  T7	  promoter	  was	  added	  to	  sgRNA	  template	  by	  PCR	  amplification	  using	  primers	  CLO94/95	  (Appendix,	  Table	  S3).	  The	  T7-­‐sgRNA	  PCR	  product	  was	  gel	  purified	  and	  used	  as	  the	  template	  for	  in	  vitro	  transcription	  using	  MEGAshortscript	  T7	  kit	  (Life	  Technologies).	  sgRNAs	  were	  purified	  using	  MEGAclear	  kit	  (Life	  Technologies)	  and	  eluted	  in	  RNase-­‐free	  water.	  	  
The	  donor	  DNA	  was	  assembled	  from	  the	  following	  components	  into	  a	  pUC19	  vector	  backbone:	  gBlock	  encoding	  the	  K-­‐to-­‐A	  and	  R-­‐to-­‐A	  mutations	  (IDT)	  and	  homologous	  arms	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PCR	  amplified	  from	  a	  BAC	  clone	  (RP23-­‐272P15)	  using	  primer	  pairs	  CLO84/85	  and	  CLO86/87.	  The	  assembled	  donor	  was	  purified	  using	  	  UltraClean	  Endotoxin	  Removal	  (MO	  Bio)	  and	  eluted	  in	  nuclease-­‐free	  water.	  	  
The	  Cas9n	  mRNA	  was	  purchased	  from	  SystemBiosciences	  (CAS504A-­‐1).	  
Genotyping	  by	  PCR	  
Genomic	  DNA	  was	  isolated	  from	  mouse	  toe	  or	  tail	  tip	  tissues	  using	  NucleoSpin	  Tissue	  (Machery-­‐Nagel),	  and	  genotyped	  by	  PCR	  amplification	  using	  primers	  indicated	  in	  the	  figures,	  followed	  by	  gel	  electrophoresis	  analysis	  of	  the	  products.	  Primer	  sequences	  are	  listed	  in	  Appendix	  Table	  S3.	  For	  RFLP	  analysis,	  the	  PCR	  products	  were	  purified,	  treated	  with	  HindIII	  and	  XmaI	  for	  at	  least	  3	  hours	  at	  37degG,	  heat	  inactivated,	  and	  analyzed	  by	  gel	  electrophoresis.	  
Genotyping	  by	  melt	  curve	  analysis	  
Exon	  5	  of	  Cbx2	  is	  amplified	  by	  real-­‐time	  PCR	  using	  the	  primer	  pairs	  gDet23F/gDet24	  and	  iTaq	  Universal	  SYBR	  Green	  Supermix	  (BioRad	  #1725120).	  The	  melt	  curve	  profiles	  were	  generated	  by	  increasing	  the	  temperature	  from	  85.0	  to	  91.0	  degC	  in	  0.1	  degC	  increments,	  and	  analyzed	  using	  Bio-­‐Rad's	  CFX	  Manager™	  software.The	  PCR	  products	  from	  wild	  type	  and	  
Cbx2	  mutant	  alleles	  give	  different	  profiles	  due	  to	  differences	  in	  the	  nucleotide	  sequence.	  We	  verified	  the	  results	  from	  this	  method	  by	  cloning	  and	  sequencing	  the	  PCR	  products.	  	  
Western	  blot	  
Lysates	  were	  prepared	  by	  lysing	  whole	  embryos	  in	  RIPA	  buffer	  (50mM	  Tris-­‐HCl	  pH	  8.0,	  0.1%	  SDS,	  0.5%	  sodium	  deoxycholate,	  1%	  NP40,	  150mM	  NaCl),	  separated	  on	  4-­‐12%	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bis-­‐Tris	  gels,	  transferred	  onto	  nitrocellulose	  membranes	  and	  blotted	  for	  CBX2	  and	  CBX8	  using	  the	  antibodies	  listed	  in	  Appendix	  Table	  S1.	  H3	  levels	  were	  used	  as	  loading	  controls.	  Relative	  protein	  levels	  were	  quantified	  using	  ImageJ.	  	  
	  
Protein	  Purification	  
Flag-­‐tagged	  CBX2	  variants	  and	  untagged	  Ring1b	  were	  expressed	  and	  purified	  as	  previously	  described9.	  Briefly,	  the	  coding	  sequences	  were	  inserted	  into	  pFastBac1.	  Baculovirus	  was	  generated	  following	  the	  Bac-­‐to-­‐Bac®	  system	  procedures	  (Thermofisher).	  The	  proteins	  were	  by	  co-­‐infecting	  Sf9	  cells.	  Sf9	  nuclear	  extracts	  were	  generated	  using	  the	  Dignam	  protocol,	  flash-­‐frozen,	  and	  stored	  at	  -­‐80°C	  until	  needed39.	  To	  purify	  proteins,	  nuclear	  extracts	  were	  thawed	  in	  cold	  water	  and	  then	  incubated	  with	  M2-­‐agarose	  (Sigma	  Aldrich	  A2220)	  at	  4°C	  with	  gentle	  rocking	  for	  4	  hrs.	  The	  M2-­‐agarose	  was	  collected	  by	  centrifuging	  at	  250	  g	  for	  5	  min,	  washed	  in	  batch	  first	  with	  BC	  buffer	  (20mM	  HEPES	  7.5,	  0.2mM	  EDTA,	  20%	  glycerol,	  1mM	  DTT,)	  containing	  500mM	  KCl,	  then	  300mM	  KCl.	  Proteins	  were	  eluted	  in	  BC	  buffer	  plus	  300mM	  KCl	  containing	  0.4	  mg/ml	  flag	  peptide	  and	  quantified	  using	  standard	  techniques.	  
Nucleosome	  Remodeling	  and	  Inhibition	  Assays	  	  
A	  plasmid	  containing	  10	  5S	  nucleosome	  positioning	  sequences	  and	  a	  unique	  centrally	  located	  HhaI	  restriction	  enzyme	  site	  (pG5E4)	  has	  been	  previously	  described40.	  The	  2.5	  kb	  Asp718/ClaI	  G5E4	  fragment	  was	  digested,	  purified,	  and	  end	  labeled	  with	  Cy5.	  Chromatin	  arrays	  were	  assembled	  using	  HeLa	  core	  octamers	  and	  a	  salt-­‐gradient	  assembly	  protocol,	  and	  were	  typically	  80-­‐85%	  assembled	  by	  observing	  background	  cutting	  with	  
94
	  
HhaI41.	  Reactions	  were	  done	  essentially	  as	  described	  in	  .	  PcG	  proteins	  were	  incubated	  with	  0.5-­‐3nM	  nucleosomes	  for	  30	  min	  at	  30°C,	  and	  then	  100ng	  of	  purified	  human	  SWI/SNF	  and	  8	  units	  of	  HhaI	  were	  added	  to	  a	  volume	  of	  20μl.	  The	  reactions	  were	  allowed	  to	  proceed	  for	  1	  hr	  at	  30°C,	  and	  then	  5μl	  of	  stop	  buffer	  was	  added	  and	  reactions	  incubated	  an	  additional	  30	  min	  at	  55°C.	  Final	  reaction	  buffer	  conditions	  were	  as	  follows:	  16	  mM	  HEPES	  7.5,	  80mM	  KCl,	  2mM	  MgCl2,	  1mM	  MnCl2,	  2mM	  ATP,	  2.5	  μg	  BSA,	  8%	  glycerol,	  and	  2	  mM	  DTT.	  Stop	  buffer	  consists	  of	  10mM	  Tris	  7.5,	  70mM	  EDTA,	  1%	  SDS,	  0.1%	  Orange	  G,	  and	  1.5	  mg/ml	  Proteinase	  K.	  After	  completion,	  reactions	  were	  separated	  on	  1%	  agarose	  TAE	  gels	  and	  scanned	  and	  quantified	  using	  a	  Typhoon	  phosphoimager	  and	  ImageQuant	  TL	  software	  (GE	  Healthcare).	  Graphs	  were	  generated	  using	  KaleidaGraph	  graphing	  software	  (Synergy).	  
Skeletal	  analysis	  
Skeletal	  whole	  mounts	  of	  P15-­‐17	  mice	  were	  performed	  on	  completely	  eviscerated	  animals	  with	  the	  skin	  removed.	  Carcasses	  were	  incubated	  in	  96%	  ethanol	  for	  5	  days,	  and	  transferred	  to	  acetone	  for	  2	  days.	  Staining	  was	  performed	  in	  0.005%	  alizarin	  red	  S,	  0.015%	  alcian	  blue	  8GS	  in	  5%	  acetic	  acid,	  5%	  H20,	  and	  90%	  ethanol	  for	  3	  days	  at	  37degC	  or	  5	  days	  at	  room	  temperature.	  Samples	  were	  rinsed	  with	  water	  and	  cleared	  by	  sequential	  incubation	  in	  1%	  KOH	  (2	  days),	  0.8%	  KOH	  and	  20%	  glycerol,	  0.5%	  KOH	  and	  50%	  glycerol,	  and	  0.2%	  KOH	  and	  80%	  glycerol.	  Cleared	  skeletons	  were	  stored	  in	  100%	  glycerol	  
Histological	  analysis	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  CHAPTER	  4	  	  	  
CONCLUSIONS	  AND	  FUTURE	  DIRECTIONS	  
	  We	  tested	  the	  hypothesis	  that	  the	  in	  vitro	  compaction	  activity	  of	  CBX2	  is	  required	  for	  PRC1	  function	  in	  vivo.	  	  In	  Chapter	  2,	  we	  showed	  that	  mutations	  that	  disrupt	  CBX2	  compaction	  activity	  in	  vitro	  prevented	  CBX2	  from	  repressing	  its	  target	  genes	  in	  mouse	  embryonic	  stem	  cells.	  In	  Chapter	  3,	  we	  showed	  that	  the	  same	  mutations	  and	  a	  subset	  of	  them	  caused	  posterior	  transformations	  in	  mice,	  which	  is	  the	  classic	  PcG	  phenotype.	  Together,	  our	  work	  indicates	  that	  the	  in	  vitro	  compaction	  activity	  of	  PRC1,	  as	  conferred	  by	  CBX2,	  is	  essential	  for	  its	  function	  in	  vivo.	  	  In	  the	  following	  sections,	  we	  discuss	  what	  may	  be	  interesting	  future	  research	  directions	  following	  the	  outcome	  of	  our	  study.	  	  
Characterizing	  compacted	  chromatin	  in	  vivo	  	   It	  is	  conceptually	  simple	  to	  see	  how	  PRC1’s	  chromatin	  compaction	  activity	  can	  reduce	  DNA	  accessibility	  to	  transcriptional	  activators	  and	  the	  transcription	  machinery,	  and	  thereby	  repress	  gene	  expression.	  However,	  as	  discussed	  in	  Chapter	  1,	  there	  is	  no	  strong	  evidence	  that	  indicates	  DNA	  accessibility	  is	  markedly	  reduced	  by	  PRC1	  function.	  Moreover,	  unlike	  heterochromatin,	  PcG	  bound	  regions	  are	  more	  dynamic	  than	  previously	  perceived1-­‐3.	  This	  leads	  one	  to	  ask	  what	  are	  the	  characteristics	  of	  PcG	  compacted	  chromatin	  in	  vivo.	  	  In	  the	  previous	  studies,	  the	  assays	  for	  accessibility	  were	  either	  performed	  on	  single	  transgenes,	  or	  on	  one	  or	  two	  endogenous	  PRC1	  targets	  4-­‐7.	  The	  results	  appeared	  to	  be	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sensitive	  to	  the	  nature	  and	  genomic	  location	  of	  the	  locus	  under	  study.	  This	  suggests	  that	  the	  examination	  of	  single	  targets	  is	  insufficient	  for	  providing	  information	  about	  a	  general	  characteristic	  of	  PRC1	  bound	  regions.	  More	  recently,	  a	  genome-­‐wide	  study,	  which	  used	  the	  methylase	  M.SssI	  on	  fly	  S2	  cells,	  showed	  that	  PcG-­‐associated	  regions	  are	  collectively	  less	  accessible	  than	  non-­‐	  PcG-­‐associated	  regions,	  even	  though	  there	  is	  considerable	  variation	  among	  individual	  regions.8	  In	  view	  of	  our	  results	  presented	  here,	  which	  indicate	  that	  chromatin	  compaction	  at	  the	  nucleosomal	  level	  is	  an	  important	  activity	  of	  PRC1	  function,	  it	  seems	  warranted	  that	  we	  re-­‐visit	  the	  concept	  of	  chromatin	  accessibility	  using	  different	  technologies	  or	  approaches.	  This	  will	  inform	  us	  on	  a	  fundamental	  nature	  of	  chromatin	  that	  is	  modulated	  for	  transcriptional	  regulation.	  Several	  methodologies	  have	  been	  developed	  but	  have	  not	  been	  tested	  for	  their	  utilities	  to	  detect	  PcG-­‐dependent	  changes	  in	  the	  genome.	  We	  propose	  to	  apply	  them	  to	  our	  Cbx2	  mutants	  which	  are	  deficient	  in	  the	  compaction	  activity.	  Examples	  of	  these	  include	  micrococcal	  nuclease	  (MNase)	  titration	  and	  ATAC-­‐seq.	  ATAC-­‐seq	  has	  been	  described	  extensively	  elsewhere	  (for	  examples,	  see	  Ref.9),	  and	  hence	  will	  not	  be	  described	  here.	  We	  only	  briefly	  describe	  MNase	  titration	  below.	  	  MNase	  enzyme	  preferentially	  cuts	  linker	  DNA	  on	  chromatin,	  thereby	  producing	  DNA	  fragments	  which	  correspond	  to	  nucleosomal	  DNA	  that	  run	  in	  a	  signature	  150bp	  laddering	  pattern	  on	  gel	  electrophoresis	  analysis.	  It	  was	  observed	  that	  different	  amounts	  of	  MNase	  used	  for	  chromatin	  digestion	  releases	  distinct	  populations	  of	  nucleosomal	  DNA,	  which	  presumably	  reflect	  different	  degrees	  of	  nucleosome	  occupancy	  in	  the	  genome.	  Specifically,	  at	  low	  MNase	  concentrations,	  DNA	  around	  labile	  nucleosomes	  is	  recovered	  while	  at	  higher	  MNase	  concentrations,	  DNA	  around	  refractory	  nucleosomes	  is	  recovered.	  The	  behavior	  of	  a	  DNA	  region	  in	  response	  to	  digestion	  with	  a	  series	  of	  MNase	  concentration	  (hence,	  titration)	  can	  be	  measured	  in	  a	  metric	  called	  MNase	  accessibility	  score	  (MACC)	  (Tolstorukov	  M.	  et.al,	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manuscript	  under	  review).	  Work	  in	  our	  lab	  has	  shown	  that	  MACC	  is	  low	  	  (i.e.	  low	  accessibility)	  for	  nucleosomes	  in	  PcG-­‐bound	  regions	  in	  fly	  S2	  cells	  and	  human	  K562	  cells,	  compared	  to	  genome	  average.	  Importantly,	  the	  low	  MACC	  score	  at	  PcG-­‐bound	  regions	  in	  flies	  is	  alleviated	  by	  PcG	  knockout	  mutations,	  suggesting	  that	  MACC	  could	  be	  used	  as	  readout	  for	  PRC1-­‐dependent	  compaction.	  It	  would	  be	  interesting	  to	  determine	  whether	  mutation	  in	  the	  CBX2	  compaction	  domain	  would	  alter	  MACC	  in	  the	  mouse	  genome.	  	  
Elucidating	  the	  CBX2-­‐nucleosome	  interaction	  	   How	  the	  compaction	  domain	  of	  CBX2	  interfaces	  with	  chromatin	  to	  achieve	  compaction	  is	  unknown.	  The	  fact	  that	  it	  is	  intrinsically	  disordered	  and	  has	  high	  positive	  charge	  presents	  two	  possibilities.	  	  	   The	  first	  model	  involves	  non-­‐directed	  electrostatic	  interactions	  between	  the	  positively	  charged	  domain	  and	  the	  negatively	  charged	  DNA.	  The	  configuration	  a	  chromatin	  fiber	  is	  highly	  sensitive	  to	  the	  ionic	  condition	  of	  its	  surroundings;	  it	  spontaneously	  folds	  into	  higher	  order	  structures	  in	  the	  presence	  of	  high	  cation	  concentrations10.	  It	  is	  conceivable	  that	  the	  compaction	  domain	  of	  CBX2	  behaves	  like	  a	  series	  of	  regulated	  cations	  that	  is	  brought	  to	  the	  vicinity	  of	  chromatin	  by	  PRC1	  to	  induce	  chromatin	  folding.	  	  	   The	  second	  model	  involved	  specific	  interactions	  between	  functional	  groups	  on	  the	  compaction	  domain	  and	  chromatin.	  It	  is	  known	  that	  a	  region	  with	  intrinsic	  disorder	  may	  become	  folded	  upon	  interaction	  with	  other	  proteins.	  This	  could	  be	  the	  case	  for	  the	  compaction	  domain	  in	  CBX2,	  where	  upon	  its	  contact	  with	  chromatin	  becomes	  ordered	  and	  presents	  certain	  amino	  acid	  sides	  chains	  for	  interaction	  with	  the	  nucleosomes.	  In	  fact,	  structural	  studies	  with	  other	  nucleosome	  binding	  proteins	  suggest	  that	  this	  could	  be	  a	  common	  feature	  of	  protein-­‐nucleosome	  interactions.	  The	  protein-­‐nucleosome	  interfaces	  frequently	  involve	  arginine	  side	  chains	  from	  the	  protein	  making	  contacts	  with	  the	  acidic	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patch	  on	  the	  nucleosome	  face11-­‐15.	  This	  led	  to	  the	  ‘arginine	  anchor’	  hypothesis	  for	  protein-­‐nucleosome	  interactions.	  	  	   For	  our	  CBX2	  compaction	  mutants,	  we	  mutated	  both	  lysine	  (K)	  and	  arginine	  (R)	  residues	  to	  alanine,	  which	  removed	  both	  positive	  charge	  and	  the	  side	  chains	  that	  provided	  the	  charge;	  hence,	  we	  are	  unable	  to	  distinguish	  between	  the	  two	  models	  of	  interaction	  with	  our	  mutants.	  	  To	  separate	  charge	  from	  functional	  group,	  one	  can	  generate	  CBX2	  variants	  with	  all	  R-­‐to-­‐K	  and	  all	  K-­‐to-­‐R	  amino	  acid	  substitutions	  in	  the	  compaction	  domain	  and	  compare	  their	  
in	  vitro	  activity	  levels.	  These	  mutations	  do	  not	  alter	  the	  overall	  charge	  of	  the	  protein	  but	  modify	  the	  functional	  groups	  available.	  Through	  systematically	  comparing	  a	  series	  of	  CBX2	  variants	  with	  R-­‐to-­‐K	  and	  K-­‐to-­‐R	  changes	  at	  different	  residues,	  one	  may	  be	  able	  to	  identify	  the	  critical	  arginine	  residue(s),	  if	  indeed	  the	  arginine	  anchor	  hypothesis	  applies	  to	  CBX2.	  Alternatively,	  one	  may	  attempt	  to	  obtain	  information	  about	  CBX2-­‐nucleosome	  interaction	  via	  structural	  approaches	  such	  as	  X-­‐ray	  crystallography	  or	  high-­‐resolution	  cryo-­‐electron	  microscopy.	  
	  
Propagation	  of	  the	  repressed	  state	  	   PcG-­‐mediated	  repression	  needs	  to	  be	  propagated	  through	  cellular	  division	  in	  order	  to	  be	  inherited	  in	  daughter	  cells.	  This	  entails	  transmitting	  the	  associated	  chromatin	  states	  through	  mitosis,	  or	  rapidly	  restoring	  them	  in	  the	  following	  G1	  phase.	  	  	   The	  kinetics	  of	  CBX2	  binding	  on	  interphase	  chromatin	  and	  mitotic	  chromosomes	  are	  very	  different.	  In	  interphase,	  CBX2’s	  association	  with	  chromatin	  is	  dynamic,	  where	  its	  chromatin	  bound	  and	  nucleoplasmic	  fractions	  interchange	  rapidly16.	  In	  mitosis,	  however,	  CBX2	  becomes	  immobilized	  on	  the	  chromosomes,	  along	  with	  Ring1B,	  Mel-­‐18	  and	  Phc1,	  which	  are	  subunits	  of	  the	  canonical	  PRC117.	  Similar	  observations	  have	  been	  reported	  for	  the	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fly	  system,	  where	  sub-­‐fractions	  of	  PC,	  PH	  and	  PSC	  stay	  immobilize	  on	  chromosomes	  during	  mitosis18,19.	  The	  stable	  binding	  of	  PRC1	  components	  on	  mitotic	  chromosomes	  suggest	  that	  they	  may	  be	  retained	  to	  ‘bookmark’	  key	  sites	  so	  that	  PcG	  repressed	  regions	  can	  be	  rapidly	  restored	  following	  cell	  division.	  	  	   Among	  the	  five	  mammalian	  PC	  homologs	  CBX2/4/6/7	  and	  8,	  only	  CBX2	  immobilizes	  on	  mitotic	  chromosomes17.	  Its	  recruitment	  to	  chromosomes	  is	  independent	  of	  the	  other	  PRC1	  subunits	  and	  PRC2.	  Conversely,	  it	  is	  required	  for	  their	  recruitment.	  The	  chromodomain	  of	  CBX2	  is	  necessary	  for	  its	  own	  recruitment,	  while	  its	  C-­‐box	  domain	  is	  necessary	  for	  its	  immobilization.	  The	  chromodomain	  and	  C-­‐box	  domains	  are	  conserved	  in	  the	  other	  CBX	  proteins,	  but	  are	  insufficient	  for	  their	  retentions	  on	  chromosomes.	  This	  indicates	  that	  additional	  regulatory	  factors,	  and/or	  the	  non-­‐homologous	  regions	  of	  CBX2	  must	  also	  contribute	  to	  its	  unique	  binding	  properties.	  The	  compaction	  domain	  which	  we	  showed	  to	  be	  important	  for	  PcG	  function	  is	  a	  unique	  feature	  of	  CBX2;	  it	  will	  be	  interesting	  to	  determine	  whether	  it	  is	  required	  for	  CBX2	  association	  with	  mitotic	  chromosomes.	  	  	  	   The	  expression	  levels	  of	  Cbx2	  in	  whole	  embryos	  and	  adult	  tissues	  appear	  to	  correlate	  with	  the	  rate	  of	  cellular	  division.	  For	  example,	  CBX2	  level	  is	  generally	  lower	  in	  adult	  tissues	  compared	  to	  embryos,	  consistent	  with	  the	  adult	  tissues	  having	  lower	  mitotic	  indexes20.	  Among	  the	  adult	  tissues,	  CBX2	  is	  high	  in	  organs	  with	  active	  cell	  proliferation	  such	  as	  the	  bone	  marrow,	  liver	  and	  intestines,	  but	  is	  negligible	  in	  post-­‐mitotic	  tissues	  such	  as	  the	  brain,	  heart	  and	  muscle21.	  From	  these	  observations,	  together	  with	  CBX2	  immobilization	  on	  mitotic	  chromosomes,	  one	  may	  hypothesize	  that	  CBX2,	  in	  the	  context	  of	  PRC1,	  has	  a	  fundamental	  role	  in	  propagating	  cellular	  identities	  in	  rapidly	  dividing	  cells.	  Therefore,	  increased	  molecular	  and	  mechanistic	  understanding	  of	  CBX2	  may	  yield	  promising	  insights	  into	  the	  mechanisms	  of	  epigenetic	  inheritance.	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  APPENDIX	  	  	  
Table	  S1	  	  Antibody	  list	  The	  amounts	  used	  for	  the	  various	  applications	  are	  indicated.	  	  	  
	  	  	  
Table	  S2	  	  Taqman	  probe	  list	  	  
Gene	  	   Assay	  ID	  Sall3	   Mm01265835_m1	  Wt1	   Mm01337048_m1	  Six1	   Mm00808212_m1	  Ebf1	   Mm01288946_m1	  Mllt10	   Mm00487708_m1	  B2m	   Mm00437762_m1	  Hprt	   Mm00446968_m1	  Pou5f1	   Mm00658129_gH	  Nanog	   Mm02384862_g1	  Actb	   Mm00607939_s1	  
Antibodies	   Company	   Catalog	  Number	   ChIP	   IP	   Western-­‐blot	  CBX2	   Bethyl	  Laboratories	  Inc	   A302-­‐524A	   4ug	   	   	  CBX2	  (C-­‐18)	   Santa-­‐Cruz	   sc-­‐19297	   	   	   1/500	  CBX7	   Abcam	  Inc	   ab21873	   4ug	   	   	  CBX7	   EMD	  Millipore	   07-­‐981	   	   	   1/2000	  CBX7	  (G-­‐3)	   Santa-­‐Cruz	   sc-­‐376274	   	   	   1/500	  CBX8	   Bethyl	  Laboratories	  Inc	   A300-­‐882A	   	   	   1/1000	  H2AK119Ub	   Cell	  Signaling	  Technology	   8240S	   4ug	   	   	  H3	   Abcam	  Inc	   ab1791	   	   	   1/10,000	  H3K27me3	   EMD	  Millipore	   07-­‐449	   4ug	   	   	  HA	   Covance	  Research	  Inc	   MMS-­‐101P	   	   	   1/2000	  HA	   Abcam	  Inc	   ab9110	   	   	   1/2000	  Phc1	   Active	  Motif	   39723	   	   	   1/2000	  Rabbit	  IgG	   Abcam	  Inc	   ab37415	   	   4ug	   	  Ring1B	   Bethyl	  Laboratories	  Inc	   A302-­‐869A	   4ug	   4ug	   	  Ring1B	   Active	  Motif	   39663	   	   	   1/2000	  TBP	   Abcam	  Inc	   ab818	   	   	   1/2000	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Table	  S3	  Primer	  list	  	  
ChIP	  primers	  Mllt10_F	   CAATGCCTCGTCACAGCTAATA	  	  Mllt10_R	   GCCTCCTGTGAAAGTGAAAGA	  	  Sall3_F	   CAGAGATGGAACTGGTGCTTTA	  Sall3_R	   GCCCAGAGTACAGTGTGTTAG	  Wt1_F	   GGAAGTGTTGGGAATCTCTCTT	  Wt1_R	   CTCCAGGGATTTGGTTCGTATC	  Six1_F	   CACTGTCCCGAGAAACATAGAG	  	  Six1_R	   GTATGAGGAGAGGATAGGGATAGG	  Ebf1_F	   CTCCTGACTTCTGTGTGGTTT	  	  Ebf1_R	   CTGAGTCCTGGTTACACATAGC	  	  Gata6-­‐F	   GCTCCTTTCCCAGAGCGTTGAAT	  Gata6-­‐R	   CCCTCCTTCCAAATTAAGCCC	  Hoxa11-­‐F	   GGAAGTAAGCAGAAAGATACAGGGAAGG	  Hoxa11-­‐R	   TTTGTCAATAATCCGCGCTGTCCG	  Sox17-­‐F	   TTACTTGTGGCATTTGTGGCTGGC	  Sox17-­‐R	   CAGCAGTGTGAGTGGGCCATATTT	  Gene	  desert_F	   CCACTCTTCTTATAGGACCCTTTG	  Gene	  desert_R	   CCTGTCTACCTGTTCTTTACATTCT	  Gata1_F	   GATCACCCTGAACTCGTCATAC	  Gata1_R	   TTTGGGAATCAAGACTGACCTG	  	   	  Cloning	  and	  genotyping	  primers	  CLO75	   GGAGTCTAGGTCGCTGTCGT	  CLO84	   GTGAATTCGAGCTCGGTACCCGCTCTGCGGGGCTAACCGC	  CLO85	   AGAGGACGAACTGCTGGATTTGGA	  CLO86	   CATGAGCCAGAGTCAGGTTCAGGC	  CLO87	   TTGCATGCCTGCAGGTCGACTCAGCACTAGACTTATCTCC	  CLO94	   TTAATACGACTCACTATAGG	  CLO95	   AAAAGCACCGACTCGGTGCC	  gDet23	   GAACCAGATGCGCCATCCAAATC	  gDet24	   TCATGTAGTGTACGATGGAGC	  gDet28	   GGTGGTCAGACTAGGAACACAGAAAT	  gDet33	   CCGATTCGCAGCGCATCGCCTTCTATCGCC	  gDet39	   GAATCAACGCCATAACTTCG	  seqP28	   CCCCTATTGGAGCTAGAGCA	  seqP37	   AGTTTGCCTGTGGGTTTGAG	  seqP55	   AAAGGCACCAAATTGGGATT	  	  
107
